US20040186551A1 - Multiple independent nested stent structures and methods for their preparation and deployment - Google Patents

Multiple independent nested stent structures and methods for their preparation and deployment Download PDF

Info

Publication number
US20040186551A1
US20040186551A1 US10/738,666 US73866603A US2004186551A1 US 20040186551 A1 US20040186551 A1 US 20040186551A1 US 73866603 A US73866603 A US 73866603A US 2004186551 A1 US2004186551 A1 US 2004186551A1
Authority
US
United States
Prior art keywords
rings
stent
structures
expansible
axially extending
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/738,666
Inventor
Stephen Kao
Bernard Andreas
Hanson Gifford
Mark Deem
David Snow
Jeffry Grainger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xtent Inc
Original Assignee
Xtent Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xtent Inc filed Critical Xtent Inc
Priority to US10/738,666 priority Critical patent/US20040186551A1/en
Priority to US10/814,593 priority patent/US8080048B2/en
Assigned to XTENT, INC. reassignment XTENT, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KAO, STEPHEN
Publication of US20040186551A1 publication Critical patent/US20040186551A1/en
Priority to US12/061,951 priority patent/US20080208318A1/en
Priority to US12/109,477 priority patent/US20080208311A1/en
Priority to US12/492,828 priority patent/US8282680B2/en
Priority to US13/599,957 priority patent/US8740968B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/826Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents more than one stent being applied sequentially
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/828Means for connecting a plurality of stents allowing flexibility of the whole structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91508Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91516Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • A61F2002/9583Means for holding the stent on the balloon, e.g. using protrusions, adhesives or an outer sleeve

Definitions

  • the present invention relates generally to medical devices and methods. More particularly, the present invention relates to apparatus and methods for delivering a plurality of separate luminal prostheses within a body lumen, such as a blood vessel.
  • Coronary artery disease is the leading cause of death and morbidity in the United States and Western society.
  • atherosclerosis in the coronary arteries can cause myocardial infarction, commonly referred to as a heart attack, which can be immediately fatal or, even if survived, can cause damage to the heart which can incapacitate the patient.
  • coronary artery bypass surgery can be an effective treatment for stenosed arteries resulting from atherosclerosis or other causes, it is a highly invasive procedure which is also expensive and which requires substantial hospital and recovery time.
  • Percutaneous transluminal angioplasty commonly referred to as balloon angioplasty
  • balloon angioplasty is less invasive, less traumatic, and significantly less expensive than bypass surgery.
  • balloon angioplasty has not been considered as effective a treatment as bypass surgery.
  • the effectiveness of balloon angioplasty has improved significantly with the introduction of stenting, which involves the placement of a scaffold structure within an artery that has been treated by balloon angioplasty.
  • the stent inhibits abrupt reclosure of the artery and has some benefit in inhibiting subsequent restenosis resulting from hyperplasia.
  • Presently available stents may be generally categorized as either “closed cell configurations” or “open cell configurations.” Closed cell configurations are characterized by ellipses, ovals, and polygonal structures, such as closed boxes, rhomboids, diamonds, and the like, which open in the circumferential direction and shorten in the axial direction as the stent is expanded. Open cell configurations include zigzag and serpentine structures which may be formed as a plurality of discreet rings or may be formed from a single continuous wire or other element. Closed cell stents are advantageous in that they provide better coverage of the blood vessel wall when the stent is deployed.
  • U.S. Pat. Nos. 6,200,337 and 5,870,381 describe stents having closed cell rings with overlapping portions connected by axial connecting members.
  • U.S. Pat. No. 6,375,676 describes a stent having open cell rings with overlapping portions connected by axial connecting members.
  • U.S. Patent Application Publication Nos. 2002/0188343 and 2002/0188347 describe expandable stents having interconnecting elements which interlock circumferentially adjacent bridges between axially adjacent stent segments.
  • U.S. Pat. No. 4,580,568 describes the sequential placement of a plurality of zigzag ring stents where the stents may optionally be overlapped (FIGS. 7 and 8).
  • U.S. Pat. No. 6,319,277 describes a stent formed from a single element into a plurality of nested “waves.”
  • U.S. Pat. No. 5,554,181 describes a stent formed from a single element into partially overlapping windings.
  • Other patents of interest include U.S. Pat. Nos. 6,312,458; 5,879,370; 5,755,776; 5,507,771; and 5,104,404.
  • U.S. Pat. No. 6,258,117 BI describes a stent having multiple sections connected by separable or frangible connecting regions. Optionally, the connecting regions are severed after the stent structure has been implanted in the blood vessel.
  • the present invention provides methods and apparatus for prosthesis placement, such as stenting of body lumens, typically blood vessels, and more typically coronary arteries.
  • the methods and systems will also find significant use in the peripheral vasculature, the cerebral vasculature, and in other ducts, such as the biliary duct, the fallopian tubes, and the like.
  • the terms “stent” and “stenting” are defined to include any of the wide variety of expandable prostheses and scaffolds which are designed to be intraluminally introduced to a treatment site and expanded in situ to apply a radially outward force against the inner wall of the body lumen at that site.
  • the stents and prostheses of the present invention commonly comprise a closed or, less preferably, an open lattice structure, and are typically formed from a malleable or elastic metal.
  • a malleable metal such as stainless steel, gold, platinum, titanium, and super alloys
  • the stents When formed from a malleable metal, such as stainless steel, gold, platinum, titanium, and super alloys, the stents will typically be expanded by a balloon which causes plastic deformation of the lattice so that it remains opened after deployment.
  • an elastic metal including super elastic metals such as nickel-titanium alloys, the lattice structures will usually be radially constrained when delivered and deployed by releasing the structures from such radial constraint so that they “self-expand” at the target site.
  • grafts When the stent or lattice structures are covered with a fabric or polymeric membrane covering, they are commonly referred to as grafts. Grafts may be used for the treatment of aneurysms or other conditions which require placement of a non-permeable or semi-permeable barrier at the treatment site.
  • the terms “stent” and “stent structures” refer broadly to all radially expansible stents, grafts, and other scaffold-like structures which are intended for deployment within body lumens.
  • the stents and stent structures of the present invention may have any of a variety of common constructions, including closed cell constructions such as expansible ovals, ellipses, box structures, expandable diamond structures, expandable rhomboid structures, as well as other regular and irregular polygonal structures, etc.
  • the closed cells may have complex slotted geometries, such as H-shaped slots, I-shaped slots, J-shaped slots, etc.
  • Suitable open cell structures include zigzag structures, serpentine structures, and the like.
  • Such conventional stent structures are well described in the patent and medical literature. Specific examples of suitable stent structures are described in the following U.S. Patents, the full disclosures of which are incorporated herein by reference: U.S. Pat.
  • stents will comprise a plurality of independent expansible rings each having a length of 1 mm or greater, usually 2 mm or greater, and sometimes of 3 mm or greater, usually being in the range from 1 mm to 10 mm, typically from 2 mm to 7 mm, more typically from 2 mm to 5 mm.
  • the use of such short ring lengths is advantageous since the overall stent length will be a multiple of the ring length.
  • the methods and apparatus of the present invention will provide for the deployment of a plurality of stents or other prostheses from a common stent delivery catheter.
  • the number of delivered stents will be in the range from 2 to 50, typically from 3 to 30, and most typically from 3 to 25.
  • the individual stent length will often be somewhat less, although this is not necessarily the case in all instances.
  • the multiple prostheses may be deployed individually or in groups of two or more at a single location or at multiple spaced-apart locations in the body lumen or lumens.
  • stent structures will comprise a plurality of radially expansible rings, as generally described above, arranged along an axial line. Expansible rings are arranged adjacent to each other and will include axially extending elements which interleave or nest with similarly axially extending elements on adjacent rings.
  • interleaved it is meant that the axially extending elements on adjacent rings will interpenetrate with each other in an axial direction, at least prior to stent expansion and preferably even after stent expansion.
  • the interpenetrating elements will not overlap, i.e., be positioned one over another in the radial direction, but it is possible that in some implementations there may be some overlapping prior to or even after expansion.
  • the axial interpenetration will be at least 0.1 mm, usually being at least 1 mm, and often being in the range from 1 mm to 5 mm, and will of course depend on the axial length(s) of the adjacent ring(s). Expressed as a percentage, the axial length of the axially extending elements will usually be at least 5% of the axial length of the ring, usually being from 5% to 50%, and preferably being from 20% to 30%.
  • the axially extending elements on adjacent rings will interleave without interlocking so as to permit axial separation between the adjacent rings prior to expansion of the rings.
  • axially extending elements may, in some instances, also interpenetrate in a peripheral direction prior to expansion.
  • Such peripheral interpenetration can provide axial interlocking of the axially adjacent expansible rings prior to expansion. It will usually be desirable or even necessary that the peripheral interpenetration be relieved during radial expansion of the stent structures so that the independent rings be released from each other when deployed.
  • a tether or other types of links may be provided to interconnect or otherwise restrain the rings even after expansion and deployment.
  • each expansible ring will preferably comprise expansible closed cell structures, as set forth above. Less preferably, the expansible rings may comprise expansible open cell structures, as set forth above. The lengths and diameters of the individual rings have been set forth generally above.
  • the stent structure will typically comprise from 2 to 50 individual rings, usually from 3 to 30 individual rings, and often from 3 to 25 individual rings.
  • the spacing between adjacent rings may be uniform or non-uniform, preferably being uniform.
  • the stent structures will be configured to shorten upon expansion to increase the spacing between rings. It is usually preferable that the edges of the adjacent rings not overlap, at least prior to deployment. Deployment of the stents, particularly in curved and tortuous luminal regions, may sometimes result in touching and overlapping of the stent rings.
  • the stent structures may be modified in a variety of ways which are used with other conventional stents.
  • some or all of the radially expansible rings may releasably carry a biologically active agent, such as an agent which inhibits hyperplasia.
  • anti-hyperplasia agents include anti-neoplastic drugs, such as paclitaxel, methotrexate, and batimastal; antibiotics such as doxycycline, tetracycline, rapamycin, everolimus and other analogs and derivatives of rapamycin, and actinomycin; amino suppressants such as dexamethasone and methyl prednisolone; nitric oxide sources such as nitroprussides; estrogen; estradiols; and the like.
  • anti-neoplastic drugs such as paclitaxel, methotrexate, and batimastal
  • antibiotics such as doxycycline, tetracycline, rapamycin, everolimus and other analogs and derivatives of rapamycin, and actinomycin
  • amino suppressants such as dexamethasone and methyl prednisolone
  • nitric oxide sources such as nitroprussides; estrogen; estradiols; and the like.
  • a stent deployment system comprises an elongate carrier having a central axis and including a plurality of radially expansible rings arranged over a surface thereof. At least some of the radially expansible rings will have the features and characteristics just described with respect to the present invention.
  • the elongate carriers of the stent deployment systems will typically comprise a radially expansible balloon having an outer surface where the radially expansible rings are disposed over the outer surface of the balloon.
  • the balloon may comprise a single inflation chamber in which case all of the rings will be expanded simultaneously.
  • the balloon may comprise a plurality of independently inflatable chambers so that individual expansible rings may be deployed separately from the other rings.
  • the elongated carrier of the stent deployment system may alternatively comprise a carrier tube having an inner surface which carries and constrains the radially expansible rings.
  • the expansible rings will usually be self-expanding, i.e., held in a radially constrained configuration by the carrier tube prior to release and expansion at a luminal target site.
  • the carrier tube structures will further comprise a pusher tube arranged to axially advance the radially expansible rings from the carrier tube.
  • the elongated carrier may still further comprise a balloon arranged to receive and expand individual rings as they advance from the carrier tube, in which case the carrier may be used for delivering the formable (balloon-expansible) stent structures.
  • such a balloon may also be used with self-expanding stent structures to control or enhance expansion, to perform predilatation of a lesion prior to stent deployment, or to further expand the stent structures and dilate the vessel lumen after the structures have self-expanded.
  • multiple independent stent rings are arranged on a carrier by the following methods.
  • An elongated carrier structure is provided and a plurality of radially expansible rings comprising axially extending elements are mounted on the carrier structure such that the axially extending elements on adjacent rings interleave or nest after they are mounted.
  • the number of rings mounted on the carrier is selected to provide a desired overall stent length, and the number of rings is typically in the ranges set forth above, providing overall stent lengths in the range from 6 mm to 120 mm, usually from 9 mm to 100 mm, and typically from 12 mm to 50 mm.
  • Other aspects of the individual radially expansible rings have been described above.
  • methods for stenting a body lumen comprise delivering to the body lumen a stent structure having a plurality of radially expansible rings.
  • the rings are as described above with respect to other aspects of the present invention, and at least some of the rings are expanded within the body lumen so that the axially extending elements open and axially move apart from each other as they radially expand.
  • the length of the axially extending elements and degree of radial expansion will be selected so that the elements remain interleaved even after being fully expanded within the body lumen.
  • Such an interleaving structure enhances the continuity of lumenal wall coverage provided by the deployed stent structure.
  • Target body lumens are typically blood vessels, more typically arteries, such as coronary arteries.
  • the rings may be delivered simultaneously, typically using a single inflatable balloon, or sequentially, typically using a carrier tube, pusher tube and optionally deployment balloon.
  • Methods may be used for delivering from 3 to 50 rings, usually from 3 to 30 rings, and typically from 3 to 25 rings, to cover a luminal length in the range from 6 mm to 120 mm, usually from 9 mm to 100 mm, and typically from 12 mm to 50 mm.
  • FIG. 1 is a schematic illustration of a stent structure according to the present invention comprising a plurality of closed cell ring structures.
  • FIG. 2 illustrates the stent structure of FIG. 1 shown in its radially expanded configuration.
  • FIGS. 2A and 2B illustrate the difference in deployed configuration of non-nested and nested stent structures, respectively.
  • FIG. 3 illustrates a stent structure constructed in accordance with the principles of the present invention comprising a plurality of open cell expansible rings.
  • FIG. 4 illustrates the stent structure of FIG. 3 shown in its radially expanded configuration.
  • FIG. 5 illustrates a first exemplary expansible ring structure in accordance with the principles of the invention.
  • FIG. 6 illustrates a stent structure comprising a plurality of the ring structures of FIG. 5, shown in a rolled out radially collapsed configuration.
  • FIGS. 6A and 6B illustrate variations on the ring structure of FIG. 6, where the variations are chosen to inhibit axial separation of the ring structures prior to deployment.
  • FIG. 7 illustrates the stent structure of FIG. 6 shown in its radially expanded configuration.
  • FIG. 8 illustrates a second exemplary expansible ring structure in accordance with the principles of the present invention.
  • FIG. 9 illustrates a stent structure comprising a plurality of the rings of FIG. 8.
  • FIG. 10 illustrates the stent structure of FIG. 8 in its radially expanded configuration.
  • FIGS. 11-14 illustrate further exemplary expansible ring structures in accordance with the principles of the present invention.
  • FIGS. 15A and 15B illustrate a further embodiment of a stent structure according to the present invention shown in unexpanded and expanded configurations, respectively.
  • FIGS. 16A and 16B illustrate a still further embodiment of a stent structure according to the present invention shown in unexpanded and expanded configurations, respectively.
  • FIGS. 17A and 17B illustrate deployment of a closed cell stent structure according to the present invention with both a balloon having a single chamber (FIG. 16) and a balloon having multiple chambers to permit selective delivery of portions of the stent structure (FIG. 17).
  • FIGS. 18A-18D illustrate deployment of a plurality of a expansible rings which form a stent structure according to the present invention using a delivery tube and pusher tube in combination with an expansion balloon.
  • FIG. 19 illustrates a kit constructed in accordance with the principles of the present invention.
  • FIGS. 20A-20B, 21 A- 21 B, and 22 A- 22 B illustrate further embodiments of stent structures according to the invention in unexpanded and expanded configurations.
  • the present invention provides apparatus, systems, and methods for preparing and delivering stent structures comprising a plurality of “separate” or “discreet” radially expansible ring segments.
  • “separate” or “discreet” it is meant that the ring segments are unconnected (or easily disconnected) at the time they are delivered to a target body lumen.
  • the ring segments will be closely packed to provide a relatively high degree of vessel wall coverage after they are expanded. By disconnecting the adjacent segments, however, such a tightly packed structured can retain a very high degree of flexibility permitting delivery and conformance in even highly torturous regions of the vasculature and other body lumens.
  • the ability to closely pack the expansible ring segments and achieve a high degree of vessel wall coverage is achieved at least partly because at least some of the axially adjacent rings comprise axially extending elements which interleave or nest with axially extending elements on an adjacent connected ring.
  • the axially extending elements will be formed from a radially expansible portion of the ring, e.g., the element will be part of the closed cell structure or open cell structure as described in more detail hereinbelow.
  • these expansible sections will typically foreshorten as they are radially expanded, interleaving and nesting the segments on adjacent rings prior to expansion minimizes or preferably eliminates any gaps in coverage after the stent is expanded, as described in more detail below.
  • the stent structures of the present invention may be fabricated as either balloon-expansible or self-expanding stents according to methods well known in the art.
  • Typical deformable materials suitable for fabricating balloon-expansible stent structures include 316L stainless steel, gold, platinum, cobalt chrome, platinum, and the like.
  • Suitable resilient materials for self-expanding stents include nickel titanium alloys, various spring stainless steel alloys, Eligloy® alloy, and the like. It will also be possible to form the stent structures of the present invention from both natural and synthetic polymers. Natural polymers include collagen, gelatin, chitin, cellulose, and the like.
  • Suitable synthetic polymers include polyglycolic acids (PGA), polylactic acids (PLA), poly ethylene glycols (PEG), polyamides, polyimides, polyesters, and the like. In some instances, it would be possible to form different radially expansible segments from different materials in order to achieve different properties.
  • the stent structures will comprise a plurality of the individual radially expansible ring segments with typical dimensions, numbers, and the like, described above in the summary.
  • the plurality of ring segments will be arranged prior to delivery, in a manner suitable for delivery to and deployment within a target blood vessel or other body lumen.
  • the plurality of radially expansible rings will be arranged along an axial line, typically defined by a deployment balloon, a delivery tube, or some combination thereof.
  • the expansible ring segments will be arranged so that the axially extending elements on each of the segments is interleaved with corresponding axial extending elements on adjacent but unconnected ring segments. Referring now to FIGS. 1-4, such arrangements will be generally described for both closed cell ring structures (FIGS. 1 and 2) and open cell ring structures (FIGS. 3 and 4).
  • FIG. 1 a portion of a stent structure 10 comprising a plurality of radially expansible rings 12 is illustrated.
  • Each radially expansible ring 12 includes a plurality of closed rhomboid or diamond structures 14 circumferentially joined by connectors 16 .
  • the stent structure 10 is shown in a “rolled-out” configuration, and that only a portion of the structure is depicted for simplicity.
  • the stent structure would contain a greater number of expansible rings 12 , and each ring would include a larger number of rhomboid cells.
  • FIG. 1 illustrates that each rhomboid cell 14 includes an axially extending element 18 which interleaves with a similar element on an adjacent ring structure.
  • This interleaved structure permits a very close packing of the rings without the need to physically attach the rings.
  • the axially extending elements 18 will usually continue to axially interleave which increases the coverage of the body lumen wall being treated.
  • FIGS. 2A and 2B An expanded, non-interleaved multiple ring stent is shown in FIG. 2A. Substantial gaps G appear between the axially extending elements 18 on the large diameter side of the curved vessel segment.
  • the nested stent configurations of the present invention are able to maintain interleaving of the axially extending elements 18 , even on the large diameter side of the curved vessel segment, as shown in FIG. 2B. While the present invention cannot assure that gaps will always be eliminated, the number and extent of the gaps will at least be reduced, thus improving wall coverage.
  • a stent structure 20 comprising a plurality of open cell zigzag ring structures 22 , shown in FIGS. 3 and 4.
  • Each zigzag ring includes axially extending elements which alternate directions, and the rings are arranged so that the elements are “nested” as shown in FIG. 3.
  • the nested axially extending elements of the rings 22 remain generally overlapping, as shown in FIG. 4, even when the stent has undergone significant radial expansion.
  • prior stent structures have utilized nested zigzag structures, they have generally either connected adjacent structures or utilized only a single filament for forming such structures. In neither case can the flexibility achieved by the present invention in combination with the ability to selectively deliver independent radially expansible segments be achieved.
  • Each ring 32 comprises a plurality of closed cell boxes 34 joined at their midpoints by circumferentially directed connectors 36 .
  • Each box 34 includes a central opening 35 which is generally an axial cut enlarged at each end and in the middle.
  • the ring structure 32 is shown in its rolled-out or flattened configurations. In the actual stent structure, the ring would be rolled so that the “broken” connectors 34 ′ are in fact connected to form a cylindrical shape.
  • the “bow tie” shape of the central opening 35 is advantageous as it permits maximum radial compression of the stent while minimizing both the delivery profile and the stress relief of the stent during expansion in the body lumen.
  • FIG. 6 illustrates the very tight packing of the stent structure 30 that can be achieved.
  • the stent structure 30 in FIG. 6 is in its pre-deployment configuration as it would be when placed over a balloon or within a delivery tube, as described in more detail hereinbelow. It can be seen that virtually all of the available area for carrying the stent is covered. Thus, when the stent is expanded as shown in FIG. 7, the area of the blood vessel or other luminal wall will be maximized. Moreover, this very close packing of the stent is achieved while concurrently providing a very high degree of flexibility while the stent is being delivered and conformability after the stent is deployed.
  • Axial separation of the rings 32 of stent structure 30 can be inhibited by modifying the ring geometries in a variety of ways, such as shown in FIGS. 6A and 6B.
  • the boxes 34 a are fabricated (or deformed after fabrication) to collapse near the centers so that they form “bow tie” structures, with enlarged ends 34 b interlocking.
  • the boxes 34 c can be inclined relative to the axial direction, as shown in FIG. 6B, to also provide interlocking of adjacent rings prior to deployment. Such inclination can be used with at least most of the embodiments of the present invention to improve axial retention.
  • other patterns such as chevrons, interleaved sigmoidal shapes, and the like could also be used to provide the desired interlocking prior to stent expansion.
  • Stent structure 40 (FIG. 9) comprises a plurality of open cell expansible rings 42 formed in a “castellated” pattern, as shown in more detail in FIG. 8.
  • the castellations comprise narrow U-shaped loops 44 and 46 which alternatively extend in a right hand direction (loop 44 ) and left hand direction (loop 46 ) relative to a circumferential center line 48 .
  • the rings 42 are arranged so that the loops 44 and 46 overlap, as shown in FIG. 9, to form a tightly packed configuration. When expanded, as shown in FIG.
  • the loops 44 and 46 continue to overlap to provide a very high degree of vessel wall coverage, as shown in FIG. 10.
  • the open cell configuration of FIGS. 8-10 will also improve coverage in curved vessels, minimizing gaps as discussed previously.
  • the length of the open cells will be in the range from 0.5 to 10 mm, usually from 2 to 5 mm.
  • Ring structure 50 of FIG. 11 comprises a plurality of closed cell box elements 52 joined by circumferential connectors 54 and 56 .
  • Ring 50 is similar to ring 32 of FIG. 5, except that the circumferential connectors 54 are split to form H-shaped slots 55 which span pairs of adjacent box structures 52 and the intermediate connectors 54 form a single, larger cell structures.
  • Such larger openings are advantageous when stenting in blood vessels with side branches which must be kept open.
  • the side branches may be accessed by opening the slots 55 with a balloon structure.
  • the cell pattern of stent 32 (FIG. 5) provides a greater coverage that may be of particular importance with drug eluting stents.
  • Stent structures comprising multiple rings 50 are shown in their unexpanded and expanded configuration in FIGS. 1A and 11B, respectively.
  • the open slots 55 (FIG. 11B) provide for significant additional expansion (via balloon dilation or other subsequent intervention) in order to provide access to a side branch or for any other purpose.
  • a further expanded slot 55 is shown in FIG. 11C, as expanded by balloon B.
  • Ring structure 60 of FIG. 12 comprises a plurality of interconnected box structures 62 , 64 , and 66 .
  • Each of the box structures shares common axial struts or beams, but the axially offset nature of the three box structures permits radial expansion.
  • the box structures 62 and 66 provide the axially extending elements which may be interleaved in forming a stent structure from a plurality of the rings 60 .
  • Axially extending elements 62 and 66 interleave and mate so that interleaved extending elements of adjacent stents can be interference fit with each other to provide a friction fit which inhibits separation of the stents, or be kept out of contact to allow for separation.
  • extending elements can deflect radially inward which will provide additional adherence to an expandable delivery balloon and increased stent retention.
  • Ring structure 70 in FIG. 13 comprises paired, symmetric box structures 72 and 74 joined by short circumferential connectors 76 .
  • Each of the box structures 72 and 74 define a long and a short axially extending member which can be aligned with each other when forming a stent structure from a plurality of the rings 70 .
  • This particular structure will provide good adherence to an expandable delivery balloon during deployment and have many of the same advantages as the embodiment of FIG. 12.
  • Ring structure 80 of FIG. 14 is similar to that of ring structure 70 of FIG. 13, except that the “longer” rings terminate in a retainer, such as T-ends 82 .
  • T-ends When deploying multiple rings 80 in a stent structure, the T-ends will interlock to help hold the ring in place on the balloon or within the delivery tube. The interlock, however, does not provide a permanent attachment and, adjacent ring segments 80 will naturally release from each other during deployment. Moreover, since the interlocking structures are not actually attached, they permit a high degree of flexibility while the stent is being deployed. While T-ends are shown in FIG. 14, the terminal retainers could be L- or J-shaped ends or have any other geometry, which also provides for interlocking.
  • each of these geometries will include a peripherally extending segment 83 which interlocks with a peripherally extending segment 83 on an adjacent T-end 82 .
  • the segment 83 will move apart allowing the adjacent rings to deploy separately.
  • the T-, L- or J-ends will interlock to help hold the ring in place on the balloon or within the delivery tube.
  • the interlock does not provide a permanent attachment and, adjacent ring segments 80 will naturally release from each other during deployment. Such interlocking could also incorporated in the embodiments of FIGS. 5, 8, 11 and 12 .
  • the stent structures have generally maximized to vessel wall coverage achieved after expansion. While this will often be desired, in some instances it may be desired to lessen the amount of wall coverage.
  • a stent structure 90 includes independent rings 92 having boxes 93 circumferentially separated by spacers 94 .
  • the spacers 94 will either not expand or expand only after the boxes 93 have expanded, thus maintaining an axial distance D between adjacent rings after expansion, as shown in FIG. 15B.
  • the distance D will be equal to about one-half the total axial length of the spacer 94 .
  • Stent structure 96 (FIGS. 16A and 16B) is similar to structure 90 , except that spaces 97 are axially split to define an H-shaped cell (as discussed with earlier embodiments) and certain of the rings 98 and joined by sigmoidal links 99 .
  • Stent structures according to the present invention may be delivered in a variety of ways. As illustrated in FIGS. 17A-17C, the stent structure 30 may be delivered on a balloon catheter 90 having a balloon 92 with a single inflation chamber. Deployment of the stent 30 is illustrated in FIG. 17B where all independent ring structures 32 are expanded simultaneously. Alternatively, as illustrated in FIG. 17C, catheter may carry a balloon 94 having a plurality of independently inflatable compartments. In that way, one or more of the independent compartments may be inflated separately from others of the compartments to selectively deploy one, two, three, or more of the independent ring structures 32 . In that case, others of the ring structures 32 will remain unexpanded and available for separate expansion or may be simply removed from the patient if unused.
  • FIGS. 18A-18D an alternative stent structure delivery protocol employing a carrier tube will be described.
  • Such delivery protocols are described in more detail in co-pending application Ser. No. 10/306,813, filed on Nov. 27, 2002 (Attorney Docket Number 021629-000320US), and in copending application Ser. No. 10/637,713, filed Aug. 8, 2003 (Attorney Docket No. 21629-000340US), the full disclosures of which are incorporated herein by reference.
  • Catheter 160 (FIG. 18A) comprises a sheath 164 , pusher tube 166 , and a catheter body 168 .
  • the catheter body 168 includes an expansible balloon 170 over its distal portion.
  • Individual expansible rings are deployed, as illustrated in FIGS. 18B and 18C, by first advancing the distal-most ring 162 using the pusher tube 166 .
  • the catheter body 168 is also distally advanced so that a distal portion of the balloon 170 lies within the distal-most deployed ring 162 , as shown in FIG. 18B.
  • the remaining proximal portion of the balloon 170 will, of course, remain within the other rings 162 which themselves remain within the sheath 164 .
  • the balloon 170 is then inflated, but only the advanced distal portion of the balloon inflates within the advanced ring 162 , as illustrated in FIG. 18C. Expansion of the remaining proximal portion of the balloon is prevented by the sheath 164 .
  • the remaining rings 162 remain unexpanded since they remain within the sheath 164 .
  • additional rings 162 may be deployed, either at the same target location within the blood vessel or at a different, spaced-apart locations within the blood vessel. Deployment of two rings 162 is illustrated. The two rings 162 are axially advanced using the pusher tube 162 so that they are positioned over the uninflated balloon 170 . The balloon 170 is then inflated, as illustrated in FIG. 18D, thus expanding the rings 162 within the blood vessel BV.
  • the catheter 160 could carry many more than the four illustrated rings 162 , and three, four, five, ten, and even 20 or more individual rings could be deployed at one time, with additional single prostheses or groups of prostheses being deployed at different times and/or at different locations within the blood vessel.
  • the use of “stent valves” as described in application Ser. No. 10/306,813, previously incorporated herein by reference, may preferably be employed to facilitate controlling the number of rings deployed and the spacing between the deployed and undeployed rings.
  • kits 200 comprise a catheter 160 (or a balloon catheter) in combination with instructions for use IFU.
  • the instructions for use set forth any of the methods of the present invention, and in particular set forth how the catheter 160 may be used to implant a stent structure comprising multiple rings within a blood vessel or other body lumen.
  • the catheter 160 and instructions for use will typically be packaged together, for example within a conventional package 202 , such as a box, tube, pouch, tray, or the like.
  • Catheter 160 will typically be maintained in a sterile condition within the package 202 .
  • the instructions for use may be provided on a package insert, may be printed in whole or in part on the packaging, or may be provided in other ways, such as electronically over the internet, on an electronic medium, such as a CD, DVD, or the like.
  • FIG. 20A illustrates a portion of a stent segment 201 in an unexpanded configuration, shown in a planar shape for clarity.
  • Stent segment 201 comprises two parallel rows 203 A, 203 B of I-shaped cells 205 formed around an axis A so that stent segment 201 has a cylindrical shape.
  • I-shaped and H-shaped as used herein may refer to a similar cell geometry comprising two generally parallel slots connected by an interconnecting slot. Such cells may appear H-shaped when axis A is in a vertical orientation, or I-shaped axis A is in a horizontal orientation.
  • Each cell 205 has upper and lower axial slots 207 aligned with the axial direction and a circumferential slot 204 .
  • Upper and lower slots 207 preferably have an oval, racetrack, rectangular or other oblong shape with a long dimension L generally parallel to axis A and a short dimension W perpendicular thereto.
  • Axial slots 207 are bounded by upper axial struts 206 A and lower axial struts 206 B, curved outer ends 208 and curved inner ends 210 .
  • Each circumferential slot 204 is bounded by an outer circumferential strut 209 and an inner circumferential strut 211 .
  • Each I-shaped cell 205 is connected to the adjacent I-shaped cell 205 in the same row 98 A or 98 B by a circumferential connecting strut 213 . All or a portion of cells 205 in row 98 A merge or join with cells 205 in row 98 B at the inner ends 210 , which are integrally formed with the inner ends 210 of the adjacent cells 205 .
  • Stent segment 201 is configured to interleave with an adjacent stent segment of similar construction.
  • Upper and lower axial struts 206 A, 206 B and outer ends 208 form axial elements E that are received in the spaces S between each element E of the adjacent stent segment 201 .
  • a spacing member 212 extends outwardly in the axial direction from a selected number of outer circumferential struts 209 and/or connecting struts 213 .
  • Spacing member 212 preferably itself forms a subcell 214 in its interior, but alternatively may be solid without any cell or opening therein.
  • subcell 214 preferably communicates with I-shaped cell 205 .
  • Spacing members 212 are configured to engage the curved outer ends 208 of an adjacent stent segment 201 so as to maintain appropriate spacing between adjacent stent segments.
  • spacing members 212 have outer ends 216 with two spaced-apart protrusions 218 that provide a cradle-like structure to index and stabilize the curved outer end 208 of the adjacent stent segment.
  • spacing members 212 have an axial length of at least about 10%, more preferably at least about 25%, of the long dimension L of I-shaped cells 205 , so that the I-shaped cells 205 of adjacent stent segments are spaced apart at least that distance. This results in elements E interleaving a distance of at least about 10%, preferably at least about 25%, and more preferably at least about 50% of their axial length as measured from the circumferential connecting struts 213 . Because spacing members 212 experience little or no axial shortening during expansion of stent segments 201 , this minimum spacing between stent segments is maintained both in the unexpanded and expanded configurations.
  • FIG. 20B shows stent segment 201 of FIG. 20A in an expanded configuration. It may be seen that cells 205 are expanded so that upper and lower slots 207 are diamond shaped with circumferential slots 204 remaining basically unchanged. This results in some axial shortening of the stent segment, thereby increasing the spacing between adjacent stent segments.
  • the stent geometry is optimized by balancing the amount of axial shortening and associated inter-segment spacing, the desired degree of vessel wall coverage, the desired metal density, and other factors. Because the stent is comprised of multiple unconnected stent segments 201 , any desired number from 2 up to 10 or more stent segments may be deployed simultaneously to treat lesions of any length from 2 mm up to 100 mm or more. Further, because such segments are unconnected to each other, the deployed stent structure is highly flexible and capable of deployment in long lesions having curves and other complex shapes.
  • circumferential slots 204 provide a pathway through which vessel side branches can be accessed for catheter interventions.
  • a balloon dilatation catheter may be positioned through circumferential slot 204 and expanded. This deforms circumferential struts 209 , 211 axially outward, thereby expanding circumferential slot 204 and further expanding upper and lower slots 207 , as shown in phantom in FIG. 20B.
  • This provides a relatively large opening 220 through which a catheter may be inserted through stent segment 201 and into the side branch for placing stents, performing angioplasty, or carrying out other interventions.
  • FIGS. 21A-21B illustrate a second embodiment of a stent segment 201 ′ according to the invention.
  • two stent segments 201 ′ are shown interleaved in a planar shape for clarity.
  • stent segment 201 ′ comprises two parallel rows 222 A, 222 B of I-shaped cells 224 formed into a cylindrical shape around axial axis A.
  • Cells 224 have upper and lower axial slots 226 and a connecting circumferential slot 228 .
  • Upper and lower axial slots 226 are bounded by upper axial struts 230 , lower axial struts 232 , curved outer ends 234 , and curved inner ends 236 , forming axial elements E configured to be received in spaces S between elements E in the adjacent stent segment 201 ′.
  • Circumferential slots 228 are bounded by an outer circumferential strut 238 and inner circumferential strut 240 .
  • Each I-shaped cell 224 is connected to the adjacent I-shaped cell 224 in the same row 222 by a circumferential connecting strut 242 .
  • Row 222 A is connected to row 222 B by the merger or joining of curved inner ends 236 of at least one and preferably two of slots 226 in each row 222 .
  • FIGS. 21A-21B differs from that of FIGS. 20A-20B in that of FIGS. 20A-20B in that of the adjacent interleaved stent segments.
  • the embodiment of FIG. 21A includes a bulge 244 in upper and lower axial struts 230 , 232 extending circumferentially outwardly from axial slots 226 . These give axial slots 226 an arrowhead or cross shape at their inner and outer ends.
  • each upper axial strut 230 extends toward the bulge 244 in a lower axial strut 232 in the same cell 205 or in an adjacent cell 205 , thus narrowing the space S therebetween and creating a concave abutment 246 in the space between each axial slot 226 .
  • Concave abutments 246 are configured to receive and engage curved outer ends 234 of cells 224 in the adjacent stent segment, thereby maintaining spacing between the stent segments.
  • the axial location of bulges 244 along upper and lower axial struts 230 , 232 may be selected to provide the desired degree of inter-segment spacing.
  • the axial depth of concave abutments 246 from curved outer ends 234 is at least about 10% of the axial length of elements E (measured from circumferential struts 242 ), preferably at least about 25% of the axial length of elements E, and more preferably at least about 50% of the axial length of elements E.
  • FIG. 21B shows two stent segments 201 of FIG. 21A in an expanded condition. It may be seen that axial slots 226 are deformed into a circumferentially-widened modified diamond shape with bulges 244 on the now diagonal upper and lower axial struts 230 , 232 . Circumferential slots 228 are generally the same size and shape as in the unexpanded configuration. Bulges 244 have been pulled away from each other to some extent, but still provide a concave abutment 246 to maintain a minimum degree of spacing between adjacent stent segments. As in the earlier embodiment, some axial shortening of each segment occurs upon expansion and stent geometry can be optimized to provide the ideal intersegment spacing.
  • stent segments 201 ′ retain some degree of interleaving in the expanded configuration, with outer ends 234 of elements E on adjacent stent segments being at least circumferentially aligned with each other, and preferably extending into spaces S of the adjacent stent segment a distance of at least about 1%, more preferably at least about 5%, and in some cases at least about 10% of the axial length of elements E as measured from circumferential connecting struts 242 .
  • elements E have an axial length of about 1 mm and are interleaved a distance D u of about 0.1-0.5 mm in the unexpanded configuration.
  • Segments 201 ′ are expandable to a diameter of 2.5-3.5 mm and elements E are interleaved a distance De of about 0.01-0.1 mm in the expanded configuration.
  • FIGS. 21A-21B retains the feature described above with respect to FIGS. 20A-20B to enable access to vessel side branches blocked by stent segment 201 ′. Should such side branch access be desired, a dilatation catheter may be inserted into circumferential slot 228 and expanded to provide an enlarged opening through which a side branch may be entered.
  • FIGS. 22A-22B illustrate a variant of the stent structure of FIGS. 21A-21B that has a larger expanded diameter.
  • the primary difference in the embodiment of FIGS. 22A-22B is the geometry of the inner ends 236 ′ of each axial slot 226 ′. Rather than being curved, inner ends 236 ′ are generally straight and oriented in the circumferential direction. Because of the longer circumferential dimension of the inner ends 236 ′, an inner portion 250 of each axial strut 230 ′, 232 ′ is disposed at an angle relative to the axial direction, giving the inner half 252 of each axial slot 226 ′ a trapezoidal shape.
  • bulges 244 ′ are disposed along axial struts 230 ′, 232 ′ so as to create concave abutments 246 ′ that engage the outer ends 234 ′ of axial slots 226 ′ and maintain inter-segment spacing.
  • stent segment 201 ′′ expands to a configuration similar to that of FIG. 21B, with the exception that inner ends 236 ′ remain generally straight and aligned with the circumferential direction.
  • Axial slots 226 ′ are again expanded into a modified diamond shape, with bulges 244 ′ extending into spaces S to maintain inter-segment spacing.
  • stent segment 201 ′′ has a length of about 4 mm and diameter of about 1.0-2.0 mm when unexpanded, and is expandable to a diameter of about 3.0-4.0 mm.
  • the stent structures of the invention are preferably radiopaque so as to be visible by means of fluoroscopy.
  • Radiopaque markers and/or materials may be used in or on the stent structures. Markers of radiopaque materials may be applied to the exterior of the stents, e.g, by applying a metal such as gold, platinum, a radiopaque polymer, or other suitable coating or mark on all or a portion of the stents.
  • the stent structures may include a radiopaque cladding or coating or may be composed of radiopaque materials such as MP35N (ASTM 562 ), L- 605 cobalt chromium (ASTM F90), other suitable alloys containing radiopaque elements, or multilayered materials having radiopaque layers.
  • the stent structures may have a geometry conducive to fluoroscopic visualization, such as having struts of greater thickness, sections of higher density, or overlapping struts.
  • F1472- 02 a Wrought Titanium-6 Aluminum-4 Vanadium Alloy

Abstract

Blood vessels and other body lumens are stented using stent structures comprising a plurality of radially expansible rings where at least some of the rings comprise axially extending elements which interleave with axially extending elements on adjacent unconnected rings. The ring structures may be open cell structures or closed cell structures, and the axially extending elements will typically be formed as part of the open cell or closed cell structure.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application claims the priority benefit of U.S. Provisional Patent Application No. 60/440,839 (Attorney Docket No. 21629-000500US), filed Jan. 17, 2003, entitled “Multiple Independent Nested Stent Structures & Methods for Their Deployment,” which application is hereby incorporated fully by reference.[0001]
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0002]
  • The present invention relates generally to medical devices and methods. More particularly, the present invention relates to apparatus and methods for delivering a plurality of separate luminal prostheses within a body lumen, such as a blood vessel. [0003]
  • Coronary artery disease is the leading cause of death and morbidity in the United States and Western society. In particular, atherosclerosis in the coronary arteries can cause myocardial infarction, commonly referred to as a heart attack, which can be immediately fatal or, even if survived, can cause damage to the heart which can incapacitate the patient. [0004]
  • While coronary artery bypass surgery can be an effective treatment for stenosed arteries resulting from atherosclerosis or other causes, it is a highly invasive procedure which is also expensive and which requires substantial hospital and recovery time. Percutaneous transluminal angioplasty, commonly referred to as balloon angioplasty, is less invasive, less traumatic, and significantly less expensive than bypass surgery. Heretofore, however, balloon angioplasty has not been considered as effective a treatment as bypass surgery. The effectiveness of balloon angioplasty, however, has improved significantly with the introduction of stenting, which involves the placement of a scaffold structure within an artery that has been treated by balloon angioplasty. The stent inhibits abrupt reclosure of the artery and has some benefit in inhibiting subsequent restenosis resulting from hyperplasia. [0005]
  • Presently available stents may be generally categorized as either “closed cell configurations” or “open cell configurations.” Closed cell configurations are characterized by ellipses, ovals, and polygonal structures, such as closed boxes, rhomboids, diamonds, and the like, which open in the circumferential direction and shorten in the axial direction as the stent is expanded. Open cell configurations include zigzag and serpentine structures which may be formed as a plurality of discreet rings or may be formed from a single continuous wire or other element. Closed cell stents are advantageous in that they provide better coverage of the blood vessel wall when the stent is deployed. This is particularly advantageous in tightly curved segments of the vasculature where even stent coverage in both the axial and circumferential directions on the outer wall of the vessel has been shown to reduce restenosis. Such even coverage is also an advantage in achieving uniform delivery from drug eluting stents. In contrast, open cell stent configurations are generally more flexible than the closed cell configurations. Such flexibility is advantageous in the tortuous regions of the vasculature where enhanced flexibility can provide better conformance to the vessel being treated. Better conformance can reduce the stress on the vessel wall, particularly at the stent ends, and lead to reduced restenosis. [0006]
  • For these reasons, it would be desirable to provide improved stents and stent structures. In particular, it would be desirable to provide stents and stent structures which combine the improved wall coverage of closed cell stent structures with the increased flexibility of open cell stent structures. It would be still further desirable if such improved stent structures allowed a physician to optimize the length of vessel being treated in accordance with the nature of the disease, allowed for the delivery of both very short and very long stent structures, and optionally permited delivery of stent structures at multiple contiguous and/or non-contiguous locations within a body lumen. At least some of these objectives will be met by the inventions described hereinafter. [0007]
  • 2. Description of the Background Art [0008]
  • U.S. Pat. Nos. 6,200,337 and 5,870,381 describe stents having closed cell rings with overlapping portions connected by axial connecting members. U.S. Pat. No. 6,375,676 describes a stent having open cell rings with overlapping portions connected by axial connecting members. U.S. Patent Application Publication Nos. 2002/0188343 and 2002/0188347 describe expandable stents having interconnecting elements which interlock circumferentially adjacent bridges between axially adjacent stent segments. U.S. Pat. No. 4,580,568 describes the sequential placement of a plurality of zigzag ring stents where the stents may optionally be overlapped (FIGS. 7 and 8). U.S. Pat. No. 6,319,277 describes a stent formed from a single element into a plurality of nested “waves.” U.S. Pat. No. 5,554,181 describes a stent formed from a single element into partially overlapping windings. Other patents of interest include U.S. Pat. Nos. 6,312,458; 5,879,370; 5,755,776; 5,507,771; and 5,104,404. U.S. Pat. No. 6,258,117 BI describes a stent having multiple sections connected by separable or frangible connecting regions. Optionally, the connecting regions are severed after the stent structure has been implanted in the blood vessel. U.S. Pat. Nos. 5,571,086; 5,776,141, and 6,143,016 describe an expandable sleeve for placement over a balloon catheter for the delivery of one or two stent structures to the vasculature. U.S. Pat. No. 5,697,948, describes a catheter for delivering stents covered by a sheath. [0009]
  • BRIEF SUMMARY OF THE INVENTION
  • The present invention provides methods and apparatus for prosthesis placement, such as stenting of body lumens, typically blood vessels, and more typically coronary arteries. The methods and systems will also find significant use in the peripheral vasculature, the cerebral vasculature, and in other ducts, such as the biliary duct, the fallopian tubes, and the like. The terms “stent” and “stenting” are defined to include any of the wide variety of expandable prostheses and scaffolds which are designed to be intraluminally introduced to a treatment site and expanded in situ to apply a radially outward force against the inner wall of the body lumen at that site. The stents and prostheses of the present invention commonly comprise a closed or, less preferably, an open lattice structure, and are typically formed from a malleable or elastic metal. When formed from a malleable metal, such as stainless steel, gold, platinum, titanium, and super alloys, the stents will typically be expanded by a balloon which causes plastic deformation of the lattice so that it remains opened after deployment. When formed from an elastic metal, including super elastic metals such as nickel-titanium alloys, the lattice structures will usually be radially constrained when delivered and deployed by releasing the structures from such radial constraint so that they “self-expand” at the target site. When the stent or lattice structures are covered with a fabric or polymeric membrane covering, they are commonly referred to as grafts. Grafts may be used for the treatment of aneurysms or other conditions which require placement of a non-permeable or semi-permeable barrier at the treatment site. The terms “stent” and “stent structures” refer broadly to all radially expansible stents, grafts, and other scaffold-like structures which are intended for deployment within body lumens. [0010]
  • The stents and stent structures of the present invention may have any of a variety of common constructions, including closed cell constructions such as expansible ovals, ellipses, box structures, expandable diamond structures, expandable rhomboid structures, as well as other regular and irregular polygonal structures, etc. In addition, the closed cells may have complex slotted geometries, such as H-shaped slots, I-shaped slots, J-shaped slots, etc. Suitable open cell structures include zigzag structures, serpentine structures, and the like. Such conventional stent structures are well described in the patent and medical literature. Specific examples of suitable stent structures are described in the following U.S. Patents, the full disclosures of which are incorporated herein by reference: U.S. Pat. Nos. 6,315,794; 5,980,552; 5,836,964; 5,527,354; 5,421,955; 4,886,062; and 4,776,337. Preferred structures are described herein with reference to FIGS. 4 and 5. [0011]
  • According to one aspect of the present invention, stents will comprise a plurality of independent expansible rings each having a length of 1 mm or greater, usually 2 mm or greater, and sometimes of 3 mm or greater, usually being in the range from 1 mm to 10 mm, typically from 2 mm to 7 mm, more typically from 2 mm to 5 mm. The use of such short ring lengths is advantageous since the overall stent length will be a multiple of the ring length. [0012]
  • The methods and apparatus of the present invention will provide for the deployment of a plurality of stents or other prostheses from a common stent delivery catheter. Usually, the number of delivered stents will be in the range from 2 to 50, typically from 3 to 30, and most typically from 3 to 25. As more stents are placed on the delivery catheter, the individual stent length will often be somewhat less, although this is not necessarily the case in all instances. The multiple prostheses may be deployed individually or in groups of two or more at a single location or at multiple spaced-apart locations in the body lumen or lumens. [0013]
  • In another aspect of the present invention, stent structures will comprise a plurality of radially expansible rings, as generally described above, arranged along an axial line. Expansible rings are arranged adjacent to each other and will include axially extending elements which interleave or nest with similarly axially extending elements on adjacent rings. By “interleaved” it is meant that the axially extending elements on adjacent rings will interpenetrate with each other in an axial direction, at least prior to stent expansion and preferably even after stent expansion. Usually, the interpenetrating elements will not overlap, i.e., be positioned one over another in the radial direction, but it is possible that in some implementations there may be some overlapping prior to or even after expansion. The axial interpenetration will be at least 0.1 mm, usually being at least 1 mm, and often being in the range from 1 mm to 5 mm, and will of course depend on the axial length(s) of the adjacent ring(s). Expressed as a percentage, the axial length of the axially extending elements will usually be at least 5% of the axial length of the ring, usually being from 5% to 50%, and preferably being from 20% to 30%. [0014]
  • Preferably, the axially extending elements on adjacent rings will interleave without interlocking so as to permit axial separation between the adjacent rings prior to expansion of the rings. However, axially extending elements may, in some instances, also interpenetrate in a peripheral direction prior to expansion. Such peripheral interpenetration can provide axial interlocking of the axially adjacent expansible rings prior to expansion. It will usually be desirable or even necessary that the peripheral interpenetration be relieved during radial expansion of the stent structures so that the independent rings be released from each other when deployed. In other instances, however, a tether or other types of links may be provided to interconnect or otherwise restrain the rings even after expansion and deployment. [0015]
  • It is not necessary that all adjacent rings be unconnected, although at least two, and preferably three, four, five, eight, ten, or more adjacent rings will be unconnected. Thus, some (but fewer than all) of the adjacent rings of the stent structures may have ties or links therebetween, including flexible or non-flexible (deflectable) ties or links. The axially adjacent rings, however, will usually not be connected, although in some cases they may have easily separable or non-permanent connections as described in more detail below. Each expansible ring will preferably comprise expansible closed cell structures, as set forth above. Less preferably, the expansible rings may comprise expansible open cell structures, as set forth above. The lengths and diameters of the individual rings have been set forth generally above. The stent structure will typically comprise from 2 to 50 individual rings, usually from 3 to 30 individual rings, and often from 3 to 25 individual rings. [0016]
  • The spacing between adjacent rings may be uniform or non-uniform, preferably being uniform. In some cases, it is desirable that the edges of the adjacent rings be spaced-apart by a uniform distance in the axial direction, typically at least 0.1 mm, usually being from 0.1 mm to 0.5 mm, prior to stent expansion. In other situations, it will be preferred that the adjacent rings be in contact with each other at discreet points or along continuous sections of the edges. In some cases, the stent structures will be configured to shorten upon expansion to increase the spacing between rings. It is usually preferable that the edges of the adjacent rings not overlap, at least prior to deployment. Deployment of the stents, particularly in curved and tortuous luminal regions, may sometimes result in touching and overlapping of the stent rings. [0017]
  • The stent structures may be modified in a variety of ways which are used with other conventional stents. For example, some or all of the radially expansible rings may releasably carry a biologically active agent, such as an agent which inhibits hyperplasia. Exemplary anti-hyperplasia agents include anti-neoplastic drugs, such as paclitaxel, methotrexate, and batimastal; antibiotics such as doxycycline, tetracycline, rapamycin, everolimus and other analogs and derivatives of rapamycin, and actinomycin; amino suppressants such as dexamethasone and methyl prednisolone; nitric oxide sources such as nitroprussides; estrogen; estradiols; and the like. [0018]
  • In another aspect of the present invention, a stent deployment system comprises an elongate carrier having a central axis and including a plurality of radially expansible rings arranged over a surface thereof. At least some of the radially expansible rings will have the features and characteristics just described with respect to the present invention. The elongate carriers of the stent deployment systems will typically comprise a radially expansible balloon having an outer surface where the radially expansible rings are disposed over the outer surface of the balloon. In such cases, the balloon may comprise a single inflation chamber in which case all of the rings will be expanded simultaneously. Alternatively, the balloon may comprise a plurality of independently inflatable chambers so that individual expansible rings may be deployed separately from the other rings. [0019]
  • The elongated carrier of the stent deployment system may alternatively comprise a carrier tube having an inner surface which carries and constrains the radially expansible rings. In such cases, the expansible rings will usually be self-expanding, i.e., held in a radially constrained configuration by the carrier tube prior to release and expansion at a luminal target site. Usually, the carrier tube structures will further comprise a pusher tube arranged to axially advance the radially expansible rings from the carrier tube. The elongated carrier may still further comprise a balloon arranged to receive and expand individual rings as they advance from the carrier tube, in which case the carrier may be used for delivering the formable (balloon-expansible) stent structures. However, such a balloon may also be used with self-expanding stent structures to control or enhance expansion, to perform predilatation of a lesion prior to stent deployment, or to further expand the stent structures and dilate the vessel lumen after the structures have self-expanded. [0020]
  • In a further aspect of the present invention, multiple independent stent rings are arranged on a carrier by the following methods. An elongated carrier structure is provided and a plurality of radially expansible rings comprising axially extending elements are mounted on the carrier structure such that the axially extending elements on adjacent rings interleave or nest after they are mounted. The number of rings mounted on the carrier is selected to provide a desired overall stent length, and the number of rings is typically in the ranges set forth above, providing overall stent lengths in the range from 6 mm to 120 mm, usually from 9 mm to 100 mm, and typically from 12 mm to 50 mm. Other aspects of the individual radially expansible rings have been described above. [0021]
  • In yet another aspect of the present invention, methods for stenting a body lumen comprise delivering to the body lumen a stent structure having a plurality of radially expansible rings. The rings are as described above with respect to other aspects of the present invention, and at least some of the rings are expanded within the body lumen so that the axially extending elements open and axially move apart from each other as they radially expand. Preferably, the length of the axially extending elements and degree of radial expansion will be selected so that the elements remain interleaved even after being fully expanded within the body lumen. Such an interleaving structure enhances the continuity of lumenal wall coverage provided by the deployed stent structure. Target body lumens are typically blood vessels, more typically arteries, such as coronary arteries. The rings may be delivered simultaneously, typically using a single inflatable balloon, or sequentially, typically using a carrier tube, pusher tube and optionally deployment balloon. Methods may be used for delivering from 3 to 50 rings, usually from 3 to 30 rings, and typically from 3 to 25 rings, to cover a luminal length in the range from 6 mm to 120 mm, usually from 9 mm to 100 mm, and typically from 12 mm to 50 mm.[0022]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a schematic illustration of a stent structure according to the present invention comprising a plurality of closed cell ring structures. [0023]
  • FIG. 2 illustrates the stent structure of FIG. 1 shown in its radially expanded configuration. [0024]
  • FIGS. 2A and 2B illustrate the difference in deployed configuration of non-nested and nested stent structures, respectively. [0025]
  • FIG. 3 illustrates a stent structure constructed in accordance with the principles of the present invention comprising a plurality of open cell expansible rings. [0026]
  • FIG. 4 illustrates the stent structure of FIG. 3 shown in its radially expanded configuration. [0027]
  • FIG. 5 illustrates a first exemplary expansible ring structure in accordance with the principles of the invention. [0028]
  • FIG. 6 illustrates a stent structure comprising a plurality of the ring structures of FIG. 5, shown in a rolled out radially collapsed configuration. [0029]
  • FIGS. 6A and 6B illustrate variations on the ring structure of FIG. 6, where the variations are chosen to inhibit axial separation of the ring structures prior to deployment. [0030]
  • FIG. 7 illustrates the stent structure of FIG. 6 shown in its radially expanded configuration. [0031]
  • FIG. 8 illustrates a second exemplary expansible ring structure in accordance with the principles of the present invention. [0032]
  • FIG. 9 illustrates a stent structure comprising a plurality of the rings of FIG. 8. [0033]
  • FIG. 10 illustrates the stent structure of FIG. 8 in its radially expanded configuration. [0034]
  • FIGS. 11-14 illustrate further exemplary expansible ring structures in accordance with the principles of the present invention. [0035]
  • FIGS. 15A and 15B illustrate a further embodiment of a stent structure according to the present invention shown in unexpanded and expanded configurations, respectively. [0036]
  • FIGS. 16A and 16B illustrate a still further embodiment of a stent structure according to the present invention shown in unexpanded and expanded configurations, respectively. [0037]
  • FIGS. 17A and 17B illustrate deployment of a closed cell stent structure according to the present invention with both a balloon having a single chamber (FIG. 16) and a balloon having multiple chambers to permit selective delivery of portions of the stent structure (FIG. 17). [0038]
  • FIGS. 18A-18D illustrate deployment of a plurality of a expansible rings which form a stent structure according to the present invention using a delivery tube and pusher tube in combination with an expansion balloon. [0039]
  • FIG. 19 illustrates a kit constructed in accordance with the principles of the present invention. [0040]
  • FIGS. 20A-20B, [0041] 21A-21B, and 22A-22B illustrate further embodiments of stent structures according to the invention in unexpanded and expanded configurations.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention provides apparatus, systems, and methods for preparing and delivering stent structures comprising a plurality of “separate” or “discreet” radially expansible ring segments. By “separate” or “discreet,” it is meant that the ring segments are unconnected (or easily disconnected) at the time they are delivered to a target body lumen. Usually, the ring segments will be closely packed to provide a relatively high degree of vessel wall coverage after they are expanded. By disconnecting the adjacent segments, however, such a tightly packed structured can retain a very high degree of flexibility permitting delivery and conformance in even highly torturous regions of the vasculature and other body lumens. [0042]
  • The ability to closely pack the expansible ring segments and achieve a high degree of vessel wall coverage is achieved at least partly because at least some of the axially adjacent rings comprise axially extending elements which interleave or nest with axially extending elements on an adjacent connected ring. Usually, the axially extending elements will be formed from a radially expansible portion of the ring, e.g., the element will be part of the closed cell structure or open cell structure as described in more detail hereinbelow. As these expansible sections will typically foreshorten as they are radially expanded, interleaving and nesting the segments on adjacent rings prior to expansion minimizes or preferably eliminates any gaps in coverage after the stent is expanded, as described in more detail below. [0043]
  • The stent structures of the present invention may be fabricated as either balloon-expansible or self-expanding stents according to methods well known in the art. Typical deformable materials suitable for fabricating balloon-expansible stent structures include 316L stainless steel, gold, platinum, cobalt chrome, platinum, and the like. Suitable resilient materials for self-expanding stents include nickel titanium alloys, various spring stainless steel alloys, Eligloy® alloy, and the like. It will also be possible to form the stent structures of the present invention from both natural and synthetic polymers. Natural polymers include collagen, gelatin, chitin, cellulose, and the like. Suitable synthetic polymers include polyglycolic acids (PGA), polylactic acids (PLA), poly ethylene glycols (PEG), polyamides, polyimides, polyesters, and the like. In some instances, it would be possible to form different radially expansible segments from different materials in order to achieve different properties. [0044]
  • The stent structures will comprise a plurality of the individual radially expansible ring segments with typical dimensions, numbers, and the like, described above in the summary. The plurality of ring segments will be arranged prior to delivery, in a manner suitable for delivery to and deployment within a target blood vessel or other body lumen. Usually, the plurality of radially expansible rings will be arranged along an axial line, typically defined by a deployment balloon, a delivery tube, or some combination thereof. The expansible ring segments will be arranged so that the axially extending elements on each of the segments is interleaved with corresponding axial extending elements on adjacent but unconnected ring segments. Referring now to FIGS. 1-4, such arrangements will be generally described for both closed cell ring structures (FIGS. 1 and 2) and open cell ring structures (FIGS. 3 and 4). [0045]
  • In FIG. 1, a portion of a [0046] stent structure 10 comprising a plurality of radially expansible rings 12 is illustrated. Each radially expansible ring 12 includes a plurality of closed rhomboid or diamond structures 14 circumferentially joined by connectors 16. It will appreciated that the stent structure 10 is shown in a “rolled-out” configuration, and that only a portion of the structure is depicted for simplicity. Usually, the stent structure would contain a greater number of expansible rings 12, and each ring would include a larger number of rhomboid cells.
  • Of particular importance to the present invention, FIG. 1 illustrates that each [0047] rhomboid cell 14 includes an axially extending element 18 which interleaves with a similar element on an adjacent ring structure. This interleaved structure permits a very close packing of the rings without the need to physically attach the rings. Moreover, when the stent structure is radially expanded, as shown in FIG. 2, the axially extending elements 18 will usually continue to axially interleave which increases the coverage of the body lumen wall being treated.
  • The advantages of the present invention are particularly apparent in curved blood vessels BV, as illustrated in FIGS. 2A and 2B. An expanded, non-interleaved multiple ring stent is shown in FIG. 2A. Substantial gaps G appear between the [0048] axially extending elements 18 on the large diameter side of the curved vessel segment. In contrast, the nested stent configurations of the present invention are able to maintain interleaving of the axially extending elements 18, even on the large diameter side of the curved vessel segment, as shown in FIG. 2B. While the present invention cannot assure that gaps will always be eliminated, the number and extent of the gaps will at least be reduced, thus improving wall coverage.
  • A similar result can be achieved with a [0049] stent structure 20 comprising a plurality of open cell zigzag ring structures 22, shown in FIGS. 3 and 4. Each zigzag ring includes axially extending elements which alternate directions, and the rings are arranged so that the elements are “nested” as shown in FIG. 3. After radially expansion of the stent structure 20, the nested axially extending elements of the rings 22 remain generally overlapping, as shown in FIG. 4, even when the stent has undergone significant radial expansion. While prior stent structures have utilized nested zigzag structures, they have generally either connected adjacent structures or utilized only a single filament for forming such structures. In neither case can the flexibility achieved by the present invention in combination with the ability to selectively deliver independent radially expansible segments be achieved.
  • Referring now to FIGS. 5-7, a [0050] particular stent structure 30 comprising a plurality of radially expansible rings 32 is illustrated. Each ring 32, as shown in FIG. 5, comprises a plurality of closed cell boxes 34 joined at their midpoints by circumferentially directed connectors 36. Each box 34 includes a central opening 35 which is generally an axial cut enlarged at each end and in the middle. As with prior illustrations, the ring structure 32 is shown in its rolled-out or flattened configurations. In the actual stent structure, the ring would be rolled so that the “broken” connectors 34′ are in fact connected to form a cylindrical shape. The “bow tie” shape of the central opening 35 is advantageous as it permits maximum radial compression of the stent while minimizing both the delivery profile and the stress relief of the stent during expansion in the body lumen.
  • FIG. 6 illustrates the very tight packing of the [0051] stent structure 30 that can be achieved. The stent structure 30 in FIG. 6 is in its pre-deployment configuration as it would be when placed over a balloon or within a delivery tube, as described in more detail hereinbelow. It can be seen that virtually all of the available area for carrying the stent is covered. Thus, when the stent is expanded as shown in FIG. 7, the area of the blood vessel or other luminal wall will be maximized. Moreover, this very close packing of the stent is achieved while concurrently providing a very high degree of flexibility while the stent is being delivered and conformability after the stent is deployed. Such flexibility results in large part from the fact that the adjacent rings are unconnected and free to move relative to each other as the stent is delivered and deployed. Coverage in curved vessels will be improved with the specific design of FIGS. 6 and 7 generally as shown in FIGS. 2A and 2B.
  • Axial separation of the [0052] rings 32 of stent structure 30 can be inhibited by modifying the ring geometries in a variety of ways, such as shown in FIGS. 6A and 6B. In FIG. 6A, the boxes 34 a are fabricated (or deformed after fabrication) to collapse near the centers so that they form “bow tie” structures, with enlarged ends 34 b interlocking. Alternatively, the boxes 34 c can be inclined relative to the axial direction, as shown in FIG. 6B, to also provide interlocking of adjacent rings prior to deployment. Such inclination can be used with at least most of the embodiments of the present invention to improve axial retention. In addition, other patterns, such as chevrons, interleaved sigmoidal shapes, and the like could also be used to provide the desired interlocking prior to stent expansion.
  • Referring now to FIGS. 8-10, a similar degree of wall coverage and flexibility can be achieved with open cell stent structures. Stent structure [0053] 40 (FIG. 9) comprises a plurality of open cell expansible rings 42 formed in a “castellated” pattern, as shown in more detail in FIG. 8. The castellations comprise narrow U-shaped loops 44 and 46 which alternatively extend in a right hand direction (loop 44) and left hand direction (loop 46) relative to a circumferential center line 48. The rings 42 are arranged so that the loops 44 and 46 overlap, as shown in FIG. 9, to form a tightly packed configuration. When expanded, as shown in FIG. 9, the loops 44 and 46 continue to overlap to provide a very high degree of vessel wall coverage, as shown in FIG. 10. The open cell configuration of FIGS. 8-10 will also improve coverage in curved vessels, minimizing gaps as discussed previously. The length of the open cells will be in the range from 0.5 to 10 mm, usually from 2 to 5 mm.
  • Referring now to FIGS. 11-14, additional embodiments of the radially expansible ring segments are illustrated. As with prior illustrations, the ring segments are shown in their pre-deployed configuration in a rolled-out manner. [0054] Ring structure 50 of FIG. 11 comprises a plurality of closed cell box elements 52 joined by circumferential connectors 54 and 56. Ring 50 is similar to ring 32 of FIG. 5, except that the circumferential connectors 54 are split to form H-shaped slots 55 which span pairs of adjacent box structures 52 and the intermediate connectors 54 form a single, larger cell structures. Such larger openings are advantageous when stenting in blood vessels with side branches which must be kept open. In particular, the side branches may be accessed by opening the slots 55 with a balloon structure. In contrast, the cell pattern of stent 32 (FIG. 5) provides a greater coverage that may be of particular importance with drug eluting stents.
  • Stent structures comprising [0055] multiple rings 50 are shown in their unexpanded and expanded configuration in FIGS. 1A and 11B, respectively. Of particular note, the open slots 55 (FIG. 11B) provide for significant additional expansion (via balloon dilation or other subsequent intervention) in order to provide access to a side branch or for any other purpose. A further expanded slot 55 is shown in FIG. 11C, as expanded by balloon B.
  • [0056] Ring structure 60 of FIG. 12 comprises a plurality of interconnected box structures 62, 64, and 66. Each of the box structures shares common axial struts or beams, but the axially offset nature of the three box structures permits radial expansion. Moreover, the box structures 62 and 66 provide the axially extending elements which may be interleaved in forming a stent structure from a plurality of the rings 60. Axially extending elements 62 and 66 interleave and mate so that interleaved extending elements of adjacent stents can be interference fit with each other to provide a friction fit which inhibits separation of the stents, or be kept out of contact to allow for separation. Furthermore, extending elements can deflect radially inward which will provide additional adherence to an expandable delivery balloon and increased stent retention.
  • [0057] Ring structure 70 in FIG. 13 comprises paired, symmetric box structures 72 and 74 joined by short circumferential connectors 76. Each of the box structures 72 and 74 define a long and a short axially extending member which can be aligned with each other when forming a stent structure from a plurality of the rings 70. This particular structure will provide good adherence to an expandable delivery balloon during deployment and have many of the same advantages as the embodiment of FIG. 12.
  • [0058] Ring structure 80 of FIG. 14 is similar to that of ring structure 70 of FIG. 13, except that the “longer” rings terminate in a retainer, such as T-ends 82. When deploying multiple rings 80 in a stent structure, the T-ends will interlock to help hold the ring in place on the balloon or within the delivery tube. The interlock, however, does not provide a permanent attachment and, adjacent ring segments 80 will naturally release from each other during deployment. Moreover, since the interlocking structures are not actually attached, they permit a high degree of flexibility while the stent is being deployed. While T-ends are shown in FIG. 14, the terminal retainers could be L- or J-shaped ends or have any other geometry, which also provides for interlocking. In particular, each of these geometries will include a peripherally extending segment 83 which interlocks with a peripherally extending segment 83 on an adjacent T-end 82. Upon expansion of the ring 80, the segment 83 will move apart allowing the adjacent rings to deploy separately. When deploying multiple rings 80 in a stent structure, the T-, L- or J-ends will interlock to help hold the ring in place on the balloon or within the delivery tube. The interlock, however, does not provide a permanent attachment and, adjacent ring segments 80 will naturally release from each other during deployment. Such interlocking could also incorporated in the embodiments of FIGS. 5, 8, 11 and 12.
  • As illustrated thus far, the stent structures have generally maximized to vessel wall coverage achieved after expansion. While this will often be desired, in some instances it may be desired to lessen the amount of wall coverage. The stent structures shown in FIGS. 15A and 15B and FIGS. 16A and 16B, achieve such reduced wall coverage by providing “spacers” between adjacent rings. [0059]
  • In FIG. 15A, a [0060] stent structure 90 includes independent rings 92 having boxes 93 circumferentially separated by spacers 94. The spacers 94 will either not expand or expand only after the boxes 93 have expanded, thus maintaining an axial distance D between adjacent rings after expansion, as shown in FIG. 15B. The distance D will be equal to about one-half the total axial length of the spacer 94.
  • Stent structure [0061] 96 (FIGS. 16A and 16B) is similar to structure 90, except that spaces 97 are axially split to define an H-shaped cell (as discussed with earlier embodiments) and certain of the rings 98 and joined by sigmoidal links 99.
  • Stent structures according to the present invention may be delivered in a variety of ways. As illustrated in FIGS. 17A-17C, the [0062] stent structure 30 may be delivered on a balloon catheter 90 having a balloon 92 with a single inflation chamber. Deployment of the stent 30 is illustrated in FIG. 17B where all independent ring structures 32 are expanded simultaneously. Alternatively, as illustrated in FIG. 17C, catheter may carry a balloon 94 having a plurality of independently inflatable compartments. In that way, one or more of the independent compartments may be inflated separately from others of the compartments to selectively deploy one, two, three, or more of the independent ring structures 32. In that case, others of the ring structures 32 will remain unexpanded and available for separate expansion or may be simply removed from the patient if unused.
  • Referring now to FIGS. 18A-18D, an alternative stent structure delivery protocol employing a carrier tube will be described. Such delivery protocols are described in more detail in co-pending application Ser. No. 10/306,813, filed on Nov. 27, 2002 (Attorney Docket Number 021629-000320US), and in copending application Ser. No. 10/637,713, filed Aug. 8, 2003 (Attorney Docket No. 21629-000340US), the full disclosures of which are incorporated herein by reference. Catheter [0063] 160 (FIG. 18A) comprises a sheath 164, pusher tube 166, and a catheter body 168. The catheter body 168 includes an expansible balloon 170 over its distal portion. Individual expansible rings, as described above, are deployed, as illustrated in FIGS. 18B and 18C, by first advancing the distal-most ring 162 using the pusher tube 166. The catheter body 168 is also distally advanced so that a distal portion of the balloon 170 lies within the distal-most deployed ring 162, as shown in FIG. 18B. The remaining proximal portion of the balloon 170 will, of course, remain within the other rings 162 which themselves remain within the sheath 164. The balloon 170 is then inflated, but only the advanced distal portion of the balloon inflates within the advanced ring 162, as illustrated in FIG. 18C. Expansion of the remaining proximal portion of the balloon is prevented by the sheath 164. Similarly, the remaining rings 162 remain unexpanded since they remain within the sheath 164.
  • Referring now to FIG. 18D, [0064] additional rings 162 may be deployed, either at the same target location within the blood vessel or at a different, spaced-apart locations within the blood vessel. Deployment of two rings 162 is illustrated. The two rings 162 are axially advanced using the pusher tube 162 so that they are positioned over the uninflated balloon 170. The balloon 170 is then inflated, as illustrated in FIG. 18D, thus expanding the rings 162 within the blood vessel BV. It will be appreciated that the catheter 160 could carry many more than the four illustrated rings 162, and three, four, five, ten, and even 20 or more individual rings could be deployed at one time, with additional single prostheses or groups of prostheses being deployed at different times and/or at different locations within the blood vessel. The use of “stent valves” as described in application Ser. No. 10/306,813, previously incorporated herein by reference, may preferably be employed to facilitate controlling the number of rings deployed and the spacing between the deployed and undeployed rings.
  • Referring now to FIG. 13, [0065] kits 200 according to the present invention comprise a catheter 160 (or a balloon catheter) in combination with instructions for use IFU. The instructions for use set forth any of the methods of the present invention, and in particular set forth how the catheter 160 may be used to implant a stent structure comprising multiple rings within a blood vessel or other body lumen. The catheter 160 and instructions for use will typically be packaged together, for example within a conventional package 202, such as a box, tube, pouch, tray, or the like. Catheter 160 will typically be maintained in a sterile condition within the package 202. The instructions for use may be provided on a package insert, may be printed in whole or in part on the packaging, or may be provided in other ways, such as electronically over the internet, on an electronic medium, such as a CD, DVD, or the like.
  • A further alternative stent structure according to the invention is illustrated in FIGS. 20A-20B. FIG. 20A illustrates a portion of a [0066] stent segment 201 in an unexpanded configuration, shown in a planar shape for clarity. Stent segment 201 comprises two parallel rows 203A, 203B of I-shaped cells 205 formed around an axis A so that stent segment 201 has a cylindrical shape. The terms “I-shaped” and “H-shaped” as used herein may refer to a similar cell geometry comprising two generally parallel slots connected by an interconnecting slot. Such cells may appear H-shaped when axis A is in a vertical orientation, or I-shaped axis A is in a horizontal orientation. Each cell 205 has upper and lower axial slots 207 aligned with the axial direction and a circumferential slot 204. Upper and lower slots 207 preferably have an oval, racetrack, rectangular or other oblong shape with a long dimension L generally parallel to axis A and a short dimension W perpendicular thereto. Axial slots 207 are bounded by upper axial struts 206A and lower axial struts 206B, curved outer ends 208 and curved inner ends 210. Each circumferential slot 204 is bounded by an outer circumferential strut 209 and an inner circumferential strut 211. Each I-shaped cell 205 is connected to the adjacent I-shaped cell 205 in the same row 98A or 98B by a circumferential connecting strut 213. All or a portion of cells 205 in row 98A merge or join with cells 205 in row 98B at the inner ends 210, which are integrally formed with the inner ends 210 of the adjacent cells 205.
  • [0067] Stent segment 201 is configured to interleave with an adjacent stent segment of similar construction. Upper and lower axial struts 206A, 206B and outer ends 208 form axial elements E that are received in the spaces S between each element E of the adjacent stent segment 201.
  • In a preferred embodiment, a spacing [0068] member 212 extends outwardly in the axial direction from a selected number of outer circumferential struts 209 and/or connecting struts 213. Spacing member 212 preferably itself forms a subcell 214 in its interior, but alternatively may be solid without any cell or opening therein. For those spacing members 212 attached to outer circumferential struts 209, subcell 214 preferably communicates with I-shaped cell 205. Spacing members 212 are configured to engage the curved outer ends 208 of an adjacent stent segment 201 so as to maintain appropriate spacing between adjacent stent segments. In one embodiment, spacing members 212 have outer ends 216 with two spaced-apart protrusions 218 that provide a cradle-like structure to index and stabilize the curved outer end 208 of the adjacent stent segment. Preferably, spacing members 212 have an axial length of at least about 10%, more preferably at least about 25%, of the long dimension L of I-shaped cells 205, so that the I-shaped cells 205 of adjacent stent segments are spaced apart at least that distance. This results in elements E interleaving a distance of at least about 10%, preferably at least about 25%, and more preferably at least about 50% of their axial length as measured from the circumferential connecting struts 213. Because spacing members 212 experience little or no axial shortening during expansion of stent segments 201, this minimum spacing between stent segments is maintained both in the unexpanded and expanded configurations.
  • FIG. 20B shows [0069] stent segment 201 of FIG. 20A in an expanded configuration. It may be seen that cells 205 are expanded so that upper and lower slots 207 are diamond shaped with circumferential slots 204 remaining basically unchanged. This results in some axial shortening of the stent segment, thereby increasing the spacing between adjacent stent segments. The stent geometry is optimized by balancing the amount of axial shortening and associated inter-segment spacing, the desired degree of vessel wall coverage, the desired metal density, and other factors. Because the stent is comprised of multiple unconnected stent segments 201, any desired number from 2 up to 10 or more stent segments may be deployed simultaneously to treat lesions of any length from 2 mm up to 100 mm or more. Further, because such segments are unconnected to each other, the deployed stent structure is highly flexible and capable of deployment in long lesions having curves and other complex shapes.
  • As an additional feature, [0070] circumferential slots 204 provide a pathway through which vessel side branches can be accessed for catheter interventions. Should stent segment 201 be deployed at a location in which it covers the ostium of a side branch to which access is desired, a balloon dilatation catheter may be positioned through circumferential slot 204 and expanded. This deforms circumferential struts 209, 211 axially outward, thereby expanding circumferential slot 204 and further expanding upper and lower slots 207, as shown in phantom in FIG. 20B. This provides a relatively large opening 220 through which a catheter may be inserted through stent segment 201 and into the side branch for placing stents, performing angioplasty, or carrying out other interventions.
  • FIGS. 21A-21B illustrate a second embodiment of a [0071] stent segment 201′ according to the invention. In FIG. 21A, two stent segments 201′ are shown interleaved in a planar shape for clarity. Similar to the embodiment of FIG. 20A, stent segment 201′ comprises two parallel rows 222A, 222B of I-shaped cells 224 formed into a cylindrical shape around axial axis A. Cells 224 have upper and lower axial slots 226 and a connecting circumferential slot 228. Upper and lower axial slots 226 are bounded by upper axial struts 230, lower axial struts 232, curved outer ends 234, and curved inner ends 236, forming axial elements E configured to be received in spaces S between elements E in the adjacent stent segment 201′. Circumferential slots 228 are bounded by an outer circumferential strut 238 and inner circumferential strut 240. Each I-shaped cell 224 is connected to the adjacent I-shaped cell 224 in the same row 222 by a circumferential connecting strut 242. Row 222A is connected to row 222B by the merger or joining of curved inner ends 236 of at least one and preferably two of slots 226 in each row 222.
  • One of the differences between the embodiment of FIGS. 21A-21B and that of FIGS. 20A-20B is the way in which spacing is maintained between the adjacent interleaved stent segments. In place of the [0072] spacing members 212 of the earlier embodiment, the embodiment of FIG. 21A includes a bulge 244 in upper and lower axial struts 230, 232 extending circumferentially outwardly from axial slots 226. These give axial slots 226 an arrowhead or cross shape at their inner and outer ends. The bulge 244 in each upper axial strut 230 extends toward the bulge 244 in a lower axial strut 232 in the same cell 205 or in an adjacent cell 205, thus narrowing the space S therebetween and creating a concave abutment 246 in the space between each axial slot 226. Concave abutments 246 are configured to receive and engage curved outer ends 234 of cells 224 in the adjacent stent segment, thereby maintaining spacing between the stent segments. The axial location of bulges 244 along upper and lower axial struts 230, 232 may be selected to provide the desired degree of inter-segment spacing. Preferably, the axial depth of concave abutments 246 from curved outer ends 234 is at least about 10% of the axial length of elements E (measured from circumferential struts 242), preferably at least about 25% of the axial length of elements E, and more preferably at least about 50% of the axial length of elements E.
  • FIG. 21B shows two [0073] stent segments 201 of FIG. 21A in an expanded condition. It may be seen that axial slots 226 are deformed into a circumferentially-widened modified diamond shape with bulges 244 on the now diagonal upper and lower axial struts 230, 232. Circumferential slots 228 are generally the same size and shape as in the unexpanded configuration. Bulges 244 have been pulled away from each other to some extent, but still provide a concave abutment 246 to maintain a minimum degree of spacing between adjacent stent segments. As in the earlier embodiment, some axial shortening of each segment occurs upon expansion and stent geometry can be optimized to provide the ideal intersegment spacing.
  • In a preferred embodiment, [0074] stent segments 201′ retain some degree of interleaving in the expanded configuration, with outer ends 234 of elements E on adjacent stent segments being at least circumferentially aligned with each other, and preferably extending into spaces S of the adjacent stent segment a distance of at least about 1%, more preferably at least about 5%, and in some cases at least about 10% of the axial length of elements E as measured from circumferential connecting struts 242. In one exemplary embodiment, for a stent segment 201′ having an axial length of 4 mm and an unexpanded diameter of about 0.5-1.5 mm, elements E have an axial length of about 1 mm and are interleaved a distance Du of about 0.1-0.5 mm in the unexpanded configuration. Segments 201′ are expandable to a diameter of 2.5-3.5 mm and elements E are interleaved a distance De of about 0.01-0.1 mm in the expanded configuration.
  • It should also be noted that the embodiment of FIGS. 21A-21B retains the feature described above with respect to FIGS. 20A-20B to enable access to vessel side branches blocked by [0075] stent segment 201′. Should such side branch access be desired, a dilatation catheter may be inserted into circumferential slot 228 and expanded to provide an enlarged opening through which a side branch may be entered.
  • FIGS. 22A-22B illustrate a variant of the stent structure of FIGS. 21A-21B that has a larger expanded diameter. The primary difference in the embodiment of FIGS. 22A-22B is the geometry of the inner ends [0076] 236′ of each axial slot 226′. Rather than being curved, inner ends 236′ are generally straight and oriented in the circumferential direction. Because of the longer circumferential dimension of the inner ends 236′, an inner portion 250 of each axial strut 230′, 232′ is disposed at an angle relative to the axial direction, giving the inner half 252 of each axial slot 226a trapezoidal shape. Again, bulges 244′ are disposed along axial struts 230′, 232′ so as to create concave abutments 246′ that engage the outer ends 234′ of axial slots 226′ and maintain inter-segment spacing.
  • As shown in FIG. 22B, [0077] stent segment 201″ expands to a configuration similar to that of FIG. 21B, with the exception that inner ends 236′ remain generally straight and aligned with the circumferential direction. Axial slots 226′ are again expanded into a modified diamond shape, with bulges 244′ extending into spaces S to maintain inter-segment spacing. In an exemplary embodiment, stent segment 201″ has a length of about 4 mm and diameter of about 1.0-2.0 mm when unexpanded, and is expandable to a diameter of about 3.0-4.0 mm.
  • The stent structures of the invention are preferably radiopaque so as to be visible by means of fluoroscopy. Radiopaque markers and/or materials may be used in or on the stent structures. Markers of radiopaque materials may be applied to the exterior of the stents, e.g, by applying a metal such as gold, platinum, a radiopaque polymer, or other suitable coating or mark on all or a portion of the stents. Alternatively, the stent structures may include a radiopaque cladding or coating or may be composed of radiopaque materials such as MP35N (ASTM [0078] 562), L-605 cobalt chromium (ASTM F90), other suitable alloys containing radiopaque elements, or multilayered materials having radiopaque layers. As a further option, the stent structures may have a geometry conducive to fluoroscopic visualization, such as having struts of greater thickness, sections of higher density, or overlapping struts. Some of the possible materials that may be used in the stent segments, either alone or in combination, include (by ASTM number):
  • F67-00 Unalloyed Titanium [0079]
  • F75-01 Cobalt-28 Chromium-6 Molybdenum Alloy [0080]
  • F90-01 Wrought Cobalt-20 Chromium-15 Tungsten-10 Nickel Alloy [0081]
  • F136-02a Wrought Titanium-6 Aluminum-4 Vanadium ELI Alloy [0082]
  • F138-00, F139-00 Wrought 18 Chromium-14 Nickel-2.5 Molybdenum Stainless Steel Bar or Sheet [0083]
  • F560-98 Unalloyed Tantalum [0084]
  • F562-02 Wrought 35 Cobalt-35 Nickel-20 Chromium-10 Molybdenum Alloy [0085]
  • F563-00 Wrought Cobalt-20 Nickel-20 Chromium 3.5 Molybdenum-3.5 Tungste-5 Iron Alloy [0086]
  • F688 Wrought Cobalt-35 Nickel-20 Chromium-10 Molybdenum Alloy [0087]
  • F745-00 18 Chromium-12.5 Nickel-2.5 Molybdenum Stainless Steel [0088]
  • F799-02 Cobalt-28 Chromium-6 Molybdenum Alloy [0089]
  • F961-96 Cobalt-35 Nickel-20 Chromium-10 Molybdenum Alloy [0090]
  • F1058-02 Wrought 40 Cobalt-20 Chromium-16 Iron-15 Nickel-7 Molybdenum Alloy [0091]
  • F1091-02 Wrought Cobalt-20 Chromium-15 Tungsten-10 Nickel Alloy [0092]
  • F1108 Titanium-6 Aluminum-4 Vanadium Alloy [0093]
  • F1295-01 Wrought Titanium-6 Aluminum-7 Niobium Alloy [0094]
  • F1314-01 Wrought Nitrogen-strengthened 22 Chromium-13 Nickel-5 Manganese-2.5 Molybdenum Stainless Steel Alloy [0095]
  • F1241-99 Unalloyed Titanium Wire [0096]
  • F1350-02 Wrought 18 Chromium-14 Nickel-2.5 Molybdenum Stainless Steel Wire [0097]
  • F1377-98a Cobalt-28 Chromium-6 Molybdenum Powder coating [0098]
  • F1472-[0099] 02 a Wrought Titanium-6 Aluminum-4 Vanadium Alloy
  • F1537-00 Wrought Cobalt-28 Chromium-6 Molybdenum Alloy [0100]
  • F1580-01 Titanium and Titanium-6 Aluminum-4 Vanadium Alloy Powder coating [0101]
  • F1586-02 Wrought Nitrogen Strengthened 21 Chromium-10 Nickel-3 Mnaganese-2.5 Molybdenum Stainless Steel Bar [0102]
  • F1713-96 Wrought Titanium-13 Niobium-13 Zirconium Alloy [0103]
  • F1813-01 Wrought Titanium-12 Molybdenum-6 Zirconium-2 Iron Alloy [0104]
  • F2063-00 Wrought Nickel-Titanium Shape Memory Alloys [0105]
  • F2066-01 Wrought Titanium-15 Molybdenum Alloy [0106]
  • F2146-01 Wrought Titanium-3 Aluminum-2.5 Vanadium Alloy Seamless Tubing [0107]
  • F2181-02a Wrought Stainless Steel Tubing [0108]
  • The preferred embodiments of the invention are described above in detail for the purpose of setting forth a complete disclosure and for the sake of explanation and clarity. Those skilled in the art will envision other modifications within the scope and sprit of the present disclosure. [0109]

Claims (76)

What is claimed is:
1. A stent structure comprising:
a plurality of radially expansible rings arranged along an axial line, wherein at least some of the axially adjacent rings are not connected and wherein at least some of the axially unconnected rings comprise axially extending elements which interleave with axially extending elements on an adjacent unconnected ring without interlocking with the adjacent unconnected ring.
2. A stent structure as in claim 1, wherein at least some of the axially extending elements comprise expansible closed structures which open as the rings are expanded.
3. A stent structure as in claim 2, wherein the expansible closed structures are selected from the group consisting of boxes, diamonds, rhomboids, ovals, and ellipses.
4. A stent structure as in claim 2, wherein the closed cells are defined by a slot pattern selected from the group consisting of I-patterns, H-patterns, and J-patterns.
5. A stent structure as in claim 1, wherein at least some of the axially extending elements comprise expansible open structures.
6. A stent structure as in claim 5, wherein the expansible open structures are selected from the group consisting of serpentine structures, zigzag structures, and castellated structures.
7. A stent structure as in claim 1, wherein at least some of the axially unconnected rings further comprise spacers which engage the axially extending elements on adjacent rings to provide a preselected spacing between adjacent rings upon radial expansion.
8. A stent structure as in claim 1, wherein the axially unconnected rings are configured to axially shorten upon expansion.
9. A stent structure as in claim 1, wherein the axially extending elements remain interleaved following expansion.
10. A stent structure as in claim 1, wherein the axially extending elements axially interleave over a distance of at least 0.1 mm prior to stent expansion.
11. A stent structure as in claim 10, wherein the distance is in the range from 1 mm to 5 mm.
12. A stent structure as in claim 1, wherein the rings have axial lengths in range from 1 mm to 10 mm, prior to radial expansion.
13. A stent structure as in claim 1, consisting of from two to 50 expansible ring structures.
14. A stent structure as in claim 1, wherein the radially expansible rings releasably carry a biologically active agent.
15. A stent structure as in claim 14, wherein the biologically active agent inhibits hyperplasia.
16. A stent structure as in claim 15, wherein the biologically active agent is selected from the group consisting of anti-neoplastic drugs, including paclitaxel, methotrexate, and batimastal; antibiotics including doxycycline, tetracycline, rapamycin, and actinomycin; immunosuppressants including dexamethasone, and methyl prednisolone; nitric oxide sources including nitroprussides; estrogen; and estradiols.
17. A stent deployment system comprising:
an elongated carrier having a central axis;
a plurality of radially expansible rings arranged over a surface of the elongated carrier, wherein at least some of the radially expansible rings comprise axially extending elements which interleave with axially extending elements on an adjacent unconnected ring without interlocking with the adjacent radially expansible ring.
18. A stent deployment system as in claim 17, wherein the elongated carrier comprises a radially expansible balloon having an outer surface, wherein the radially expansible rings are disposed over the outer surface of the balloon.
19. A stent deployment system as in claim 18, wherein the balloon consists of a single inflation chamber.
20. A stent deployment system as in claim 18, wherein the balloon comprises a plurality of independent chambers wherein individual expansible rings are disposed over single independently inflatable chambers.
21. A stent deployment system as in claim 17, wherein the elongated carrier comprises a carrier tube having an inner surface which constrains the radially expansible rings.
22. A stent deployment system as in claim 21, further comprising a pusher tube arranged to axially advance the radially expansible rings from the carrier tube.
23. A stent deployment system as in claim 22, wherein the radially expansible rings are resilient and radially constrained so that they expand when advanced distally from the carrier tube.
24. A stent deployment system as in claim 17, wherein the radially expansible rings are deformable, said structure further comprising a balloon arranged to expand individual rings as said rings are advanced from the carrier tube.
25. A stent deployment system as in claim 17, wherein at least some of the axially expanding elements comprise expansible closed structures.
26. A stent deployment system as in claim 25, wherein the expansible closed structures are selected from the group consisting of boxes, rhomboids, ovals, ellipses, diamonds, and irregular polygons.
27. A stent deployment structure as in claim 25, wherein the closed cells are defined by a slot pattern selected from the group consisting of I-patterns and H-patterns.
28. A stent deployment structure as in claim 17, wherein at least some of the axially unconnected rings further comprise spacers which engage the axially extending elements on adjacent rings to provide a preselected spacing between adjacent rings upon radial expansion.
29. A stent deployment system as in claim 17, wherein at least some of the axially extending elements comprise expansible open structures.
30. A stent deployment system as in claim 29, wherein the expansible open structures are selected from the group consisting of expansible structures, zigzag structures, and castellated structures.
31. A stent deployment structure as in claim 17, wherein the radially expansible rings are configured to axially shorten upon expansion.
32. A stent deployment structure as in claim 17, wherein the axially extending elements remain interleaved following expansion.
33. A stent deployment structure as in claim 17, wherein the axially extending elements axially interleave over a distance of at least 0.1 mm prior to stent expansion.
34. A stent deployment structure as in claim 33, wherein the distance is in the range from 1 mm to 5 mm.
35. A stent deployment system as in claim 17, wherein the rings have axial lengths in range from 11 mm to 10 mm, prior to radial expansion.
36. A stent deployment system as in claim 35, consisting of from two to 50 expansible ring structures.
37. A stent deployment system as in claim 17, wherein the radially expansible rings releasably carry a biologically active agent.
38. A stent deployment system as in claim 37, wherein the biologically active agent inhibits hyperplasia.
39. A stent deployment system as in claim 38, wherein the biologically active agent is selected from the group consisting of anti-neoplastic drugs including paclitaxel, methotrexate, and batimastal; antibiotics including doxycycline, tetracycline, rapamycin, and actinomycin; immunosuppressants including dexamethasone and methyl prednisolone; nitric oxide sources including nitroprussides; estrogen; and estradiols.
40. A method for arranging multiple independent stent rings on a carrier of a catheter, said method comprising:
providing an elongated carrier structure;
mounting a plurality of radially expansible rings comprising axially extending elements on the carrier structure, wherein the axially extending elements on adjacent rings interleave when mounted on the carrier structure without interlocking.
41. A method as in claim 40, wherein the number of rings mounted on the carrier structure is selected to provide a desired overall stent length.
42. A method as in claim 41, wherein the number of rings is from two to 50 and the overall stent length is in the range from 2 mm to 200 mm.
43. A method as in claim 40, wherein at least some of the axially extending elements comprise expansible closed structures.
44. A method as in claim 43, wherein the expansible closed structures are selected from the group consisting of boxes, rhomboids, ovals, ellipses, diamonds, and irregular polygons.
45. A method as in claim 43, wherein the expansible closed structures are defined by a slot pattern selected from the group consisting of I-patterns and H-patterns, and J-patterns.
46. A method as in claim 40, wherein at least some of the axially extending elements comprise expansible open structures.
47. A method as in claim 46, wherein the expansible open structures are selected from the group consisting of serpentine structures, zigzag structures, and castellated structures.
48. A method as in claim 40, wherein at least some of the axially unconnected rings further comprise spacers which engage the axially extending elements on adjacent rings to provide a preselected spacing between adjacent rings upon radial expansion.
49. A method as in claim 40, wherein the radially expansible rings are configured to axially shorten upon expansion.
50. A method as in claim 40, wherein the axially extending elements remain interleaved following expansion.
51. A method as in claim 40, wherein the axially extending elements axially interleave over a distance of at least 0.1 mm prior to stent expansion.
52. A method as in claim 51, wherein the distance is in the range from 1 mm to 5 mm.
53. A method as in claim 40, wherein the rings have axial lengths in range from 1 mm to 10 mm, prior to radial expansion.
54. A method as in claim 53, wherein the rings have axial lengths in the range from 0.9 mm to 9 mm after radial expansion.
55. A method as in claim 54, consisting of from two to 50 expansible ring structures.
56. A method as in claim 40, wherein the radially expansible rings releasably carry a biologically active agent.
57. A method as in claim 56, wherein the biologically active agent inhibits hyperplasia.
58. A method as in claim 57, wherein the biologically active agent is selected from the group consisting of anti-neoplastic drugs including paclitaxel, methotrexate and batimastal; antibiotics including doxycycline, tetracycline, rapamycin, and actinomycin; immunosuppressants including dexamethasone and methyl prednisolone; nitric oxide sources including nitroprussides; estrogen; and estradiols.
59. A method for stenting a body lumen, said method comprising:
delivering to the body lumen a stent structure having a plurality of radially expansible rings arranged along an axial line, wherein at least some of the axially adjacent rings are not connected and wherein at least some of the axially unconnected rings comprise axially extending elements which interleave with axially extending elements on an adjacent unconnected ring without interlocking with the adjacent unconnected ring; and
expanding at least some of the rings within the body lumen so that the axially extending elements open and axially move apart from each other.
60. A method as in claim 59, wherein the body lumen is a blood vessel.
61. A method as in claim 60, wherein the blood vessel is an artery.
62. A method as in claim 59, wherein two to 50 rings are delivered over a luminal length in the range from 2 mm to 200 mm.
63. A method as in claim 59, wherein at least some of the axially extending elements comprise expansible closed structures which circumferentially expand as the rings are expanded.
64. A method as in claim 63, wherein the expansible closed structures are selected from the group consisting of boxes, rhomboids, ovals, ellipses, diamonds, and irregular polygons.
65. A method as in claim 63, wherein the closed cells are defined by a slot pattern selected from the group consisting of I-patterns, H-patterns, and J-patterns.
66. A method as in claim 59, wherein at least some of the axially extending elements comprise expansible open structures which circumferentially expand as the rings are expanded.
67. A method as in claim 66, wherein the expansible open structures are selected from the group consisting of serpentine structure, zigzag structures, and castellated structures.
68. A method as in claim 59, wherein at least some of the axially unconnected rings further comprise spacers which engage the axially extending elements on adjacent rings to provide a preselected spacing between adjacent rings upon radial expansion.
69. A method as in claim 59, wherein the axially extending elements remain interleaved following expansion.
70. A method as in claim 59 wherein the radially expansible rings are configured to axially shorten upon expansion.
71. A method as in claim 59, wherein the axially extending elements axially interleave over a distance of at least 0.1 mm prior to stent expansion.
72. A method as in claim 71, wherein the distance is in the range from 1 mm to 5 mm.
73. A method as in claim 59, wherein the radially expansible rings carry a biologically active agent which is released in the body lumen after the rings are expanded.
74. A method as in claim 73, wherein the biologically active agent inhibits hyperplasia.
75. A method as in claim 74, wherein the biologically active agent is selected from the group consisting of anti-neoplastic drugs including paclitaxel, methotrexate and batimastal; antibiotics including doxycycline, tetracycline, rapamycin, and actinomycin; immunosuppressants including dexamethasone and methyl prednisolone;
nitric oxide sources including nitroprussides; estrogen; and estradiols.
76. A method as in claim 59, wherein the body lumen is curved, and wherein the axially extending members remain interleaved after expansion of the stent is performed.
US10/738,666 2001-12-03 2003-12-16 Multiple independent nested stent structures and methods for their preparation and deployment Abandoned US20040186551A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US10/738,666 US20040186551A1 (en) 2003-01-17 2003-12-16 Multiple independent nested stent structures and methods for their preparation and deployment
US10/814,593 US8080048B2 (en) 2001-12-03 2004-03-30 Stent delivery for bifurcated vessels
US12/061,951 US20080208318A1 (en) 2003-01-17 2008-04-03 Multiple independent nested stent structures and methods for their preparation and deployment
US12/109,477 US20080208311A1 (en) 2003-01-17 2008-04-25 Multiple independent nested stent structures and methods for their preparation and deployment
US12/492,828 US8282680B2 (en) 2003-01-17 2009-06-26 Multiple independent nested stent structures and methods for their preparation and deployment
US13/599,957 US8740968B2 (en) 2003-01-17 2012-08-30 Multiple independent nested stent structures and methods for their preparation and deployment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44083903P 2003-01-17 2003-01-17
US10/738,666 US20040186551A1 (en) 2003-01-17 2003-12-16 Multiple independent nested stent structures and methods for their preparation and deployment

Related Child Applications (4)

Application Number Title Priority Date Filing Date
US10/814,593 Continuation-In-Part US8080048B2 (en) 2001-12-03 2004-03-30 Stent delivery for bifurcated vessels
US12/061,951 Continuation US20080208318A1 (en) 2003-01-17 2008-04-03 Multiple independent nested stent structures and methods for their preparation and deployment
US12/109,477 Continuation US20080208311A1 (en) 2003-01-17 2008-04-25 Multiple independent nested stent structures and methods for their preparation and deployment
US12/492,828 Continuation US8282680B2 (en) 2003-01-17 2009-06-26 Multiple independent nested stent structures and methods for their preparation and deployment

Publications (1)

Publication Number Publication Date
US20040186551A1 true US20040186551A1 (en) 2004-09-23

Family

ID=32994184

Family Applications (5)

Application Number Title Priority Date Filing Date
US10/738,666 Abandoned US20040186551A1 (en) 2001-12-03 2003-12-16 Multiple independent nested stent structures and methods for their preparation and deployment
US12/061,951 Abandoned US20080208318A1 (en) 2003-01-17 2008-04-03 Multiple independent nested stent structures and methods for their preparation and deployment
US12/109,477 Abandoned US20080208311A1 (en) 2003-01-17 2008-04-25 Multiple independent nested stent structures and methods for their preparation and deployment
US12/492,828 Expired - Lifetime US8282680B2 (en) 2003-01-17 2009-06-26 Multiple independent nested stent structures and methods for their preparation and deployment
US13/599,957 Expired - Fee Related US8740968B2 (en) 2003-01-17 2012-08-30 Multiple independent nested stent structures and methods for their preparation and deployment

Family Applications After (4)

Application Number Title Priority Date Filing Date
US12/061,951 Abandoned US20080208318A1 (en) 2003-01-17 2008-04-03 Multiple independent nested stent structures and methods for their preparation and deployment
US12/109,477 Abandoned US20080208311A1 (en) 2003-01-17 2008-04-25 Multiple independent nested stent structures and methods for their preparation and deployment
US12/492,828 Expired - Lifetime US8282680B2 (en) 2003-01-17 2009-06-26 Multiple independent nested stent structures and methods for their preparation and deployment
US13/599,957 Expired - Fee Related US8740968B2 (en) 2003-01-17 2012-08-30 Multiple independent nested stent structures and methods for their preparation and deployment

Country Status (1)

Country Link
US (5) US20040186551A1 (en)

Cited By (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130683A1 (en) * 2001-12-03 2003-07-10 Xtent, Inc., Apparatus and methods for delivering coiled prostheses
US20050017540A1 (en) * 2003-07-22 2005-01-27 Leigh Arthur Donald Caravan
US20050085897A1 (en) * 2003-10-17 2005-04-21 Craig Bonsignore Stent design having independent stent segments which uncouple upon deployment
WO2006005082A2 (en) 2004-06-28 2006-01-12 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
WO2006036939A2 (en) 2004-09-27 2006-04-06 Xtent, Inc. Self-constrained segmented stents and methods for their deployment
US20060271151A1 (en) * 2005-05-31 2006-11-30 Xtent, Inc. In situ stent formation
EP1749545A2 (en) * 2005-07-29 2007-02-07 Cordis Corporation System for treating aneurysmal disease
EP1769779A2 (en) * 2005-09-28 2007-04-04 Nitinol Development Corporation Intraluminal medical device with nested interlocking segments
US20070100424A1 (en) * 2001-12-03 2007-05-03 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US20070213810A1 (en) * 2005-03-14 2007-09-13 Richard Newhauser Segmented endoprosthesis
US20070233270A1 (en) * 2006-03-29 2007-10-04 Boston Scientific Scimed, Inc. Stent with overlap and high expansion
US20070239257A1 (en) * 2006-03-29 2007-10-11 Jan Weber Stent with overlap and high extension
US20070288183A1 (en) * 2006-06-07 2007-12-13 Cherik Bulkes Analog signal transition detector
US20070288076A1 (en) * 2006-06-07 2007-12-13 Cherik Bulkes Biological tissue stimulator with flexible electrode carrier
WO2007143609A2 (en) 2006-06-02 2007-12-13 Xtent, Inc. Use of plasma in formation of biodegradable stent coating
US20070288077A1 (en) * 2006-06-07 2007-12-13 Cherik Bulkes Self-anchoring electrical lead with multiple electrodes
WO2008103741A1 (en) 2007-02-20 2008-08-28 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
WO2009012417A1 (en) * 2007-07-19 2009-01-22 Bay Street Medical, Inc. Radially expandable stent
US20090157159A1 (en) * 2007-12-12 2009-06-18 Peter Schneider Device and method for tacking plaque to blood vessel wall
US20090171449A1 (en) * 2008-01-02 2009-07-02 Yunbing Wang Stent formed from polymer-bioceramic composite with radiopaque bioceramic particles
US20090240270A1 (en) * 2008-03-21 2009-09-24 Peter Schneider Device and method for opening blood vessels by pre-angioplasty serration and dilatation of atherosclerotic plaque
US20100010622A1 (en) * 2006-03-13 2010-01-14 Abbott Laboratories Hybrid segmented endoprosthesis
US20100042121A1 (en) * 2008-03-21 2010-02-18 Peter Schneider Pre-angioplasty serration of atherosclerotic plaque enabling low-pressure balloon angioplasty and avoidance of stenting
US7704275B2 (en) 2007-01-26 2010-04-27 Reva Medical, Inc. Circumferentially nested expandable device
US20100114294A1 (en) * 2008-11-06 2010-05-06 William Cook Europe Aps Stent Member
US7722662B2 (en) 1998-02-17 2010-05-25 Reva Medical, Inc. Expandable stent with sliding and locking radial elements
US7763065B2 (en) 2004-07-21 2010-07-27 Reva Medical, Inc. Balloon expandable crush-recoverable stent device
US20100262225A1 (en) * 2007-12-12 2010-10-14 Peter Schneider Device and method for tacking plaque to a blood vessel wall
US20100274114A1 (en) * 2007-06-07 2010-10-28 Denker Stephen T Signal sensing in an implanted apparatus with an internal reference
WO2010129846A1 (en) * 2009-05-08 2010-11-11 Synthes Usa, Llc Expandable bone implant
US7837726B2 (en) 2005-03-14 2010-11-23 Abbott Laboratories Visible endoprosthesis
US7892273B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Custom length stent apparatus
US7892274B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Apparatus and methods for deployment of vascular prostheses
US20110046737A1 (en) * 2009-08-19 2011-02-24 Jacques Teisen Method and apparatus for augmenting bone
US7914574B2 (en) 2005-08-02 2011-03-29 Reva Medical, Inc. Axially nested slide and lock expandable device
US7918881B2 (en) 2003-06-09 2011-04-05 Xtent, Inc. Stent deployment systems and methods
US7922755B2 (en) 2001-12-03 2011-04-12 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7938852B2 (en) 2001-12-03 2011-05-10 Xtent, Inc. Apparatus and methods for delivery of braided prostheses
US7947071B2 (en) 2008-10-10 2011-05-24 Reva Medical, Inc. Expandable slide and lock stent
US7988721B2 (en) 2007-11-30 2011-08-02 Reva Medical, Inc. Axially-radially nested expandable device
US8016870B2 (en) 2001-12-03 2011-09-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
US20110230954A1 (en) * 2009-06-11 2011-09-22 Peter Schneider Stent device having focal elevating elements for minimal surface area contact with lumen walls
US8080048B2 (en) 2001-12-03 2011-12-20 Xtent, Inc. Stent delivery for bifurcated vessels
US8083788B2 (en) 2001-12-03 2011-12-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US8142487B2 (en) 2001-03-29 2012-03-27 Xtent, Inc. Balloon catheter for multiple adjustable stent deployment
US20120102708A1 (en) * 2005-02-25 2012-05-03 Abbott Laboratories Vascular Enterprises Limited Modular vascular prosthesis and methods of use
US8177831B2 (en) 2001-12-03 2012-05-15 Xtent, Inc. Stent delivery apparatus and method
US8257427B2 (en) 2001-09-11 2012-09-04 J.W. Medical Systems, Ltd. Expandable stent
US8277500B2 (en) 2004-12-17 2012-10-02 Reva Medical, Inc. Slide-and-lock stent
US8282680B2 (en) 2003-01-17 2012-10-09 J. W. Medical Systems Ltd. Multiple independent nested stent structures and methods for their preparation and deployment
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8425591B1 (en) 2007-06-11 2013-04-23 Abbott Cardiovascular Systems Inc. Methods of forming polymer-bioceramic composite medical devices with bioceramic particles
US8460358B2 (en) 2004-03-30 2013-06-11 J.W. Medical Systems, Ltd. Rapid exchange interventional devices and methods
US20130172976A1 (en) * 2005-05-25 2013-07-04 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US8486132B2 (en) 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8523936B2 (en) 2010-04-10 2013-09-03 Reva Medical, Inc. Expandable slide and lock stent
US8585747B2 (en) 2003-12-23 2013-11-19 J.W. Medical Systems Ltd. Devices and methods for controlling and indicating the length of an interventional element
US8652198B2 (en) 2006-03-20 2014-02-18 J.W. Medical Systems Ltd. Apparatus and methods for deployment of linked prosthetic segments
US20140052232A1 (en) * 2012-08-10 2014-02-20 Altura Medical, Inc. Handle assemblies for stent graft delivery systems and associated systems and methods
WO2014028062A1 (en) * 2012-08-13 2014-02-20 Abbott Cardiovascular Systems Inc. Segmented scaffold designs
WO2013151576A3 (en) * 2012-04-06 2014-03-27 Abbott Cardiovascular Systems Inc. Delivery system for segmented scaffolds
US20140135888A1 (en) * 2012-11-15 2014-05-15 Palmaz Scientific, Inc. Stents having a hybrid pattern and methods of manufacture
US8769796B2 (en) 2008-09-25 2014-07-08 Advanced Bifurcation Systems, Inc. Selective stent crimping
US8795347B2 (en) 2008-09-25 2014-08-05 Advanced Bifurcation Systems, Inc. Methods and systems for treating a bifurcation with provisional side branch stenting
US8808347B2 (en) 2008-09-25 2014-08-19 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
US8821562B2 (en) 2008-09-25 2014-09-02 Advanced Bifurcation Systems, Inc. Partially crimped stent
US20150005870A1 (en) * 2013-03-15 2015-01-01 W. L. Gore & Associates, Inc. Self-expanding, balloon expandable stent-grafts
JP2015503946A (en) * 2011-12-16 2015-02-05 ストライカー コーポレイションStryker Corporation Embolization removal cage
US8979917B2 (en) 2008-09-25 2015-03-17 Advanced Bifurcation Systems, Inc. System and methods for treating a bifurcation
US8986362B2 (en) 2004-06-28 2015-03-24 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US9101503B2 (en) 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
US9149378B2 (en) 2005-08-02 2015-10-06 Reva Medical, Inc. Axially nested slide and lock expandable device
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US9192500B1 (en) 2015-01-29 2015-11-24 Intact Vascular, Inc. Delivery device and method of delivery
US9198666B2 (en) 2005-05-25 2015-12-01 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9198784B2 (en) 2005-06-08 2015-12-01 J.W. Medical Systems Ltd. Apparatus and methods for deployment of multiple custom-length prostheses
US20150366686A1 (en) * 2013-03-01 2015-12-24 The Regents Of The University Of California Apparatus and methods for bidirectional hyperelastic stent covers
US9254210B2 (en) 2011-02-08 2016-02-09 Advanced Bifurcation Systems, Inc. Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US9364356B2 (en) 2011-02-08 2016-06-14 Advanced Bifurcation System, Inc. System and methods for treating a bifurcation with a fully crimped stent
US9375327B2 (en) 2007-12-12 2016-06-28 Intact Vascular, Inc. Endovascular implant
US9375336B1 (en) 2015-01-29 2016-06-28 Intact Vascular, Inc. Delivery device and method of delivery
US9381103B2 (en) * 2014-10-06 2016-07-05 Abbott Cardiovascular Systems Inc. Stent with elongating struts
US9408732B2 (en) 2013-03-14 2016-08-09 Reva Medical, Inc. Reduced-profile slide and lock stent
US9433520B2 (en) 2015-01-29 2016-09-06 Intact Vascular, Inc. Delivery device and method of delivery
US9456914B2 (en) 2015-01-29 2016-10-04 Intact Vascular, Inc. Delivery device and method of delivery
US9603730B2 (en) 2007-12-12 2017-03-28 Intact Vascular, Inc. Endoluminal device and method
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US9730818B2 (en) 2007-12-12 2017-08-15 Intact Vascular, Inc. Endoluminal device and method
US9737424B2 (en) 2008-09-25 2017-08-22 Advanced Bifurcation Systems, Inc. Partially crimped stent
US20180042740A1 (en) * 2015-03-03 2018-02-15 Efemoral Medical Llc Multi-element bioresorbable intravascular stent
US9907684B2 (en) 2013-05-08 2018-03-06 Aneuclose Llc Method of radially-asymmetric stent expansion
US10022250B2 (en) 2007-12-12 2018-07-17 Intact Vascular, Inc. Deployment device for placement of multiple intraluminal surgical staples
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US10166127B2 (en) 2007-12-12 2019-01-01 Intact Vascular, Inc. Endoluminal device and method
US10166374B2 (en) 2015-09-17 2019-01-01 Cagent Vascular, Llc Wedge dissectors for a medical balloon
EP3437865A1 (en) * 2017-07-31 2019-02-06 General Electric Company Components including structures having decoupled load paths
WO2019045695A1 (en) * 2017-08-29 2019-03-07 C.R. Bard, Inc. Reconfigurable stent, and systems and methods for use thereof
US10231856B2 (en) 2016-10-27 2019-03-19 Cook Medical Technologies Llc Stent with segments capable of uncoupling during expansion
US10271973B2 (en) 2011-06-03 2019-04-30 Intact Vascular, Inc. Endovascular implant
US10471238B2 (en) 2014-11-03 2019-11-12 Cagent Vascular, Llc Serration balloon
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10905863B2 (en) 2016-11-16 2021-02-02 Cagent Vascular, Llc Systems and methods of depositing drug into tissue through serrations
US10993824B2 (en) 2016-01-01 2021-05-04 Intact Vascular, Inc. Delivery device and method of delivery
CN113088759A (en) * 2021-04-14 2021-07-09 中国矿业大学 Low-modulus nontoxic harmless biomedical beta-type titanium alloy and preparation method thereof
US11219750B2 (en) 2008-03-21 2022-01-11 Cagent Vascular, Inc. System and method for plaque serration
US11298252B2 (en) 2008-09-25 2022-04-12 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
US11369779B2 (en) 2018-07-25 2022-06-28 Cagent Vascular, Inc. Medical balloon catheters with enhanced pushability
US11622872B2 (en) * 2016-05-16 2023-04-11 Elixir Medical Corporation Uncaging stent
US11660218B2 (en) 2017-07-26 2023-05-30 Intact Vascular, Inc. Delivery device and method of delivery
US11738181B2 (en) 2014-06-04 2023-08-29 Cagent Vascular, Inc. Cage for medical balloon

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6814746B2 (en) * 2002-11-01 2004-11-09 Ev3 Peripheral, Inc. Implant delivery system with marker interlock
US7971333B2 (en) 2006-05-30 2011-07-05 Advanced Cardiovascular Systems, Inc. Manufacturing process for polymetric stents
US7731890B2 (en) * 2006-06-15 2010-06-08 Advanced Cardiovascular Systems, Inc. Methods of fabricating stents with enhanced fracture toughness
US8747879B2 (en) 2006-04-28 2014-06-10 Advanced Cardiovascular Systems, Inc. Method of fabricating an implantable medical device to reduce chance of late inflammatory response
US20140107761A1 (en) 2004-07-26 2014-04-17 Abbott Cardiovascular Systems Inc. Biodegradable stent with enhanced fracture toughness
US8840660B2 (en) 2006-01-05 2014-09-23 Boston Scientific Scimed, Inc. Bioerodible endoprostheses and methods of making the same
US9375215B2 (en) * 2006-01-20 2016-06-28 W. L. Gore & Associates, Inc. Device for rapid repair of body conduits
JP2010503489A (en) 2006-09-15 2010-02-04 ボストン サイエンティフィック リミテッド Biodegradable endoprosthesis and method for producing the same
EP2125065B1 (en) 2006-12-28 2010-11-17 Boston Scientific Limited Bioerodible endoprostheses and methods of making same
US20100318180A1 (en) * 2009-06-15 2010-12-16 Boston Scientific Scimed, Inc. Multi-layer stent assembly
WO2011119573A1 (en) * 2010-03-23 2011-09-29 Boston Scientific Scimed, Inc. Surface treated bioerodible metal endoprostheses
AU2012253583B2 (en) 2011-05-11 2014-09-25 Covidien Lp Vascular remodeling device
EP2564812B1 (en) 2011-08-31 2018-12-19 Cook Medical Technologies LLC Delivery system for an endoluminal prosthesis
US8771341B2 (en) * 2011-11-04 2014-07-08 Reverse Medical Corporation Protuberant aneurysm bridging device and method of use
US9072620B2 (en) 2011-11-04 2015-07-07 Covidien Lp Protuberant aneurysm bridging device deployment method
US9233015B2 (en) 2012-06-15 2016-01-12 Trivascular, Inc. Endovascular delivery system with an improved radiopaque marker scheme
KR101424201B1 (en) * 2012-08-14 2014-08-13 이종훈 Stent provided with window and graft thereof
DE102012220129B4 (en) * 2012-11-05 2022-12-15 Optimed Medizinische Lnstrumente Gmbh stent
US10219924B2 (en) 2012-12-26 2019-03-05 Stryker Corporation Multilayer stent
JP6857140B2 (en) * 2015-05-11 2021-04-14 トリバスキュラー インコーポレイテッド Stent-graft with increased flexibility
WO2017200956A1 (en) 2016-05-16 2017-11-23 Elixir Medical Corporation Uncaging stent
CN111212617B (en) * 2017-08-11 2022-06-03 万能医药公司 Opening support
US10271977B2 (en) 2017-09-08 2019-04-30 Vesper Medical, Inc. Hybrid stent
US11628076B2 (en) 2017-09-08 2023-04-18 Vesper Medical, Inc. Hybrid stent
US11357650B2 (en) 2019-02-28 2022-06-14 Vesper Medical, Inc. Hybrid stent
CN110251284B (en) * 2019-05-21 2021-06-18 泰升医疗有限公司 Expanding stent

Citations (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069825A (en) * 1976-01-28 1978-01-24 Taichiro Akiyama Surgical thread and cutting apparatus for the same
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4564014A (en) * 1980-01-30 1986-01-14 Thomas J. Fogarty Variable length dilatation catheter apparatus and method
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4733685A (en) * 1985-10-10 1988-03-29 Dan Bron Cyclic flow distributor
US4739762A (en) * 1985-11-07 1988-04-26 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4891225A (en) * 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4988356A (en) * 1987-02-27 1991-01-29 C. R. Bard, Inc. Catheter and guidewire exchange system
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5092677A (en) * 1989-08-02 1992-03-03 Artel, Inc. Photometer having a long lamp life, reduced warm-up period and resonant frequency mixing
US5102417A (en) * 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5104404A (en) * 1989-10-02 1992-04-14 Medtronic, Inc. Articulated stent
US5195984A (en) * 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US5282824A (en) * 1990-10-09 1994-02-01 Cook, Incorporated Percutaneous stent assembly
US5300085A (en) * 1986-04-15 1994-04-05 Advanced Cardiovascular Systems, Inc. Angioplasty apparatus facilitating rapid exchanges and method
US5406346A (en) * 1992-04-20 1995-04-11 Asahi Kogaku Kogyo Kabushiki Kaisha Adaptor for film cartridge
US5490837A (en) * 1991-07-05 1996-02-13 Scimed Life Systems, Inc. Single operator exchange catheter having a distal catheter shaft section
US5507768A (en) * 1991-01-28 1996-04-16 Advanced Cardiovascular Systems, Inc. Stent delivery system
US5507771A (en) * 1992-06-15 1996-04-16 Cook Incorporated Stent assembly
US5593412A (en) * 1994-03-01 1997-01-14 Cordis Corporation Stent delivery method and apparatus
US5607444A (en) * 1993-12-02 1997-03-04 Advanced Cardiovascular Systems, Inc. Ostial stent for bifurcations
US5607463A (en) * 1993-03-30 1997-03-04 Medtronic, Inc. Intravascular medical device
US5709701A (en) * 1996-05-30 1998-01-20 Parodi; Juan C. Apparatus for implanting a prothesis within a body passageway
US5716393A (en) * 1994-05-26 1998-02-10 Angiomed Gmbh & Co. Medizintechnik Kg Stent with an end of greater diameter than its main body
US5723003A (en) * 1994-09-13 1998-03-03 Ultrasonic Sensing And Monitoring Systems Expandable graft assembly and method of use
US5722669A (en) * 1995-09-26 1998-03-03 Keeper Co., Ltd. Resin CVJ boot with distinct large and small crest portions
US5735869A (en) * 1994-11-30 1998-04-07 Schneider (Europe) A.G. Balloon catheter and stent delivery device
US5741323A (en) * 1993-04-28 1998-04-21 Focal, Inc. Polymeric article for intraluminal photothermoforming
US5855125A (en) * 1995-07-26 1999-01-05 Malden Mills Industries, Inc. Method for constructing a double face fabric and fabric produced thereby
US5855563A (en) * 1992-11-02 1999-01-05 Localmed, Inc. Method and apparatus for sequentially performing multiple intraluminal procedures
US5858556A (en) * 1997-01-21 1999-01-12 Uti Corporation Multilayer composite tubular structure and method of making
US5870381A (en) * 1995-07-10 1999-02-09 Matsushita Electric Industrial Co., Ltd. Method for transmitting signals from a plurality of transmitting units and receiving the signals
US5879370A (en) * 1994-02-25 1999-03-09 Fischell; Robert E. Stent having a multiplicity of undulating longitudinals
US5891190A (en) * 1989-08-24 1999-04-06 Boneau; Michael D. Endovascular support device and method
US5895398A (en) * 1996-02-02 1999-04-20 The Regents Of The University Of California Method of using a clot capture coil
US6022374A (en) * 1997-12-16 2000-02-08 Cardiovasc, Inc. Expandable stent having radiopaque marker and method
US6022359A (en) * 1999-01-13 2000-02-08 Frantzen; John J. Stent delivery system featuring a flexible balloon
US6033434A (en) * 1995-06-08 2000-03-07 Ave Galway Limited Bifurcated endovascular stent and methods for forming and placing
US6036725A (en) * 1998-06-10 2000-03-14 General Science And Technology Expandable endovascular support device
US6039721A (en) * 1996-07-24 2000-03-21 Cordis Corporation Method and catheter system for delivering medication with an everting balloon catheter
US6042589A (en) * 1998-03-17 2000-03-28 Medicorp, S.A. Reversible-action endoprosthesis delivery device
US6179878B1 (en) * 1996-10-22 2001-01-30 Thomas Duerig Composite self expanding stent device having a restraining element
US6183509B1 (en) * 1995-05-04 2001-02-06 Alain Dibie Endoprosthesis for the treatment of blood-vessel bifurcation stenosis and purpose-built installation device
US6187034B1 (en) * 1999-01-13 2001-02-13 John J. Frantzen Segmented stent for flexible stent delivery system
US6190402B1 (en) * 1996-06-21 2001-02-20 Musc Foundation For Research Development Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same
US6196995B1 (en) * 1998-09-30 2001-03-06 Medtronic Ave, Inc. Reinforced edge exchange catheter
US6200337B1 (en) * 1996-03-10 2001-03-13 Terumo Kabushiki Kaisha Implanting stent
US6334871B1 (en) * 1996-03-13 2002-01-01 Medtronic, Inc. Radiopaque stent markers
US6344272B1 (en) * 1997-03-12 2002-02-05 Wm. Marsh Rice University Metal nanoshells
US6357104B1 (en) * 1993-08-18 2002-03-19 David J. Myers Method of making an intraluminal stent graft
US6363171B1 (en) * 1994-01-13 2002-03-26 Stmicroelectronics S.R.L. Apparatus for recognizing alphanumeric characters
US20020037358A1 (en) * 1997-08-13 2002-03-28 Barry James J. Loading and release of water-insoluble drugs
US6375676B1 (en) * 1999-05-17 2002-04-23 Advanced Cardiovascular Systems, Inc. Self-expanding stent with enhanced delivery precision and stent delivery system
US6379365B1 (en) * 1999-03-29 2002-04-30 Alexis Diaz Stent delivery catheter system having grooved shaft
US6511468B1 (en) * 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
US6520986B2 (en) * 1995-12-14 2003-02-18 Gore Enterprise Holdings, Inc. Kink resistant stent-graft
US6520967B1 (en) * 1999-10-20 2003-02-18 Cauthen Research Group, Inc. Spinal implant insertion instrument for spinal interbody prostheses
US6527549B1 (en) * 2001-09-28 2003-03-04 Guntars Berzins Two-part dental impression tray
US20030045923A1 (en) * 2001-08-31 2003-03-06 Mehran Bashiri Hybrid balloon expandable/self expanding stent
US6530944B2 (en) * 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US6540777B2 (en) * 2001-02-15 2003-04-01 Scimed Life Systems, Inc. Locking stent
US6551350B1 (en) * 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
US6555157B1 (en) * 2000-07-25 2003-04-29 Advanced Cardiovascular Systems, Inc. Method for coating an implantable device and system for performing the method
US6676695B2 (en) * 2001-05-30 2004-01-13 Jan Otto Solem Vascular instrument and method
US6679909B2 (en) * 2001-07-31 2004-01-20 Advanced Cardiovascular Systems, Inc. Rapid exchange delivery system for self-expanding stent
US6685730B2 (en) * 2001-09-26 2004-02-03 Rice University Optically-absorbing nanoparticles for enhanced tissue repair
US20040024450A1 (en) * 2002-04-24 2004-02-05 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
US20040030380A1 (en) * 2002-04-24 2004-02-12 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
US6692465B2 (en) * 1991-06-11 2004-02-17 Advanced Cardiovascular Systems, Inc. Catheter system with catheter and guidewire exchange
US6699724B1 (en) * 1998-03-11 2004-03-02 Wm. Marsh Rice University Metal nanoshells for biosensing applications
US6699280B2 (en) * 1999-04-15 2004-03-02 Mayo Foundation For Medical Education And Research Multi-section stent
US20040044395A1 (en) * 2002-09-03 2004-03-04 Scimed Life Systems, Inc. Elephant trunk thoracic endograft and delivery system
US6702843B1 (en) * 2000-04-12 2004-03-09 Scimed Life Systems, Inc. Stent delivery means with balloon retraction means
US6709440B2 (en) * 2001-05-17 2004-03-23 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6709379B1 (en) * 1998-11-02 2004-03-23 Alcove Surfaces Gmbh Implant with cavities containing therapeutic agents
US6712845B2 (en) * 2001-04-24 2004-03-30 Advanced Cardiovascular Systems, Inc. Coating for a stent and a method of forming the same
US6712827B2 (en) * 1996-08-23 2004-03-30 Scimed Life Systems, Inc. Stent delivery system
US6723071B2 (en) * 2001-03-14 2004-04-20 Scimed Life Systems, Inc. Rapid exchange stent delivery system and associated components
US6837901B2 (en) * 2001-04-27 2005-01-04 Intek Technology L.L.C. Methods for delivering, repositioning and/or retrieving self-expanding stents
US20050010276A1 (en) * 2001-12-03 2005-01-13 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US6849064B2 (en) * 2002-10-25 2005-02-01 James S. Hamada Minimal access lumbar diskectomy instrumentation and method
US6852252B2 (en) * 1997-03-12 2005-02-08 William Marsh Rice University Use of metalnanoshells to impede the photo-oxidation of conjugated polymer
US20050038505A1 (en) * 2001-11-05 2005-02-17 Sun Biomedical Ltd. Drug-delivery endovascular stent and method of forming the same
US6858034B1 (en) * 1999-05-20 2005-02-22 Scimed Life Systems, Inc. Stent delivery system for prevention of kinking, and method of loading and using same
US20050049673A1 (en) * 2001-12-03 2005-03-03 Xtent, Inc. A Delaware Corporation Apparatus and methods for delivery of braided prostheses
US7005454B2 (en) * 1995-07-28 2006-02-28 Rutgers, The State University Polymeric drug formulations
US20060069424A1 (en) * 2004-09-27 2006-03-30 Xtent, Inc. Self-constrained segmented stents and methods for their deployment
US20070027521A1 (en) * 2005-06-08 2007-02-01 Xtent, Inc., A Delaware Corporation Apparatus and methods for deployment of multiple custom-length prostheses
US7192440B2 (en) * 2003-10-15 2007-03-20 Xtent, Inc. Implantable stent delivery devices and methods
US20070067012A1 (en) * 2001-12-03 2007-03-22 Xtent, Inc. Custom length stent apparatus
US7314480B2 (en) * 2003-02-27 2008-01-01 Boston Scientific Scimed, Inc. Rotating balloon expandable sheath bifurcation delivery
US7323006B2 (en) * 2004-03-30 2008-01-29 Xtent, Inc. Rapid exchange interventional devices and methods
US7326236B2 (en) * 2003-12-23 2008-02-05 Xtent, Inc. Devices and methods for controlling and indicating the length of an interventional element
US20080077229A1 (en) * 2004-06-28 2008-03-27 Xtent, Inc. Custom-length self-expanding stent delivery systems with stent bumpers

Family Cites Families (340)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468224A (en) 1982-01-28 1984-08-28 Advanced Cardiovascular Systems, Inc. System and method for catheter placement in blood vessels of a human patient
US5693083A (en) 1983-12-09 1997-12-02 Endovascular Technologies, Inc. Thoracic graft and delivery catheter
DE3442736A1 (en) 1984-11-23 1986-06-05 Tassilo Dr.med. 7800 Freiburg Bonzel DILATATION CATHETER
US4690684A (en) 1985-07-12 1987-09-01 C. R. Bard, Inc. Meltable stent for anastomosis
US4770176A (en) 1985-07-12 1988-09-13 C. R. Bard, Inc. Vessel anastomosis using meltable stent
US4681110A (en) 1985-12-02 1987-07-21 Wiktor Dominik M Catheter arrangement having a blood vessel liner, and method of using it
US5061273A (en) 1989-06-01 1991-10-29 Yock Paul G Angioplasty apparatus facilitating rapid exchanges
US5040548A (en) 1989-06-01 1991-08-20 Yock Paul G Angioplasty mehtod
US4775337A (en) 1986-12-02 1988-10-04 Universal Manufacturing Corporation Conductive wire with integral electrical terminal
US4748982A (en) * 1987-01-06 1988-06-07 Advanced Cardiovascular Systems, Inc. Reinforced balloon dilatation catheter with slitted exchange sleeve and method
ES2043796T3 (en) 1987-02-27 1994-01-01 Bard Inc C R CATHETER AND CHUCK EXCHANGE SYSTEM.
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US5171222A (en) 1988-03-10 1992-12-15 Scimed Life Systems, Inc. Interlocking peel-away dilation catheter
US4994298A (en) * 1988-06-07 1991-02-19 Biogold Inc. Method of making a biocompatible prosthesis
US6730105B2 (en) 1988-07-29 2004-05-04 Samuel Shiber Clover leaf shaped tubular medical device
US5226913A (en) 1988-09-01 1993-07-13 Corvita Corporation Method of making a radially expandable prosthesis
US5092877A (en) * 1988-09-01 1992-03-03 Corvita Corporation Radially expandable endoprosthesis
US4994066A (en) * 1988-10-07 1991-02-19 Voss Gene A Prostatic stent
US4950227A (en) 1988-11-07 1990-08-21 Boston Scientific Corporation Stent delivery system
DE68915150T2 (en) 1989-01-30 1994-10-13 Bard Inc C R Quickly replaceable coronary catheter.
US5217495A (en) 1989-05-10 1993-06-08 United States Surgical Corporation Synthetic semiabsorbable composite yarn
US5035706A (en) 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5158548A (en) 1990-04-25 1992-10-27 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5013318A (en) 1990-07-31 1991-05-07 Special Devices Incorporated Medical instrument for measuring depth of fastener hold in bone
US5122154A (en) 1990-08-15 1992-06-16 Rhodes Valentine J Endovascular bypass graft
AR246020A1 (en) 1990-10-03 1994-03-30 Hector Daniel Barone Juan Carl A ball device for implanting an intraluminous aortic prosthesis, for repairing aneurysms.
US5533968A (en) 1991-05-15 1996-07-09 Advanced Cardiovascular Systems, Inc. Low profile catheter with expandable outer tubular member
US5527354A (en) 1991-06-28 1996-06-18 Cook Incorporated Stent formed of half-round wire
US5976107A (en) 1991-07-05 1999-11-02 Scimed Life Systems. Inc. Catheter having extendable guide wire lumen
ATE112847T1 (en) 1991-07-29 1994-10-15 Brandes Bernd EQUIPMENT AND PROCEDURE FOR DETECTING LEAKS IN TUBES FOR LIQUID MEDIA.
US5443498A (en) 1991-10-01 1995-08-22 Cook Incorporated Vascular stent and method of making and implanting a vacsular stent
US5456713A (en) 1991-10-25 1995-10-10 Cook Incorporated Expandable transluminal graft prosthesis for repairs of aneurysm and method for implanting
CA2079417C (en) 1991-10-28 2003-01-07 Lilip Lau Expandable stents and method of making same
US5628775A (en) 1991-11-08 1997-05-13 Ep Technologies, Inc. Flexible bond for sleeves enclosing a bendable electrode tip assembly
US5192297A (en) * 1991-12-31 1993-03-09 Medtronic, Inc. Apparatus and method for placement and implantation of a stent
WO1993013827A1 (en) 1992-01-09 1993-07-22 Advanced Cardiovascular Systems, Inc. Guidewire replacement device
US5246421A (en) 1992-02-12 1993-09-21 Saab Mark A Method of treating obstructed regions of bodily passages
US5273536A (en) 1992-04-02 1993-12-28 Vicky Savas Tapered balloon catheter
US5201757A (en) 1992-04-03 1993-04-13 Schneider (Usa) Inc. Medial region deployment of radially self-expanding stents
US5562725A (en) 1992-09-14 1996-10-08 Meadox Medicals Inc. Radially self-expanding implantable intraluminal device
US5312415A (en) 1992-09-22 1994-05-17 Target Therapeutics, Inc. Assembly for placement of embolic coils using frictional placement
ATE137656T1 (en) 1992-10-31 1996-05-15 Schneider Europ Ag ARRANGEMENT FOR IMPLANTING SELF-EXPANDING ENDPROSTHESES
WO1994015549A1 (en) 1992-12-30 1994-07-21 Schneider (Usa) Inc. Apparatus for deploying body implantable stents
US5328469A (en) 1993-03-19 1994-07-12 Roger Coletti Hybrid balloon angioplasty catheter and methods of use
US5549553A (en) 1993-04-29 1996-08-27 Scimed Life Systems, Inc. Dilation ballon for a single operator exchange intravascular catheter or similar device
US5480423A (en) 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
US5334187A (en) 1993-05-21 1994-08-02 Cathco, Inc. Balloon catheter system with slit opening handle
US5391172A (en) * 1993-05-24 1995-02-21 Advanced Cardiovascular Systems, Inc. Stent delivery system with coaxial catheter handle
US5458615A (en) 1993-07-06 1995-10-17 Advanced Cardiovascular Systems, Inc. Stent delivery system
US5545209A (en) 1993-09-30 1996-08-13 Texas Petrodet, Inc. Controlled deployment of a medical device
US5445646A (en) 1993-10-22 1995-08-29 Scimed Lifesystems, Inc. Single layer hydraulic sheath stent delivery apparatus and method
US5989280A (en) 1993-10-22 1999-11-23 Scimed Lifesystems, Inc Stent delivery apparatus and method
US5549635A (en) 1994-01-24 1996-08-27 Solar, Rita & Gaterud, Ltd. Non-deformable self-expanding parallel flow endovascular stent and deployment apparatus therefore
US6051020A (en) 1994-02-09 2000-04-18 Boston Scientific Technology, Inc. Bifurcated endoluminal prosthesis
US5449373A (en) 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
CA2499888C (en) 1994-04-01 2010-05-25 Gore Enterprise Holdings, Inc. Self-expandable stent and stent-graft and method of using them
US6165210A (en) 1994-04-01 2000-12-26 Gore Enterprise Holdings, Inc. Self-expandable helical intravascular stent and stent-graft
US5478349A (en) 1994-04-28 1995-12-26 Boston Scientific Corporation Placement of endoprostheses and stents
WO1995029646A1 (en) 1994-04-29 1995-11-09 Boston Scientific Corporation Medical prosthetic stent and method of manufacture
CA2188563C (en) 1994-04-29 2005-08-02 Andrew W. Buirge Stent with collagen
US5554181A (en) 1994-05-04 1996-09-10 Regents Of The University Of Minnesota Stent
US5456694A (en) 1994-05-13 1995-10-10 Stentco, Inc. Device for delivering and deploying intraluminal devices
US5514093A (en) 1994-05-19 1996-05-07 Scimed Life Systems, Inc. Variable length balloon dilatation catheter
US5683451A (en) 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
US5824041A (en) 1994-06-08 1998-10-20 Medtronic, Inc. Apparatus and methods for placement and repositioning of intraluminal prostheses
US5636641A (en) 1994-07-25 1997-06-10 Advanced Cardiovascular Systems, Inc. High strength member for intracorporeal use
US5575816A (en) 1994-08-12 1996-11-19 Meadox Medicals, Inc. High strength and high density intraluminal wire stent
US5470315A (en) 1994-09-20 1995-11-28 Scimed Life Systems, Inc. Over-the-wire type balloon catheter with proximal hypotube
US5702419A (en) 1994-09-21 1997-12-30 Wake Forest University Expandable, intraluminal stents
US5531735A (en) 1994-09-27 1996-07-02 Hercules Incorporated Medical devices containing triggerable disintegration agents
US5549563A (en) 1994-10-11 1996-08-27 Kronner; Richard F. Reinforcing insert for uterine manipulator
US5836964A (en) 1996-10-30 1998-11-17 Medinol Ltd. Stent fabrication method
EP0714640A1 (en) 1994-11-28 1996-06-05 Advanced Cardiovascular Systems, Inc. System and method for delivering multiple stents
US5628755A (en) 1995-02-20 1997-05-13 Schneider (Europe) A.G. Balloon catheter and stent delivery system
CA2163708C (en) 1994-12-07 2007-08-07 Robert E. Fischell Integrated dual-function catheter system for balloon angioplasty and stent delivery
US5549551A (en) 1994-12-22 1996-08-27 Advanced Cardiovascular Systems, Inc. Adjustable length balloon catheter
US5662675A (en) 1995-02-24 1997-09-02 Intervascular, Inc. Delivery catheter assembly
EP1163889B1 (en) 1995-03-01 2008-05-14 Boston Scientific Scimed, Inc. Improved longitudinally flexible expandable stent
US7204848B1 (en) 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US5709713A (en) 1995-03-31 1998-01-20 Cardiovascular Concepts, Inc. Radially expansible vascular prosthesis having reversible and other locking structures
WO1996032078A1 (en) 1995-04-14 1996-10-17 Schneider (Usa) Inc. Rolling membrane stent delivery device
US5807398A (en) 1995-04-28 1998-09-15 Shaknovich; Alexander Shuttle stent delivery catheter
US5534007A (en) 1995-05-18 1996-07-09 Scimed Life Systems, Inc. Stent deployment catheter with collapsible sheath
US5681347A (en) 1995-05-23 1997-10-28 Boston Scientific Corporation Vena cava filter delivery system
JPH10503411A (en) 1995-05-25 1998-03-31 メドトロニック・インコーポレーテッド Stent assembly and method of using the same
US5639274A (en) 1995-06-02 1997-06-17 Fischell; Robert E. Integrated catheter system for balloon angioplasty and stent delivery
JPH11503056A (en) 1995-06-06 1999-03-23 コルヴィタ コーポレーション Intravascular measurement device and introduction / placement means
US6010530A (en) * 1995-06-07 2000-01-04 Boston Scientific Technology, Inc. Self-expanding endoluminal prosthesis
US5797951A (en) 1995-08-09 1998-08-25 Mueller; Edward Gene Expandable support member
US5776141A (en) 1995-08-28 1998-07-07 Localmed, Inc. Method and apparatus for intraluminal prosthesis delivery
DE19531659C2 (en) 1995-08-29 1998-07-02 Ernst Peter Prof Dr M Strecker Stent
US5769882A (en) 1995-09-08 1998-06-23 Medtronic, Inc. Methods and apparatus for conformably sealing prostheses within body lumens
US5702418A (en) 1995-09-12 1997-12-30 Boston Scientific Corporation Stent delivery system
AU6862596A (en) 1995-09-18 1997-04-09 W.L. Gore & Associates, Inc. A delivery system for intraluminal vascular grafts
US5591195A (en) * 1995-10-30 1997-01-07 Taheri; Syde Apparatus and method for engrafting a blood vessel
US5749848A (en) 1995-11-13 1998-05-12 Cardiovascular Imaging Systems, Inc. Catheter system having imaging, balloon angioplasty, and stent deployment capabilities, and method of use for guided stent deployment
US6090063A (en) 1995-12-01 2000-07-18 C. R. Bard, Inc. Device, system and method for implantation of filaments and particles in the body
US5824040A (en) 1995-12-01 1998-10-20 Medtronic, Inc. Endoluminal prostheses and therapies for highly variable body lumens
US6579305B1 (en) 1995-12-07 2003-06-17 Medtronic Ave, Inc. Method and apparatus for delivery deployment and retrieval of a stent comprising shape-memory material
US6878161B2 (en) 1996-01-05 2005-04-12 Medtronic Vascular, Inc. Stent graft loading and deployment device and method
US5749921A (en) 1996-02-20 1998-05-12 Medtronic, Inc. Apparatus and methods for compression of endoluminal prostheses
CA2199890C (en) 1996-03-26 2002-02-05 Leonard Pinchuk Stents and stent-grafts having enhanced hoop strength and methods of making the same
US6533805B1 (en) 1996-04-01 2003-03-18 General Surgical Innovations, Inc. Prosthesis and method for deployment within a body lumen
US5670161A (en) 1996-05-28 1997-09-23 Healy; Kevin E. Biodegradable stent
US7238197B2 (en) 2000-05-30 2007-07-03 Devax, Inc. Endoprosthesis deployment system for treating vascular bifurcations
US6666883B1 (en) 1996-06-06 2003-12-23 Jacques Seguin Endoprosthesis for vascular bifurcation
FR2749500B1 (en) 1996-06-06 1998-11-20 Jacques Seguin DEVICE ALLOWING THE TREATMENT OF BODY DUCTS AT THE LEVEL OF A BIFURCATION
US8728143B2 (en) 1996-06-06 2014-05-20 Biosensors International Group, Ltd. Endoprosthesis deployment system for treating vascular bifurcations
US5697971A (en) 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
US5980514A (en) 1996-07-26 1999-11-09 Target Therapeutics, Inc. Aneurysm closure device assembly
DE19630469C2 (en) 1996-07-27 2000-12-21 Michael Betzler Vascular endoprosthesis, especially for the endovascular treatment of aortic aneurysms
US6090136A (en) 1996-07-29 2000-07-18 Radiance Medical Systems, Inc. Self expandable tubular support
US5922020A (en) 1996-08-02 1999-07-13 Localmed, Inc. Tubular prosthesis having improved expansion and imaging characteristics
US5755781A (en) 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US6217585B1 (en) 1996-08-16 2001-04-17 Converge Medical, Inc. Mechanical stent and graft delivery system
US6007517A (en) 1996-08-19 1999-12-28 Anderson; R. David Rapid exchange/perfusion angioplasty catheter
US6123712A (en) 1996-08-23 2000-09-26 Scimed Life Systems, Inc. Balloon catheter with stent securement means
JP3968444B2 (en) 1996-08-23 2007-08-29 ボストン サイエンティフィック サイムド,インコーポレイテッド Stent delivery mechanism with stent fixation device
US20030093143A1 (en) * 1999-03-01 2003-05-15 Yiju Zhao Medical device having surface depressions containing nitric oxide releasing compound
US5921971A (en) 1996-09-13 1999-07-13 Boston Scientific Corporation Single operator exchange biliary catheter
US6254628B1 (en) 1996-12-09 2001-07-03 Micro Therapeutics, Inc. Intracranial stent
US5772669A (en) 1996-09-27 1998-06-30 Scimed Life Systems, Inc. Stent deployment catheter with retractable sheath
US5755776A (en) 1996-10-04 1998-05-26 Al-Saadon; Khalid Permanent expandable intraluminal tubular stent
US5843119A (en) 1996-10-23 1998-12-01 United States Surgical Corporation Apparatus and method for dilatation of a body lumen and delivery of a prothesis therein
US7341598B2 (en) 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7220275B2 (en) 1996-11-04 2007-05-22 Advanced Stent Technologies, Inc. Stent with protruding branch portion for bifurcated vessels
WO1998020810A1 (en) 1996-11-12 1998-05-22 Medtronic, Inc. Flexible, radially expansible luminal prostheses
DE59610631D1 (en) 1996-11-15 2003-09-04 Schneider Europ Gmbh Buelach Balloon catheter and stent delivery device
JP3523765B2 (en) 1997-01-24 2004-04-26 テルモ株式会社 Living organ dilator
EP0961597B8 (en) 1997-01-24 2005-12-28 Paragon Intellectual Properties, LLC Bistable spring construction for a stent
US5882329A (en) 1997-02-12 1999-03-16 Prolifix Medical, Inc. Apparatus and method for removing stenotic material from stents
GB9703859D0 (en) * 1997-02-25 1997-04-16 Plante Sylvain Expandable intravascular stent
US5814064A (en) 1997-03-06 1998-09-29 Scimed Life Systems, Inc. Distal protection device
US6035856A (en) 1997-03-06 2000-03-14 Scimed Life Systems Percutaneous bypass with branching vessel
IL128261A0 (en) 1999-01-27 1999-11-30 Disc O Tech Medical Tech Ltd Expandable element
US5817101A (en) 1997-03-13 1998-10-06 Schneider (Usa) Inc Fluid actuated stent delivery system
US5792144A (en) 1997-03-31 1998-08-11 Cathco, Inc. Stent delivery catheter system
US6273913B1 (en) 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US6143016A (en) 1997-04-21 2000-11-07 Advanced Cardiovascular Systems, Inc. Sheath and method of use for a stent delivery system
EP0884063B1 (en) 1997-06-10 2004-04-28 Schneider ( Europe) GmbH Catheter system
US6004328A (en) 1997-06-19 1999-12-21 Solar; Ronald J. Radially expandable intraluminal stent and delivery catheter therefore and method of using the same
FR2764794B1 (en) 1997-06-20 1999-11-12 Nycomed Lab Sa EXPANDED TUBULAR DEVICE WITH VARIABLE THICKNESS
US6500174B1 (en) 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6070589A (en) 1997-08-01 2000-06-06 Teramed, Inc. Methods for deploying bypass graft stents
US5899935A (en) 1997-08-04 1999-05-04 Schneider (Usa) Inc. Balloon expandable braided stent with restraint
US5984957A (en) 1997-08-12 1999-11-16 Schneider (Usa) Inc Radially expanded prostheses with axial diameter control
US6056722A (en) 1997-09-18 2000-05-02 Iowa-India Investments Company Limited Of Douglas Delivery mechanism for balloons, drugs, stents and other physical/mechanical agents and methods of use
AU738502B2 (en) 1997-09-24 2001-09-20 Cook Medical Technologies Llc Radially expandable stent
US5972027A (en) 1997-09-30 1999-10-26 Scimed Life Systems, Inc Porous stent drug delivery system
US5961536A (en) 1997-10-14 1999-10-05 Scimed Life Systems, Inc. Catheter having a variable length balloon and method of using the same
NO311781B1 (en) 1997-11-13 2002-01-28 Medinol Ltd Metal multilayer stents
US6241691B1 (en) 1997-12-05 2001-06-05 Micrus Corporation Coated superelastic stent
US6027519A (en) * 1997-12-15 2000-02-22 Stanford; Ulf Harry Catheter with expandable multiband segment
US6159178A (en) * 1998-01-23 2000-12-12 Heartport, Inc. Methods and devices for occluding the ascending aorta and maintaining circulation of oxygenated blood in the patient when the patient's heart is arrested
CA2318890C (en) 1998-01-26 2007-05-22 Anson Medical Limited Reinforced graft
US6280467B1 (en) 1998-02-26 2001-08-28 World Medical Manufacturing Corporation Delivery system for deployment and endovascular assembly of a multi-stage stented graft
US6428811B1 (en) 1998-03-11 2002-08-06 Wm. Marsh Rice University Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
US6425898B1 (en) 1998-03-13 2002-07-30 Cordis Corporation Delivery apparatus for a self-expanding stent
US6129756A (en) 1998-03-16 2000-10-10 Teramed, Inc. Biluminal endovascular graft system
US6132460A (en) 1998-03-27 2000-10-17 Intratherapeutics, Inc. Stent
US6558415B2 (en) 1998-03-27 2003-05-06 Intratherapeutics, Inc. Stent
US6102942A (en) 1998-03-30 2000-08-15 Endovascular Technologies, Inc. Stent/graft deployment catheter with a stent/graft attachment mechanism
US6063111A (en) 1998-03-31 2000-05-16 Cordis Corporation Stent aneurysm treatment system and method
IE980241A1 (en) * 1998-04-02 1999-10-20 Salviac Ltd Delivery catheter with split sheath
US6037647A (en) 1998-05-08 2000-03-14 Fujitsu Limited Semiconductor device having an epitaxial substrate and a fabrication process thereof
US6171334B1 (en) * 1998-06-17 2001-01-09 Advanced Cardiovascular Systems, Inc. Expandable stent and method of use
DE19829702C1 (en) 1998-07-03 2000-03-16 Heraeus Gmbh W C Radially expandable support device V
WO2000012832A2 (en) 1998-08-26 2000-03-09 Molecular Geodesics, Inc. Radially expandable device
US6120522A (en) 1998-08-27 2000-09-19 Scimed Life Systems, Inc. Self-expanding stent delivery catheter
US5997563A (en) 1998-09-28 1999-12-07 Medtronic, Inc. Implantable stent having variable diameter
US6254612B1 (en) 1998-10-22 2001-07-03 Cordis Neurovascular, Inc. Hydraulic stent deployment system
US6293967B1 (en) * 1998-10-29 2001-09-25 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6214036B1 (en) 1998-11-09 2001-04-10 Cordis Corporation Stent which is easily recaptured and repositioned within the body
SG75982A1 (en) 1998-12-03 2000-10-24 Medinol Ltd Controlled detachment stents
US6340366B2 (en) * 1998-12-08 2002-01-22 Bandula Wijay Stent with nested or overlapping rings
US6350277B1 (en) 1999-01-15 2002-02-26 Scimed Life Systems, Inc. Stents with temporary retaining bands
US6558414B2 (en) 1999-02-02 2003-05-06 Impra, Inc. Partial encapsulation of stents using strips and bands
AU758027B2 (en) 1999-02-26 2003-03-13 Lemaitre Vascular, Inc. Catheter assembly with endoluminal prosthesis and method for placing
US6248122B1 (en) 1999-02-26 2001-06-19 Vascular Architects, Inc. Catheter with controlled release endoluminal prosthesis
US6251134B1 (en) 1999-02-28 2001-06-26 Inflow Dynamics Inc. Stent with high longitudinal flexibility
US5976155A (en) 1999-03-05 1999-11-02 Advanced Cardiovascular Systems, Inc. System for removably securing a stent on a catheter assembly and method of use
US6613074B1 (en) 1999-03-10 2003-09-02 Cordis Corporation Endovascular aneurysm embolization device
US6730116B1 (en) 1999-04-16 2004-05-04 Medtronic, Inc. Medical device for intraluminal endovascular stenting
US6273911B1 (en) 1999-04-22 2001-08-14 Advanced Cardiovascular Systems, Inc. Variable strength stent
US6585756B1 (en) 1999-05-14 2003-07-01 Ernst P. Strecker Implantable lumen prosthesis
US6290673B1 (en) * 1999-05-20 2001-09-18 Conor Medsystems, Inc. Expandable medical device delivery system and method
US6241758B1 (en) 1999-05-28 2001-06-05 Advanced Cardiovascular Systems, Inc. Self-expanding stent delivery system and method of use
DE19938377A1 (en) 1999-08-06 2001-03-01 Biotronik Mess & Therapieg Stent for vascular branching
US6415696B1 (en) 1999-09-01 2002-07-09 Kennametal Pc Inc. Toolholder assembly
US6605062B1 (en) 1999-09-02 2003-08-12 Advanced Cardiovascular Systems, Inc. Catheter for guidewire support or exchange
US6383171B1 (en) 1999-10-12 2002-05-07 Allan Will Methods and devices for protecting a passageway in a body when advancing devices through the passageway
AU1083101A (en) 1999-10-12 2001-04-23 Allan R. Will Methods and devices for protecting a passageway in a body
US6409753B1 (en) 1999-10-26 2002-06-25 Scimed Life Systems, Inc. Flexible stent
US6325823B1 (en) 1999-10-29 2001-12-04 Revasc Corporation Endovascular prosthesis accommodating torsional and longitudinal displacements and methods of use
US6428569B1 (en) 1999-11-09 2002-08-06 Scimed Life Systems Inc. Micro structure stent configurations
US6287291B1 (en) 1999-11-09 2001-09-11 Advanced Cardiovascular Systems, Inc. Protective sheath for catheters
JP4473390B2 (en) 2000-01-07 2010-06-02 川澄化学工業株式会社 Stent and stent graft
US6322586B1 (en) 2000-01-10 2001-11-27 Scimed Life Systems, Inc. Catheter tip designs and method of manufacture
US6312458B1 (en) 2000-01-19 2001-11-06 Scimed Life Systems, Inc. Tubular structure/stent/stent securement member
JP2003521334A (en) 2000-02-04 2003-07-15 ウィルソン−クック メディカル インコーポレイテッド Stent introducer device
US7373197B2 (en) 2000-03-03 2008-05-13 Intramedical Imaging, Llc Methods and devices to expand applications of intraoperative radiation probes
IL177381A0 (en) 2000-03-08 2006-12-10 Given Imaging Ltd A device for in vivo imaging
DE10012460A1 (en) 2000-03-15 2001-09-20 Biotronik Mess & Therapieg Stent consists of several adjacent lengthwise tubular sections joined by first and second connections consisting of cell-type elements of one orientation.
US6264683B1 (en) 2000-03-17 2001-07-24 Advanced Cardiovascular Systems, Inc. Stent delivery catheter with bumpers for improved retention of balloon expandable stents
AUPQ641400A0 (en) 2000-03-23 2000-04-15 Kleiner, Daniel E. A device incorporating a hollow member for being positioned along a body cavity of a patient and method of positioning same
US6315708B1 (en) 2000-03-31 2001-11-13 Cordis Corporation Stent with self-expanding end sections
US6964676B1 (en) 2000-04-14 2005-11-15 Scimed Life Systems, Inc. Stent securement system
IL152473A0 (en) 2000-04-28 2003-05-29 Sloan Kettering Inst Cancer Topical anesthetic/opioid formulations and uses thereof
US6451050B1 (en) 2000-04-28 2002-09-17 Cardiovasc, Inc. Stent graft and method
WO2001083017A1 (en) 2000-05-02 2001-11-08 Wilson-Cook Medical, Inc. Introducer device for catheters o.t.l. with eversible sleeve
US6602282B1 (en) 2000-05-04 2003-08-05 Avantec Vascular Corporation Flexible stent structure
JP4754714B2 (en) * 2000-06-01 2011-08-24 テルモ株式会社 Intraluminal indwelling
US6569180B1 (en) 2000-06-02 2003-05-27 Avantec Vascular Corporation Catheter having exchangeable balloon
US6540775B1 (en) * 2000-06-30 2003-04-01 Cordis Corporation Ultraflexible open cell stent
US6773446B1 (en) 2000-08-02 2004-08-10 Cordis Corporation Delivery apparatus for a self-expanding stent
US6629992B2 (en) 2000-08-04 2003-10-07 Advanced Cardiovascular Systems, Inc. Sheath for self-expanding stent
AU2002212621A1 (en) * 2000-09-14 2002-03-26 Tuborg Engineering Nv Adaptive balloon with improved flexibility
US6945989B1 (en) 2000-09-18 2005-09-20 Endotex Interventional Systems, Inc. Apparatus for delivering endoluminal prostheses and methods of making and using them
WO2002060344A2 (en) 2000-09-22 2002-08-08 Scimed Life Systems, Inc. Flexible and expandable stent
US6589273B1 (en) 2000-10-02 2003-07-08 Impra, Inc. Apparatus and method for relining a blood vessel
US6602226B1 (en) 2000-10-12 2003-08-05 Scimed Life Systems, Inc. Low-profile stent delivery system and apparatus
WO2002059226A2 (en) 2000-11-03 2002-08-01 Wm. Marsh Rice University Partial coverage metal nanoshells and method of making same
US6582394B1 (en) 2000-11-14 2003-06-24 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcated vessels
US6743251B1 (en) 2000-11-15 2004-06-01 Scimed Life Systems, Inc. Implantable devices with polymeric detachment junction
US6607553B1 (en) 2000-11-17 2003-08-19 B. Braun Medical, Inc. Method for deploying a thermo-mechanically expandable stent
US6582460B1 (en) 2000-11-20 2003-06-24 Advanced Cardiovascular Systems, Inc. System and method for accurately deploying a stent
US6884257B1 (en) 2000-11-28 2005-04-26 Advanced Cardiovascular Systems, Inc. Stent delivery system with adjustable length balloon
US6468298B1 (en) 2000-12-28 2002-10-22 Advanced Cardiovascular Systems, Inc. Gripping delivery system for self-expanding stents and method of using the same
DE10103000B4 (en) 2001-01-24 2007-08-30 Qualimed Innovative Medizinprodukte Gmbh Radially re-expandable vascular support
DE10105160B4 (en) 2001-02-06 2005-09-01 Osypka, Peter, Dr.-Ing. Implantable vascular support
WO2002065947A2 (en) 2001-02-16 2002-08-29 Abbott Laboratories Vascular Enterprises Limited Implants with fk506 for prophylaxis and treatment of restonoses
US7799064B2 (en) 2001-02-26 2010-09-21 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
AU2002250189A1 (en) 2001-02-26 2002-09-12 Scimed Life Systems, Inc. Bifurcated stent and delivery system
US6790227B2 (en) 2001-03-01 2004-09-14 Cordis Corporation Flexible stent
US20020123786A1 (en) 2001-03-02 2002-09-05 Ventrica, Inc. Methods and devices for bypassing an obstructed target vessel by placing the vessel in communication with a heart chamber containing blood
CA2708603C (en) 2001-03-13 2015-02-17 Yoram Richter Method and apparatus for stenting
EP1258230A3 (en) * 2001-03-29 2003-12-10 CardioSafe Ltd Balloon catheter device
US6660031B2 (en) 2001-04-11 2003-12-09 Scimed Life Systems, Inc. Multi-length delivery system
GB0110551D0 (en) 2001-04-30 2001-06-20 Angiomed Ag Self-expanding stent delivery service
EP1254644A1 (en) * 2001-05-01 2002-11-06 Pan Medical Limited Variable form stent and deployment arrangement for use therewith
US8337540B2 (en) 2001-05-17 2012-12-25 Advanced Cardiovascular Systems, Inc. Stent for treating bifurcations and method of use
US6599314B2 (en) 2001-06-08 2003-07-29 Cordis Corporation Apparatus and method for stenting a vessel using balloon-actuated stent with interlocking elements
US6676693B1 (en) * 2001-06-27 2004-01-13 Advanced Cardiovascular Systems, Inc. Apparatus and method for delivering a self-expanding stent
ATE330564T1 (en) * 2001-07-20 2006-07-15 Sorin Biomedica Cardio Srl STENT
US6599296B1 (en) 2001-07-27 2003-07-29 Advanced Cardiovascular Systems, Inc. Ratcheting handle for intraluminal catheter systems
US6796999B2 (en) 2001-09-06 2004-09-28 Medinol Ltd. Self articulating stent
GB0121980D0 (en) * 2001-09-11 2001-10-31 Cathnet Science Holding As Expandable stent
US20030055485A1 (en) 2001-09-17 2003-03-20 Intra Therapeutics, Inc. Stent with offset cell geometry
US6778316B2 (en) 2001-10-24 2004-08-17 William Marsh Rice University Nanoparticle-based all-optical sensors
JP4043216B2 (en) 2001-10-30 2008-02-06 オリンパス株式会社 Stent
US7270668B2 (en) 2001-12-03 2007-09-18 Xtent, Inc. Apparatus and methods for delivering coiled prostheses
US20030135266A1 (en) 2001-12-03 2003-07-17 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
WO2007136946A2 (en) 2001-12-03 2007-11-29 Xtent, Inc. Delivery catheter having active engagement mechanism for prosthesis
US7351255B2 (en) 2001-12-03 2008-04-01 Xtent, Inc. Stent delivery apparatus and method
US7294146B2 (en) 2001-12-03 2007-11-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
US7309350B2 (en) 2001-12-03 2007-12-18 Xtent, Inc. Apparatus and methods for deployment of vascular prostheses
US20040186551A1 (en) 2003-01-17 2004-09-23 Xtent, Inc. Multiple independent nested stent structures and methods for their preparation and deployment
US8080048B2 (en) 2001-12-03 2011-12-20 Xtent, Inc. Stent delivery for bifurcated vessels
US7137993B2 (en) 2001-12-03 2006-11-21 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US20030114919A1 (en) 2001-12-10 2003-06-19 Mcquiston Jesse Polymeric stent with metallic rings
US6991646B2 (en) * 2001-12-18 2006-01-31 Linvatec Biomaterials, Inc. Method and apparatus for delivering a stent into a body lumen
US20050182477A1 (en) * 2001-12-20 2005-08-18 White Geoffrey H. Intraluminal stent and graft
US7537607B2 (en) 2001-12-21 2009-05-26 Boston Scientific Scimed, Inc. Stent geometry for improved flexibility
AU2003205148A1 (en) 2002-01-16 2003-09-02 Eva Corporation Catheter hand-piece apparatus and method of using the same
US6939368B2 (en) 2002-01-17 2005-09-06 Scimed Life Systems, Inc. Delivery system for self expanding stents for use in bifurcated vessels
US6981985B2 (en) 2002-01-22 2006-01-03 Boston Scientific Scimed, Inc. Stent bumper struts
US6911040B2 (en) 2002-01-24 2005-06-28 Cordis Corporation Covered segmented stent
US7029493B2 (en) * 2002-01-25 2006-04-18 Cordis Corporation Stent with enhanced crossability
US6866679B2 (en) 2002-03-12 2005-03-15 Ev3 Inc. Everting stent and stent delivery system
GB0206061D0 (en) 2002-03-14 2002-04-24 Angiomed Ag Metal structure compatible with MRI imaging, and method of manufacturing such a structure
US6800065B2 (en) 2002-04-04 2004-10-05 Medtronic Ave, Inc. Catheter and guide wire exchange system
US7052511B2 (en) 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Delivery system and method for deployment of foreshortening endoluminal devices
US20030195609A1 (en) 2002-04-10 2003-10-16 Scimed Life Systems, Inc. Hybrid stent
US7648515B2 (en) 2002-04-16 2010-01-19 Tyco Healthcare Group Lp Method and apparatus for anastomosis including an expandable anchor
US7470281B2 (en) 2002-04-26 2008-12-30 Medtronic Vascular, Inc. Coated stent with crimpable coating
US6645547B1 (en) 2002-05-02 2003-11-11 Labcoat Ltd. Stent coating device
US20030225446A1 (en) 2002-05-29 2003-12-04 William A. Cook Australia Pty Ltd. Multi-piece prosthesis deployment apparatus
US7056523B1 (en) 2002-06-21 2006-06-06 Advanced Cardiovascular Systems, Inc. Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine
US20040015224A1 (en) * 2002-07-22 2004-01-22 Armstrong Joseph R. Endoluminal expansion system
US6761734B2 (en) 2002-07-22 2004-07-13 William S. Suhr Segmented balloon catheter for stenting bifurcation lesions
US7141063B2 (en) 2002-08-06 2006-11-28 Icon Medical Corp. Stent with micro-latching hinge joints
US6945995B2 (en) 2002-08-29 2005-09-20 Boston Scientific Scimed, Inc. Stent overlap point markers
US6951053B2 (en) 2002-09-04 2005-10-04 Reva Medical, Inc. Method of manufacturing a prosthesis
US6893417B2 (en) 2002-09-20 2005-05-17 Medtronic Vascular, Inc. Catheter and guide wire exchange system with improved proximal shaft and transition section
JP4033747B2 (en) 2002-09-30 2008-01-16 テルモ株式会社 Biological organ expansion device
US7223283B2 (en) 2002-10-09 2007-05-29 Boston Scientific Scimed, Inc. Stent with improved flexibility
US6994721B2 (en) * 2002-10-21 2006-02-07 Israel Henry M Stent assembly
US7169172B2 (en) * 2002-11-01 2007-01-30 Counter Clockwise, Inc. Method and apparatus for caged stent delivery
AU2003290675A1 (en) 2002-11-07 2004-06-03 Abbott Laboratories Method of loading beneficial agent to a prosthesis by fluid-jet application
KR20050086440A (en) 2002-11-08 2005-08-30 코너 메드시스템즈, 인코포레이티드 Method and apparatus for reducing tissue damage after ischemic injury
ITRM20020596A1 (en) 2002-11-27 2004-05-28 Mauro Ferrari IMPLANT VASCULAR PROSTHESIS WITH COMBINED, LAPAROSCOPIC AND ENDOVASCULAR TECHNIQUES, FOR THE TREATMENT OF ABDOMINAL AORTIC ANEURYSMS, AND OPERATIONAL EQUIPMENT FOR THE RELEASE OF A PROSTHESIS EQUIPPED WITH ANCHORING STENTS.
DE60326000D1 (en) 2002-12-04 2009-03-12 Cook Inc METHOD AND DEVICE FOR TREATMENT IN AORTASE ACTION
WO2004052237A2 (en) 2002-12-09 2004-06-24 Medtronic Vascular Modular stent having polymer bridges at modular unit contact sites
US6849084B2 (en) * 2002-12-31 2005-02-01 Intek Technology L.L.C. Stent delivery system
ES2346059T3 (en) 2003-03-26 2010-10-08 Biosensors International Group Ltd. IMPLANT SUPPLY CATHETER WITH ELECTROLYTICALLY EROSIONABLE JOINTS.
EP1613242B1 (en) 2003-03-26 2013-02-20 The Foundry, LLC Devices for treatment of abdominal aortic aneurysms
US7208001B2 (en) 2003-04-24 2007-04-24 Medtronic Vascular, Inc. Catheter with detached proximal inflation and guidewire shafts
US7241308B2 (en) 2003-06-09 2007-07-10 Xtent, Inc. Stent deployment systems and methods
US7131993B2 (en) 2003-06-25 2006-11-07 Boston Scientific Scimed, Inc. Varying circumferential spanned connectors in a stent
US7744620B2 (en) 2003-07-18 2010-06-29 Intervalve, Inc. Valvuloplasty catheter
US8784472B2 (en) * 2003-08-15 2014-07-22 Boston Scientific Scimed, Inc. Clutch driven stent delivery system
US20050209674A1 (en) 2003-09-05 2005-09-22 Kutscher Tuvia D Balloon assembly (V)
US20070219613A1 (en) 2003-10-06 2007-09-20 Xtent, Inc. Apparatus and methods for interlocking stent segments
US7553324B2 (en) 2003-10-14 2009-06-30 Xtent, Inc. Fixed stent delivery devices and methods
US20050080475A1 (en) 2003-10-14 2005-04-14 Xtent, Inc. A Delaware Corporation Stent delivery devices and methods
US7175654B2 (en) * 2003-10-16 2007-02-13 Cordis Corporation Stent design having stent segments which uncouple upon deployment
US20050085897A1 (en) 2003-10-17 2005-04-21 Craig Bonsignore Stent design having independent stent segments which uncouple upon deployment
WO2005043123A2 (en) 2003-10-31 2005-05-12 Queststar Medical, Inc. System and apparatus for body fluid analysis using surface-textured optical materials
US7220755B2 (en) 2003-11-12 2007-05-22 Biosensors International Group, Ltd. 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
US7090694B1 (en) 2003-11-19 2006-08-15 Advanced Cardiovascular Systems, Inc. Portal design for stent for treating bifurcated vessels
US8157855B2 (en) 2003-12-05 2012-04-17 Boston Scientific Scimed, Inc. Detachable segment stent
US7244336B2 (en) 2003-12-17 2007-07-17 Lam Research Corporation Temperature controlled hot edge ring assembly for reducing plasma reactor etch rate drift
US20070156225A1 (en) 2003-12-23 2007-07-05 Xtent, Inc. Automated control mechanisms and methods for custom length stent apparatus
US9232948B2 (en) 2003-12-23 2016-01-12 Stryker Corporation Catheter with distal occlusion apparatus
US20050149168A1 (en) 2003-12-30 2005-07-07 Daniel Gregorich Stent to be deployed on a bend
US20050222671A1 (en) 2004-03-31 2005-10-06 Schaeffer Darin G Partially biodegradable stent
US20050228477A1 (en) 2004-04-09 2005-10-13 Xtent, Inc. Topographic coatings and coating methods for medical devices
US7820732B2 (en) 2004-04-30 2010-10-26 Advanced Cardiovascular Systems, Inc. Methods for modulating thermal and mechanical properties of coatings on implantable devices
US20050278011A1 (en) 2004-06-10 2005-12-15 Peckham John E Stent delivery system
US7824439B2 (en) * 2004-06-25 2010-11-02 Zeon Corporation Zigzag-shaped stent configured to produce less wall damage
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
ATE506029T1 (en) 2004-10-25 2011-05-15 Merit Medical Systems Inc DEVICE FOR REMOVAL AND REPLACEMENT OF A STENT
US7402168B2 (en) 2005-04-11 2008-07-22 Xtent, Inc. Custom-length stent delivery system with independently operable expansion elements
US8460357B2 (en) 2005-05-31 2013-06-11 J.W. Medical Systems Ltd. In situ stent formation
US7938851B2 (en) 2005-06-08 2011-05-10 Xtent, Inc. Devices and methods for operating and controlling interventional apparatus
US8021426B2 (en) 2005-06-15 2011-09-20 Ouroboros Medical, Inc. Mechanical apparatus and method for artificial disc replacement
JP4797473B2 (en) * 2005-07-11 2011-10-19 ニプロ株式会社 Flexible stent with excellent expandability
WO2007035805A2 (en) 2005-09-20 2007-03-29 Purdue Research Foundation Biocompatable nanophase materials
US20070179587A1 (en) 2006-01-30 2007-08-02 Xtent, Inc. Apparatus and methods for deployment of custom-length prostheses
US8652198B2 (en) 2006-03-20 2014-02-18 J.W. Medical Systems Ltd. Apparatus and methods for deployment of linked prosthetic segments
US20070265637A1 (en) 2006-04-21 2007-11-15 Xtent, Inc. Devices and methods for controlling and counting interventional elements
US20070281117A1 (en) 2006-06-02 2007-12-06 Xtent, Inc. Use of plasma in formation of biodegradable stent coating
US8603530B2 (en) 2006-06-14 2013-12-10 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8236044B2 (en) * 2006-06-30 2012-08-07 Boston Scientific Scimed, Inc. Stent design with variable expansion columns along circumference
US20080269865A1 (en) 2006-08-07 2008-10-30 Xtent, Inc. Custom Length Stent Apparatus
US20080199510A1 (en) 2007-02-20 2008-08-21 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
US8486132B2 (en) 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US9370642B2 (en) 2007-06-29 2016-06-21 J.W. Medical Systems Ltd. Adjustable-length drug delivery balloon
US20090076584A1 (en) 2007-09-19 2009-03-19 Xtent, Inc. Apparatus and methods for deployment of multiple custom-length prostheses

Patent Citations (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069825A (en) * 1976-01-28 1978-01-24 Taichiro Akiyama Surgical thread and cutting apparatus for the same
US4564014A (en) * 1980-01-30 1986-01-14 Thomas J. Fogarty Variable length dilatation catheter apparatus and method
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4891225A (en) * 1984-05-21 1990-01-02 Massachusetts Institute Of Technology Bioerodible polyanhydrides for controlled drug delivery
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4733685A (en) * 1985-10-10 1988-03-29 Dan Bron Cyclic flow distributor
US4739762B1 (en) * 1985-11-07 1998-10-27 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4739762A (en) * 1985-11-07 1988-04-26 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5102417A (en) * 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5501227A (en) * 1986-04-15 1996-03-26 Yock; Paul G. Angioplasty apparatus facilitating rapid exchange and method
US5300085A (en) * 1986-04-15 1994-04-05 Advanced Cardiovascular Systems, Inc. Angioplasty apparatus facilitating rapid exchanges and method
US4988356A (en) * 1987-02-27 1991-01-29 C. R. Bard, Inc. Catheter and guidewire exchange system
US5195984A (en) * 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5092677A (en) * 1989-08-02 1992-03-03 Artel, Inc. Photometer having a long lamp life, reduced warm-up period and resonant frequency mixing
US5891190A (en) * 1989-08-24 1999-04-06 Boneau; Michael D. Endovascular support device and method
US5104404A (en) * 1989-10-02 1992-04-14 Medtronic, Inc. Articulated stent
US5282824A (en) * 1990-10-09 1994-02-01 Cook, Incorporated Percutaneous stent assembly
US5507768A (en) * 1991-01-28 1996-04-16 Advanced Cardiovascular Systems, Inc. Stent delivery system
US6527789B1 (en) * 1991-01-28 2003-03-04 Advanced Cardiovascular Systems, Inc. Stent delivery system
US6692465B2 (en) * 1991-06-11 2004-02-17 Advanced Cardiovascular Systems, Inc. Catheter system with catheter and guidewire exchange
US5490837A (en) * 1991-07-05 1996-02-13 Scimed Life Systems, Inc. Single operator exchange catheter having a distal catheter shaft section
US5406346A (en) * 1992-04-20 1995-04-11 Asahi Kogaku Kogyo Kabushiki Kaisha Adaptor for film cartridge
US5507771A (en) * 1992-06-15 1996-04-16 Cook Incorporated Stent assembly
US5855563A (en) * 1992-11-02 1999-01-05 Localmed, Inc. Method and apparatus for sequentially performing multiple intraluminal procedures
US5607463A (en) * 1993-03-30 1997-03-04 Medtronic, Inc. Intravascular medical device
US5741323A (en) * 1993-04-28 1998-04-21 Focal, Inc. Polymeric article for intraluminal photothermoforming
US6357104B1 (en) * 1993-08-18 2002-03-19 David J. Myers Method of making an intraluminal stent graft
US5607444A (en) * 1993-12-02 1997-03-04 Advanced Cardiovascular Systems, Inc. Ostial stent for bifurcations
US6363171B1 (en) * 1994-01-13 2002-03-26 Stmicroelectronics S.R.L. Apparatus for recognizing alphanumeric characters
US5879370A (en) * 1994-02-25 1999-03-09 Fischell; Robert E. Stent having a multiplicity of undulating longitudinals
US5593412A (en) * 1994-03-01 1997-01-14 Cordis Corporation Stent delivery method and apparatus
US5716393A (en) * 1994-05-26 1998-02-10 Angiomed Gmbh & Co. Medizintechnik Kg Stent with an end of greater diameter than its main body
US5723003A (en) * 1994-09-13 1998-03-03 Ultrasonic Sensing And Monitoring Systems Expandable graft assembly and method of use
US5735869A (en) * 1994-11-30 1998-04-07 Schneider (Europe) A.G. Balloon catheter and stent delivery device
US6183509B1 (en) * 1995-05-04 2001-02-06 Alain Dibie Endoprosthesis for the treatment of blood-vessel bifurcation stenosis and purpose-built installation device
US6033434A (en) * 1995-06-08 2000-03-07 Ave Galway Limited Bifurcated endovascular stent and methods for forming and placing
US5870381A (en) * 1995-07-10 1999-02-09 Matsushita Electric Industrial Co., Ltd. Method for transmitting signals from a plurality of transmitting units and receiving the signals
US5855125A (en) * 1995-07-26 1999-01-05 Malden Mills Industries, Inc. Method for constructing a double face fabric and fabric produced thereby
US7005454B2 (en) * 1995-07-28 2006-02-28 Rutgers, The State University Polymeric drug formulations
US5722669A (en) * 1995-09-26 1998-03-03 Keeper Co., Ltd. Resin CVJ boot with distinct large and small crest portions
US6520986B2 (en) * 1995-12-14 2003-02-18 Gore Enterprise Holdings, Inc. Kink resistant stent-graft
US5895398A (en) * 1996-02-02 1999-04-20 The Regents Of The University Of California Method of using a clot capture coil
US6200337B1 (en) * 1996-03-10 2001-03-13 Terumo Kabushiki Kaisha Implanting stent
US6334871B1 (en) * 1996-03-13 2002-01-01 Medtronic, Inc. Radiopaque stent markers
US5709701A (en) * 1996-05-30 1998-01-20 Parodi; Juan C. Apparatus for implanting a prothesis within a body passageway
US6190402B1 (en) * 1996-06-21 2001-02-20 Musc Foundation For Research Development Insitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same
US6039721A (en) * 1996-07-24 2000-03-21 Cordis Corporation Method and catheter system for delivering medication with an everting balloon catheter
US6712827B2 (en) * 1996-08-23 2004-03-30 Scimed Life Systems, Inc. Stent delivery system
US6179878B1 (en) * 1996-10-22 2001-01-30 Thomas Duerig Composite self expanding stent device having a restraining element
US6551350B1 (en) * 1996-12-23 2003-04-22 Gore Enterprise Holdings, Inc. Kink resistant bifurcated prosthesis
US5858556A (en) * 1997-01-21 1999-01-12 Uti Corporation Multilayer composite tubular structure and method of making
US6344272B1 (en) * 1997-03-12 2002-02-05 Wm. Marsh Rice University Metal nanoshells
US6852252B2 (en) * 1997-03-12 2005-02-08 William Marsh Rice University Use of metalnanoshells to impede the photo-oxidation of conjugated polymer
US20020037358A1 (en) * 1997-08-13 2002-03-28 Barry James J. Loading and release of water-insoluble drugs
US6511468B1 (en) * 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
US6022374A (en) * 1997-12-16 2000-02-08 Cardiovasc, Inc. Expandable stent having radiopaque marker and method
US6699724B1 (en) * 1998-03-11 2004-03-02 Wm. Marsh Rice University Metal nanoshells for biosensing applications
US6042589A (en) * 1998-03-17 2000-03-28 Medicorp, S.A. Reversible-action endoprosthesis delivery device
US6036725A (en) * 1998-06-10 2000-03-14 General Science And Technology Expandable endovascular support device
US6196995B1 (en) * 1998-09-30 2001-03-06 Medtronic Ave, Inc. Reinforced edge exchange catheter
US6709379B1 (en) * 1998-11-02 2004-03-23 Alcove Surfaces Gmbh Implant with cavities containing therapeutic agents
US6022359A (en) * 1999-01-13 2000-02-08 Frantzen; John J. Stent delivery system featuring a flexible balloon
US6187034B1 (en) * 1999-01-13 2001-02-13 John J. Frantzen Segmented stent for flexible stent delivery system
US6379365B1 (en) * 1999-03-29 2002-04-30 Alexis Diaz Stent delivery catheter system having grooved shaft
US6699280B2 (en) * 1999-04-15 2004-03-02 Mayo Foundation For Medical Education And Research Multi-section stent
US6375676B1 (en) * 1999-05-17 2002-04-23 Advanced Cardiovascular Systems, Inc. Self-expanding stent with enhanced delivery precision and stent delivery system
US6858034B1 (en) * 1999-05-20 2005-02-22 Scimed Life Systems, Inc. Stent delivery system for prevention of kinking, and method of loading and using same
US6520967B1 (en) * 1999-10-20 2003-02-18 Cauthen Research Group, Inc. Spinal implant insertion instrument for spinal interbody prostheses
US6530944B2 (en) * 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US6702843B1 (en) * 2000-04-12 2004-03-09 Scimed Life Systems, Inc. Stent delivery means with balloon retraction means
US6555157B1 (en) * 2000-07-25 2003-04-29 Advanced Cardiovascular Systems, Inc. Method for coating an implantable device and system for performing the method
US6540777B2 (en) * 2001-02-15 2003-04-01 Scimed Life Systems, Inc. Locking stent
US6723071B2 (en) * 2001-03-14 2004-04-20 Scimed Life Systems, Inc. Rapid exchange stent delivery system and associated components
US6712845B2 (en) * 2001-04-24 2004-03-30 Advanced Cardiovascular Systems, Inc. Coating for a stent and a method of forming the same
US6837901B2 (en) * 2001-04-27 2005-01-04 Intek Technology L.L.C. Methods for delivering, repositioning and/or retrieving self-expanding stents
US6709440B2 (en) * 2001-05-17 2004-03-23 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6676695B2 (en) * 2001-05-30 2004-01-13 Jan Otto Solem Vascular instrument and method
US6679909B2 (en) * 2001-07-31 2004-01-20 Advanced Cardiovascular Systems, Inc. Rapid exchange delivery system for self-expanding stent
US20030045923A1 (en) * 2001-08-31 2003-03-06 Mehran Bashiri Hybrid balloon expandable/self expanding stent
US6685730B2 (en) * 2001-09-26 2004-02-03 Rice University Optically-absorbing nanoparticles for enhanced tissue repair
US6527549B1 (en) * 2001-09-28 2003-03-04 Guntars Berzins Two-part dental impression tray
US20050038505A1 (en) * 2001-11-05 2005-02-17 Sun Biomedical Ltd. Drug-delivery endovascular stent and method of forming the same
US7182779B2 (en) * 2001-12-03 2007-02-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US20050049673A1 (en) * 2001-12-03 2005-03-03 Xtent, Inc. A Delaware Corporation Apparatus and methods for delivery of braided prostheses
US20050010276A1 (en) * 2001-12-03 2005-01-13 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US20070067012A1 (en) * 2001-12-03 2007-03-22 Xtent, Inc. Custom length stent apparatus
US20040030380A1 (en) * 2002-04-24 2004-02-12 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
US20040024450A1 (en) * 2002-04-24 2004-02-05 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
US20040044395A1 (en) * 2002-09-03 2004-03-04 Scimed Life Systems, Inc. Elephant trunk thoracic endograft and delivery system
US6849064B2 (en) * 2002-10-25 2005-02-01 James S. Hamada Minimal access lumbar diskectomy instrumentation and method
US7314480B2 (en) * 2003-02-27 2008-01-01 Boston Scientific Scimed, Inc. Rotating balloon expandable sheath bifurcation delivery
US7192440B2 (en) * 2003-10-15 2007-03-20 Xtent, Inc. Implantable stent delivery devices and methods
US7326236B2 (en) * 2003-12-23 2008-02-05 Xtent, Inc. Devices and methods for controlling and indicating the length of an interventional element
US7323006B2 (en) * 2004-03-30 2008-01-29 Xtent, Inc. Rapid exchange interventional devices and methods
US20080077229A1 (en) * 2004-06-28 2008-03-27 Xtent, Inc. Custom-length self-expanding stent delivery systems with stent bumpers
US20060069424A1 (en) * 2004-09-27 2006-03-30 Xtent, Inc. Self-constrained segmented stents and methods for their deployment
US20070027521A1 (en) * 2005-06-08 2007-02-01 Xtent, Inc., A Delaware Corporation Apparatus and methods for deployment of multiple custom-length prostheses
US7320702B2 (en) * 2005-06-08 2008-01-22 Xtent, Inc. Apparatus and methods for deployment of multiple custom-length prostheses (III)
US20080071345A1 (en) * 2005-06-08 2008-03-20 Xtent, Inc. Apparatus and methods for deployment of multiple custom-length prostheses (iii)

Cited By (261)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7722662B2 (en) 1998-02-17 2010-05-25 Reva Medical, Inc. Expandable stent with sliding and locking radial elements
US10912665B2 (en) 2001-03-29 2021-02-09 J.W. Medical Systems Ltd. Balloon catheter for multiple adjustable stent deployment
US9980839B2 (en) 2001-03-29 2018-05-29 J.W. Medical Systems Ltd. Balloon catheter for multiple adjustable stent deployment
US8142487B2 (en) 2001-03-29 2012-03-27 Xtent, Inc. Balloon catheter for multiple adjustable stent deployment
US9119739B2 (en) 2001-03-29 2015-09-01 J.W. Medical Systems Ltd. Balloon catheter for multiple adjustable stent deployment
US8147536B2 (en) 2001-03-29 2012-04-03 Xtent, Inc. Balloon catheter for multiple adjustable stent deployment
US8257427B2 (en) 2001-09-11 2012-09-04 J.W. Medical Systems, Ltd. Expandable stent
US8070789B2 (en) 2001-12-03 2011-12-06 Xtent, Inc. Apparatus and methods for deployment of vascular prostheses
US8177831B2 (en) 2001-12-03 2012-05-15 Xtent, Inc. Stent delivery apparatus and method
US8956398B2 (en) 2001-12-03 2015-02-17 J.W. Medical Systems Ltd. Custom length stent apparatus
US7892274B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Apparatus and methods for deployment of vascular prostheses
US20070100424A1 (en) * 2001-12-03 2007-05-03 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US8702781B2 (en) 2001-12-03 2014-04-22 J.W. Medical Systems Ltd. Apparatus and methods for delivery of multiple distributed stents
US7905913B2 (en) 2001-12-03 2011-03-15 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7922755B2 (en) 2001-12-03 2011-04-12 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US8574282B2 (en) 2001-12-03 2013-11-05 J.W. Medical Systems Ltd. Apparatus and methods for delivery of braided prostheses
US7938852B2 (en) 2001-12-03 2011-05-10 Xtent, Inc. Apparatus and methods for delivery of braided prostheses
US8016870B2 (en) 2001-12-03 2011-09-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
US8016871B2 (en) 2001-12-03 2011-09-13 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7892273B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Custom length stent apparatus
US8080048B2 (en) 2001-12-03 2011-12-20 Xtent, Inc. Stent delivery for bifurcated vessels
US8083788B2 (en) 2001-12-03 2011-12-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US9326876B2 (en) 2001-12-03 2016-05-03 J.W. Medical Systems Ltd. Apparatus and methods for delivery of multiple distributed stents
US20030130683A1 (en) * 2001-12-03 2003-07-10 Xtent, Inc., Apparatus and methods for delivering coiled prostheses
US8740968B2 (en) 2003-01-17 2014-06-03 J.W. Medical Systems Ltd. Multiple independent nested stent structures and methods for their preparation and deployment
US8282680B2 (en) 2003-01-17 2012-10-09 J. W. Medical Systems Ltd. Multiple independent nested stent structures and methods for their preparation and deployment
US7918881B2 (en) 2003-06-09 2011-04-05 Xtent, Inc. Stent deployment systems and methods
US20050017540A1 (en) * 2003-07-22 2005-01-27 Leigh Arthur Donald Caravan
US20050085897A1 (en) * 2003-10-17 2005-04-21 Craig Bonsignore Stent design having independent stent segments which uncouple upon deployment
US8585747B2 (en) 2003-12-23 2013-11-19 J.W. Medical Systems Ltd. Devices and methods for controlling and indicating the length of an interventional element
US9566179B2 (en) 2003-12-23 2017-02-14 J.W. Medical Systems Ltd. Devices and methods for controlling and indicating the length of an interventional element
US8460358B2 (en) 2004-03-30 2013-06-11 J.W. Medical Systems, Ltd. Rapid exchange interventional devices and methods
US9700448B2 (en) 2004-06-28 2017-07-11 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
WO2006005082A2 (en) 2004-06-28 2006-01-12 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8986362B2 (en) 2004-06-28 2015-03-24 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US8512394B2 (en) 2004-07-21 2013-08-20 Reva Medical Inc. Balloon expandable crush-recoverable stent device
US7763065B2 (en) 2004-07-21 2010-07-27 Reva Medical, Inc. Balloon expandable crush-recoverable stent device
JP4892485B2 (en) * 2004-09-27 2012-03-07 エックステント・インコーポレーテッド Self-constrained segmented stents and methods for their deployment
WO2006036939A3 (en) * 2004-09-27 2007-05-24 Xtent Inc Self-constrained segmented stents and methods for their deployment
WO2006036939A2 (en) 2004-09-27 2006-04-06 Xtent, Inc. Self-constrained segmented stents and methods for their deployment
US8292944B2 (en) 2004-12-17 2012-10-23 Reva Medical, Inc. Slide-and-lock stent
US9173751B2 (en) 2004-12-17 2015-11-03 Reva Medical, Inc. Slide-and-lock stent
US8277500B2 (en) 2004-12-17 2012-10-02 Reva Medical, Inc. Slide-and-lock stent
US20120102708A1 (en) * 2005-02-25 2012-05-03 Abbott Laboratories Vascular Enterprises Limited Modular vascular prosthesis and methods of use
US8603154B2 (en) * 2005-02-25 2013-12-10 Abbott Laboratories Vascular Enterprises Limited Modular vascular prosthesis and methods of use
US7837726B2 (en) 2005-03-14 2010-11-23 Abbott Laboratories Visible endoprosthesis
US20070213810A1 (en) * 2005-03-14 2007-09-13 Richard Newhauser Segmented endoprosthesis
US20130172976A1 (en) * 2005-05-25 2013-07-04 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US9204983B2 (en) * 2005-05-25 2015-12-08 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US10322018B2 (en) * 2005-05-25 2019-06-18 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9198666B2 (en) 2005-05-25 2015-12-01 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US20160151184A1 (en) * 2005-05-25 2016-06-02 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US10064747B2 (en) 2005-05-25 2018-09-04 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9381104B2 (en) 2005-05-25 2016-07-05 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US20060271151A1 (en) * 2005-05-31 2006-11-30 Xtent, Inc. In situ stent formation
US8460357B2 (en) 2005-05-31 2013-06-11 J.W. Medical Systems Ltd. In situ stent formation
US11439524B2 (en) 2005-06-08 2022-09-13 J.W. Medical Systems Ltd. Apparatus and methods for deployment of multiple custom-length prostheses (III)
US9198784B2 (en) 2005-06-08 2015-12-01 J.W. Medical Systems Ltd. Apparatus and methods for deployment of multiple custom-length prostheses
US10219923B2 (en) 2005-06-08 2019-03-05 J.W. Medical Systems Ltd. Apparatus and methods for deployment of multiple custom-length prostheses (III)
EP1749545A2 (en) * 2005-07-29 2007-02-07 Cordis Corporation System for treating aneurysmal disease
EP1749545A3 (en) * 2005-07-29 2007-03-21 Cordis Corporation System for treating aneurysmal disease
US7914574B2 (en) 2005-08-02 2011-03-29 Reva Medical, Inc. Axially nested slide and lock expandable device
US9149378B2 (en) 2005-08-02 2015-10-06 Reva Medical, Inc. Axially nested slide and lock expandable device
US8617235B2 (en) 2005-08-02 2013-12-31 Reva Medical, Inc. Axially nested slide and lock expandable device
US8562666B2 (en) 2005-09-28 2013-10-22 Nitinol Development Corporation Intraluminal medical device with nested interlocking segments
JP2007090074A (en) * 2005-09-28 2007-04-12 Nitinol Dev Corp Intraluminal medical instrument superposedly connected to one another
EP1769779A3 (en) * 2005-09-28 2007-04-11 Nitinol Development Corporation Intraluminal medical device with nested interlocking segments
EP1769779A2 (en) * 2005-09-28 2007-04-04 Nitinol Development Corporation Intraluminal medical device with nested interlocking segments
US20100010622A1 (en) * 2006-03-13 2010-01-14 Abbott Laboratories Hybrid segmented endoprosthesis
US20140236282A1 (en) * 2006-03-20 2014-08-21 J.W. Medical Systems Ltd. Apparatus and methods for deployment of linked prosthetic segments
US9883957B2 (en) * 2006-03-20 2018-02-06 J.W. Medical Systems Ltd. Apparatus and methods for deployment of linked prosthetic segments
US8652198B2 (en) 2006-03-20 2014-02-18 J.W. Medical Systems Ltd. Apparatus and methods for deployment of linked prosthetic segments
US8043358B2 (en) * 2006-03-29 2011-10-25 Boston Scientific Scimed, Inc. Stent with overlap and high extension
US20070233270A1 (en) * 2006-03-29 2007-10-04 Boston Scientific Scimed, Inc. Stent with overlap and high expansion
US8348991B2 (en) 2006-03-29 2013-01-08 Boston Scientific Scimed, Inc. Stent with overlap and high expansion
US20070239257A1 (en) * 2006-03-29 2007-10-11 Jan Weber Stent with overlap and high extension
WO2007143609A2 (en) 2006-06-02 2007-12-13 Xtent, Inc. Use of plasma in formation of biodegradable stent coating
US20070288077A1 (en) * 2006-06-07 2007-12-13 Cherik Bulkes Self-anchoring electrical lead with multiple electrodes
US20070288183A1 (en) * 2006-06-07 2007-12-13 Cherik Bulkes Analog signal transition detector
US20070288076A1 (en) * 2006-06-07 2007-12-13 Cherik Bulkes Biological tissue stimulator with flexible electrode carrier
US8540762B2 (en) 2007-01-26 2013-09-24 Reva Medical, Inc. Circumferentially nested expandable device
US8172894B2 (en) 2007-01-26 2012-05-08 Reva Medical, Inc. Circumferentially nested expandable device
US7704275B2 (en) 2007-01-26 2010-04-27 Reva Medical, Inc. Circumferentially nested expandable device
US9457133B2 (en) 2007-02-20 2016-10-04 J.W. Medical Systems Ltd. Thermo-mechanically controlled implants and methods of use
US8980297B2 (en) 2007-02-20 2015-03-17 J.W. Medical Systems Ltd. Thermo-mechanically controlled implants and methods of use
WO2008103741A1 (en) 2007-02-20 2008-08-28 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
US8486132B2 (en) 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US9339404B2 (en) 2007-03-22 2016-05-17 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US20100274114A1 (en) * 2007-06-07 2010-10-28 Denker Stephen T Signal sensing in an implanted apparatus with an internal reference
US8366628B2 (en) 2007-06-07 2013-02-05 Kenergy, Inc. Signal sensing in an implanted apparatus with an internal reference
US9144487B2 (en) 2007-06-11 2015-09-29 Abbott Cardiovascular Systems Inc. Polymer-bioceramic composite medical devices with bioceramic particles having grafted polymers
US8425591B1 (en) 2007-06-11 2013-04-23 Abbott Cardiovascular Systems Inc. Methods of forming polymer-bioceramic composite medical devices with bioceramic particles
US20090024205A1 (en) * 2007-07-19 2009-01-22 Bay Street Medical Radially Expandable Stent
WO2009012417A1 (en) * 2007-07-19 2009-01-22 Bay Street Medical, Inc. Radially expandable stent
US9144508B2 (en) * 2007-07-19 2015-09-29 Back Bay Medical Inc. Radially expandable stent
US8460363B2 (en) 2007-11-30 2013-06-11 Reva Medical, Inc. Axially-radially nested expandable device
US9314354B2 (en) 2007-11-30 2016-04-19 Reva Medical, Inc. Axially-radially nested expandable device
US7988721B2 (en) 2007-11-30 2011-08-02 Reva Medical, Inc. Axially-radially nested expandable device
US9730818B2 (en) 2007-12-12 2017-08-15 Intact Vascular, Inc. Endoluminal device and method
US10660771B2 (en) 2007-12-12 2020-05-26 Intact Vacsular, Inc. Deployment device for placement of multiple intraluminal surgical staples
US20110004237A1 (en) * 2007-12-12 2011-01-06 Peter Schneider Minimal surface area contact device for holding plaque to blood vessel wall
US8128677B2 (en) 2007-12-12 2012-03-06 Intact Vascular LLC Device and method for tacking plaque to a blood vessel wall
US10278839B2 (en) 2007-12-12 2019-05-07 Intact Vascular, Inc. Endovascular impant
US9974670B2 (en) * 2007-12-12 2018-05-22 Intact Vascular, Inc. Method of treating atherosclerotic occlusive disease
US10299945B2 (en) 2007-12-12 2019-05-28 Intact Vascular, Inc. Method of treating atherosclerotic occlusive disease
US9375327B2 (en) 2007-12-12 2016-06-28 Intact Vascular, Inc. Endovascular implant
US7896911B2 (en) 2007-12-12 2011-03-01 Innovasc Llc Device and method for tacking plaque to blood vessel wall
US10835395B2 (en) 2007-12-12 2020-11-17 Intact Vascular, Inc. Method of treating atherosclerotic occlusive disease
US10188533B2 (en) * 2007-12-12 2019-01-29 Intact Vascular, Inc. Minimal surface area contact device for holding plaque to blood vessel wall
US20090157159A1 (en) * 2007-12-12 2009-06-18 Peter Schneider Device and method for tacking plaque to blood vessel wall
US9545322B2 (en) 2007-12-12 2017-01-17 Intact Vascular, Inc. Device and method for tacking plaque to blood vessel wall
US10117762B2 (en) 2007-12-12 2018-11-06 Intact Vascular, Inc. Endoluminal device and method
US10166127B2 (en) 2007-12-12 2019-01-01 Intact Vascular, Inc. Endoluminal device and method
US10022250B2 (en) 2007-12-12 2018-07-17 Intact Vascular, Inc. Deployment device for placement of multiple intraluminal surgical staples
US20100262225A1 (en) * 2007-12-12 2010-10-14 Peter Schneider Device and method for tacking plaque to a blood vessel wall
US9603730B2 (en) 2007-12-12 2017-03-28 Intact Vascular, Inc. Endoluminal device and method
US20120083872A1 (en) * 2007-12-12 2012-04-05 Peter Schneider Device and method for tacking plaque to a blood vessel wall
US10799374B2 (en) 2007-12-12 2020-10-13 Intact Vascular, Inc. Device and method for tacking plaque to blood vessel wall
US7935143B2 (en) * 2008-01-02 2011-05-03 Abbott Cardiovascular Systems Inc. Stent formed from polymer-bioceramic composite with radiopaque bioceramic particles
US20110172758A1 (en) * 2008-01-02 2011-07-14 Yunbing Wang Stents Formed From Polymer-Bioceramic Composite With Radiopaque Bioceramic Particles
US20090171449A1 (en) * 2008-01-02 2009-07-02 Yunbing Wang Stent formed from polymer-bioceramic composite with radiopaque bioceramic particles
US8043367B2 (en) 2008-01-02 2011-10-25 Abbott Cardiovascular Systems Inc. Stents formed from polymer-bioceramic composite with radiopaque bioceramic particles
US9101503B2 (en) 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
US9393386B2 (en) 2008-03-21 2016-07-19 Cagent Vascular, Llc Intravascular device
US11219750B2 (en) 2008-03-21 2022-01-11 Cagent Vascular, Inc. System and method for plaque serration
US9480826B2 (en) 2008-03-21 2016-11-01 Cagent Vascular, Llc Intravascular device
US20090240270A1 (en) * 2008-03-21 2009-09-24 Peter Schneider Device and method for opening blood vessels by pre-angioplasty serration and dilatation of atherosclerotic plaque
US11166742B2 (en) 2008-03-21 2021-11-09 Cagent Vascular, Inc. Method of enhancing drug uptake from a drug-eluting balloon
US11229777B2 (en) 2008-03-21 2022-01-25 Cagent Vascular, Inc. System and method for plaque serration
US11529501B2 (en) 2008-03-21 2022-12-20 Gagent Vascular, Inc. System and method for plaque serration
US20100042121A1 (en) * 2008-03-21 2010-02-18 Peter Schneider Pre-angioplasty serration of atherosclerotic plaque enabling low-pressure balloon angioplasty and avoidance of stenting
US8323243B2 (en) 2008-03-21 2012-12-04 Innovasc Llc Device and method for opening blood vessels by pre-angioplasty serration and dilatation of atherosclerotic plaque
US11141573B2 (en) 2008-03-21 2021-10-12 Cagent Vascular, Inc. Method for plaque serration
US10716573B2 (en) 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US11707371B2 (en) 2008-05-13 2023-07-25 Covidien Lp Braid implant delivery systems
US10610389B2 (en) 2008-05-13 2020-04-07 Covidien Lp Braid implant delivery systems
US8979917B2 (en) 2008-09-25 2015-03-17 Advanced Bifurcation Systems, Inc. System and methods for treating a bifurcation
US8795347B2 (en) 2008-09-25 2014-08-05 Advanced Bifurcation Systems, Inc. Methods and systems for treating a bifurcation with provisional side branch stenting
US9855158B2 (en) 2008-09-25 2018-01-02 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
US8828071B2 (en) 2008-09-25 2014-09-09 Advanced Bifurcation Systems, Inc. Methods and systems for ostial stenting of a bifurcation
US11000392B2 (en) 2008-09-25 2021-05-11 Advanced Bifurcation Systems Inc. Partially crimped stent
US10610391B2 (en) 2008-09-25 2020-04-07 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
US8821562B2 (en) 2008-09-25 2014-09-02 Advanced Bifurcation Systems, Inc. Partially crimped stent
US8808347B2 (en) 2008-09-25 2014-08-19 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
US10918506B2 (en) 2008-09-25 2021-02-16 Advanced Bifurcation Systems Inc. System and methods for treating a bifurcation
US9737424B2 (en) 2008-09-25 2017-08-22 Advanced Bifurcation Systems, Inc. Partially crimped stent
US9730821B2 (en) 2008-09-25 2017-08-15 Advanced Bifurcation Systems, Inc. Methods and systems for treating a bifurcation with provisional side branch stenting
US9724218B2 (en) 2008-09-25 2017-08-08 Advanced Bifurcation Systems, Inc. Methods and systems for ostial stenting of a bifurcation
US10219926B2 (en) 2008-09-25 2019-03-05 Advanced Bifurcation Systems Inc. Selective stent crimping
US8769796B2 (en) 2008-09-25 2014-07-08 Advanced Bifurcation Systems, Inc. Selective stent crimping
US10219927B2 (en) 2008-09-25 2019-03-05 Advanced Bifurcation Systems Inc. System and methods for treating a bifurcation
US11426297B2 (en) 2008-09-25 2022-08-30 Advanced Bifurcation Systems Inc. Selective stent crimping
US11298252B2 (en) 2008-09-25 2022-04-12 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
US11839562B2 (en) 2008-09-25 2023-12-12 Advanced Bifurcation Systems Inc. Partially crimped stent
US11857442B2 (en) 2008-09-25 2024-01-02 Advanced Bifurcation Systems Inc. System and methods for treating a bifurcation
US8545547B2 (en) 2008-10-10 2013-10-01 Reva Medical Inc. Expandable slide and lock stent
US9066827B2 (en) 2008-10-10 2015-06-30 Reva Medical, Inc. Expandable slide and lock stent
US7947071B2 (en) 2008-10-10 2011-05-24 Reva Medical, Inc. Expandable slide and lock stent
US20100114294A1 (en) * 2008-11-06 2010-05-06 William Cook Europe Aps Stent Member
US8092516B2 (en) 2008-11-06 2012-01-10 Cook Medical Technologies Llc Stent member
AU2009311658B2 (en) * 2008-11-06 2013-06-27 Cook Medical Technologies Llc Stent member
WO2010053563A1 (en) * 2008-11-06 2010-05-14 William Cook Europe Aps Stent member
JP2012507387A (en) * 2008-11-06 2012-03-29 ウィリアム クック ユーロープ アーペーエス Stent member
US9216023B2 (en) 2009-05-08 2015-12-22 DePuy Synthes Products, Inc. Expandable bone implant
US20100286782A1 (en) * 2009-05-08 2010-11-11 Konrad Schaller Expandable bone implant
WO2010129846A1 (en) * 2009-05-08 2010-11-11 Synthes Usa, Llc Expandable bone implant
US9925055B2 (en) 2009-05-08 2018-03-27 DePuy Synthes Products, Inc. Expandable bone implant
US10646349B2 (en) 2009-05-08 2020-05-12 DePuy Synthes Products, Inc. Expandable bone implant
US10779971B2 (en) 2009-06-11 2020-09-22 Intact Vascular, Inc. Endovascular implant
US20110230954A1 (en) * 2009-06-11 2011-09-22 Peter Schneider Stent device having focal elevating elements for minimal surface area contact with lumen walls
US10888443B2 (en) 2009-06-11 2021-01-12 Intact Vascular, Inc. Device for holding plaque to blood vessel wall
US9247970B2 (en) 2009-08-19 2016-02-02 DePuy Synthes Products, Inc. Method and apparatus for augmenting bone
US11576704B2 (en) 2009-08-19 2023-02-14 DePuy Synthes Products, Inc. Method and apparatus for augmenting bone
US10413340B2 (en) 2009-08-19 2019-09-17 DePuy Synthes Products, Inc. Method and apparatus for augmenting bone
US20110046737A1 (en) * 2009-08-19 2011-02-24 Jacques Teisen Method and apparatus for augmenting bone
US9987055B2 (en) 2009-08-19 2018-06-05 DePuy Synthes Products, Inc. Method and apparatus for augmenting bone
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US9452068B2 (en) 2010-04-10 2016-09-27 Reva Medical, Inc. Expandable slide and lock stent
US8523936B2 (en) 2010-04-10 2013-09-03 Reva Medical, Inc. Expandable slide and lock stent
US10137013B2 (en) 2010-05-29 2018-11-27 Intact Vascular, Inc. Endoluminal device and method
US10779968B2 (en) 2010-05-29 2020-09-22 Intact Vascular, Inc. Endoluminal device and method
US11000393B2 (en) 2011-02-08 2021-05-11 Advanced Bifurcation Systems Inc. System and methods for treating a bifurcation with a fully crimped stent
US11484424B2 (en) 2011-02-08 2022-11-01 Advanced Bifurcation Systems Inc. Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
US10406010B2 (en) 2011-02-08 2019-09-10 Advanced Bifurcation Systems Inc. Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
US9364356B2 (en) 2011-02-08 2016-06-14 Advanced Bifurcation System, Inc. System and methods for treating a bifurcation with a fully crimped stent
US10285832B2 (en) 2011-02-08 2019-05-14 Advanced Bifurcation Systems Inc. System and methods for treating a bifurcation with a fully crimped stent
US9254210B2 (en) 2011-02-08 2016-02-09 Advanced Bifurcation Systems, Inc. Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
US11717428B2 (en) 2011-02-08 2023-08-08 Advanced Bifurcation Systems Inc. System and methods for treating a bifurcation with a fully crimped stent
US10390977B2 (en) 2011-06-03 2019-08-27 Intact Vascular, Inc. Endovascular implant
US10779969B2 (en) 2011-06-03 2020-09-22 Intact Vascular, Inc. Endovascular implant and deployment devices
US10285831B2 (en) 2011-06-03 2019-05-14 Intact Vascular, Inc. Endovascular implant
US10271973B2 (en) 2011-06-03 2019-04-30 Intact Vascular, Inc. Endovascular implant
EP2790598B1 (en) * 2011-12-16 2017-04-26 Stryker Corporation Embolectomy cage
US9439750B2 (en) 2011-12-16 2016-09-13 Stryker Corporation Embolectomy cage
JP2015503946A (en) * 2011-12-16 2015-02-05 ストライカー コーポレイションStryker Corporation Embolization removal cage
US9254212B2 (en) 2012-04-06 2016-02-09 Abbott Cardiovascular Systems Inc. Segmented scaffolds and delivery thereof for peripheral applications
WO2013151576A3 (en) * 2012-04-06 2014-03-27 Abbott Cardiovascular Systems Inc. Delivery system for segmented scaffolds
US9895244B2 (en) 2012-04-06 2018-02-20 Abbott Cardiovascular Systems Inc. Segmented scaffolds and delivery thereof for peripheral applications
US9877856B2 (en) 2012-07-18 2018-01-30 Covidien Lp Methods and apparatus for luminal stenting
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US20140052232A1 (en) * 2012-08-10 2014-02-20 Altura Medical, Inc. Handle assemblies for stent graft delivery systems and associated systems and methods
WO2014028062A1 (en) * 2012-08-13 2014-02-20 Abbott Cardiovascular Systems Inc. Segmented scaffold designs
JP2015529102A (en) * 2012-08-13 2015-10-05 アボット カルディオバスキュラー システムズ インコーポレーテッドAbbott Cardiovascular Systems Inc. Segmented scaffold structure
CN104540477A (en) * 2012-08-13 2015-04-22 艾博特心血管系统公司 Segmented scaffold designs
US9585778B2 (en) 2012-08-13 2017-03-07 Abbott Cardiovascular Systems Inc. Segmented scaffold designs
US9585779B2 (en) 2012-08-13 2017-03-07 Abbott Cardiovascular Systems Inc. Segmented scaffold designs
US8834556B2 (en) * 2012-08-13 2014-09-16 Abbott Cardiovascular Systems Inc. Segmented scaffold designs
US10433989B2 (en) 2012-11-15 2019-10-08 Vactronix Scientific, Llc Stents having a hybrid pattern and methods of manufacture
US9566633B2 (en) * 2012-11-15 2017-02-14 Vactronix Scientific, Inc. Stents having a hybrid pattern and methods of manufacture
US11701246B2 (en) 2012-11-15 2023-07-18 Vactronix Scientific, Llc. Stents having a hybrid pattern and methods of manufacture
US20140135888A1 (en) * 2012-11-15 2014-05-15 Palmaz Scientific, Inc. Stents having a hybrid pattern and methods of manufacture
USD887003S1 (en) 2012-11-15 2020-06-09 Vactronix Scientific, Llc Hybrid patterned stent device
US10835400B2 (en) 2013-03-01 2020-11-17 The Regents Of The University Of California Apparatus and methods for bidirectional hyperelastic stent covers
US10085862B2 (en) * 2013-03-01 2018-10-02 The Regents Of The University Of California Apparatus and methods for bidirectional hyperelastic stent covers
US20150366686A1 (en) * 2013-03-01 2015-12-24 The Regents Of The University Of California Apparatus and methods for bidirectional hyperelastic stent covers
US9408732B2 (en) 2013-03-14 2016-08-09 Reva Medical, Inc. Reduced-profile slide and lock stent
US20150005870A1 (en) * 2013-03-15 2015-01-01 W. L. Gore & Associates, Inc. Self-expanding, balloon expandable stent-grafts
US10905539B2 (en) * 2013-03-15 2021-02-02 W. L. Gore & Associates, Inc. Self-expanding, balloon expandable stent-grafts
US9907684B2 (en) 2013-05-08 2018-03-06 Aneuclose Llc Method of radially-asymmetric stent expansion
US11738181B2 (en) 2014-06-04 2023-08-29 Cagent Vascular, Inc. Cage for medical balloon
US9381103B2 (en) * 2014-10-06 2016-07-05 Abbott Cardiovascular Systems Inc. Stent with elongating struts
US10471238B2 (en) 2014-11-03 2019-11-12 Cagent Vascular, Llc Serration balloon
US11298513B2 (en) 2014-11-03 2022-04-12 Cagent Vascular, Inc. Serration balloon
US11701502B2 (en) 2014-11-03 2023-07-18 Cagent Vascular, Inc. Serration balloon
US11040178B2 (en) 2014-11-03 2021-06-22 Cagent Vascular, Llc Serration balloon
US11304836B2 (en) 2015-01-29 2022-04-19 Intact Vascular, Inc. Delivery device and method of delivery
US9602786B2 (en) 2015-01-29 2017-03-21 Intact Vascular, Inc. Delivery device and method of delivery
US10610392B2 (en) 2015-01-29 2020-04-07 Intact Vascular, Inc. Delivery device and method of delivery
US9433520B2 (en) 2015-01-29 2016-09-06 Intact Vascular, Inc. Delivery device and method of delivery
US9375336B1 (en) 2015-01-29 2016-06-28 Intact Vascular, Inc. Delivery device and method of delivery
US10898356B2 (en) 2015-01-29 2021-01-26 Intact Vascular, Inc. Delivery device and method of delivery
US9585782B2 (en) 2015-01-29 2017-03-07 Intact Vascular, Inc. Delivery device and method of delivery
US9375337B1 (en) 2015-01-29 2016-06-28 Intact Vascular, Inc. Delivery device and method of delivery
US9345603B1 (en) 2015-01-29 2016-05-24 Intact Vascular, Inc. Delivery device and method of delivery
US9320632B1 (en) 2015-01-29 2016-04-26 Intact Vascular, Inc. Delivery device and method of delivery
US9445929B2 (en) 2015-01-29 2016-09-20 Intact Vascular, Inc. Delivery device and method of delivery
US9584777B2 (en) 2015-01-29 2017-02-28 Intact Vascular, Inc. Delivery device and method of delivery
US10245167B2 (en) 2015-01-29 2019-04-02 Intact Vascular, Inc. Delivery device and method of delivery
US9456914B2 (en) 2015-01-29 2016-10-04 Intact Vascular, Inc. Delivery device and method of delivery
US9192500B1 (en) 2015-01-29 2015-11-24 Intact Vascular, Inc. Delivery device and method of delivery
US20180042740A1 (en) * 2015-03-03 2018-02-15 Efemoral Medical Llc Multi-element bioresorbable intravascular stent
US10660772B2 (en) * 2015-03-03 2020-05-26 Efemoral Medical Llc Multi-element bioresorbable intravascular stent
US10166374B2 (en) 2015-09-17 2019-01-01 Cagent Vascular, Llc Wedge dissectors for a medical balloon
US11717654B2 (en) 2015-09-17 2023-08-08 Cagent Vascular, Inc. Wedge dissectors for a medical balloon
US11266818B2 (en) 2015-09-17 2022-03-08 Cagent Vascular, Inc. Wedge dissectors for a medical balloon
US11491314B2 (en) 2015-09-17 2022-11-08 Cagent Vascular Lac. Wedge dissectors for a medical balloon
US10689154B2 (en) 2015-09-17 2020-06-23 Cagent Vascular, Llc Wedge dissectors for a medical balloon
US11266819B2 (en) 2015-09-17 2022-03-08 Cagent Vascular, Inc. Wedge dissectors for a medical balloon
US10993824B2 (en) 2016-01-01 2021-05-04 Intact Vascular, Inc. Delivery device and method of delivery
US11622872B2 (en) * 2016-05-16 2023-04-11 Elixir Medical Corporation Uncaging stent
US10231856B2 (en) 2016-10-27 2019-03-19 Cook Medical Technologies Llc Stent with segments capable of uncoupling during expansion
US10905863B2 (en) 2016-11-16 2021-02-02 Cagent Vascular, Llc Systems and methods of depositing drug into tissue through serrations
US11660218B2 (en) 2017-07-26 2023-05-30 Intact Vascular, Inc. Delivery device and method of delivery
US10832753B2 (en) 2017-07-31 2020-11-10 General Electric Company Components including structures having decoupled load paths
EP3437865A1 (en) * 2017-07-31 2019-02-06 General Electric Company Components including structures having decoupled load paths
WO2019045695A1 (en) * 2017-08-29 2019-03-07 C.R. Bard, Inc. Reconfigurable stent, and systems and methods for use thereof
US11369779B2 (en) 2018-07-25 2022-06-28 Cagent Vascular, Inc. Medical balloon catheters with enhanced pushability
CN113088759A (en) * 2021-04-14 2021-07-09 中国矿业大学 Low-modulus nontoxic harmless biomedical beta-type titanium alloy and preparation method thereof

Also Published As

Publication number Publication date
US8282680B2 (en) 2012-10-09
US8740968B2 (en) 2014-06-03
US20080208318A1 (en) 2008-08-28
US20130060321A1 (en) 2013-03-07
US20080208311A1 (en) 2008-08-28
US20090264979A1 (en) 2009-10-22

Similar Documents

Publication Publication Date Title
US8740968B2 (en) Multiple independent nested stent structures and methods for their preparation and deployment
US6520987B1 (en) Expandable intravascular stent
US7959669B2 (en) Bifurcated stent with open ended side branch support
CA2598164C (en) Expandable medical device with differential hinge performance
EP2231079B1 (en) Stent
EP1933761B1 (en) Inflatable bifurcation stent
EP1940315B1 (en) Stent with expanding side branch geometry
EP2658485B1 (en) Stent
EP2063809B1 (en) Stent having end section with constant strut lengths, transitional section and middle section with variable strut lengths
JP2009507558A (en) Overlapping stent
EP2841024B1 (en) Support for treating vascular bifurcations
EP2642946B1 (en) Support for treating vascular bifurcations
CA2630913A1 (en) Improved connectors for bifurcated stent
US20070208414A1 (en) Tapered strength rings on a bifurcated stent petal
EP2088963B1 (en) Bifurcation stent design with over expansion capability
EP1827303B1 (en) Vulnerable plaque stent
EP2081521B1 (en) Self-expanding side branch bifurcated stent
US20230131129A1 (en) Stent

Legal Events

Date Code Title Description
AS Assignment

Owner name: XTENT, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KAO, STEPHEN;REEL/FRAME:015387/0611

Effective date: 20040521

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION